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ABSTRACT
TEST OF A MULTIDISCIPLINARY HEALTH BEHAVIOR MODEL OF
MEDICARE ELDERS' ANTIHYPERTENSIVE ACQUISITIONS
Ann Marie Kopitzke
Old Dominion University, 2009
Chair: Dr. Karen Karlowicz

This study examined the relative utility of the enhanced Health Belief Model as
compared to the proposed Pharmaceutical Acquisition Model for Medicare Elders
(PAMME) in describing antihypertensive acquisition with usage intentions for Medicare
elders (65 years or older) in Southeastern Virginia. Data collection included record reviews
to identify hypertensive Medicare elders. Consenting Medicare elders were randomly
selected for invitation, with consenting Medicare elders contacted by telephone or inperson interviews. The survey instrument utilized open and closed ended questions. The
target population for this study is Southeastern Virginia Medicare elders enrolled in a Part
D plan and prescribed at least one antihypertensive. This study employed a quasiexperimental, retrospective, mixed methods design. A combination of primary and
secondary data was obtained through telephone, face-to-face interviews and administrative
record review. This study retrospectively examined antihypertensive acquisition
experiences of Southeastern Virginia's Medicare elders, to explore how the Medicare
Modernization Act of 2003 affected out-of-pocket costs and antihypertensive acquisitions.
Analyses employed aggregate-based information to test the research hypotheses. Statistical
analysis was conducted with SPSS Version 16. The majority (94 percent) of Medicare
elders were able to legally acquire their antihypertensives. When comparing the enhanced

Health Belief Model (HBM) with the Pharmaceutical Acquisition Model for Medicare
Elderly (PAMME) the HBM has 95.5 while 96.2 indicating slightly increased prediction
with the added constructs of Medication Adherence and Consumer Choice Theory. This
study confirms other research findings regarding Medicare elders' beliefs about generics
with the majority (71.6 percent) who believe that the generic works just as well as the
name brand. The complexity of antihypertensive acquisition decisions and beliefs about
hypertension continue to provide a challenge for researchers. While this study has
furthered our understanding of what factors influence legal antihypertensive acquisitions,
much research remains to be conducted to fully comprehend the multidimensional
constructs of hypertension and antihypertensives.
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Chapter I
INTRODUCTION
This study sought to understand antihypertensive acquisition behaviors' of
Medicare elders to determine which factors most influence acquisition decisions in the
context of the enhanced Health Belief Model (HBM). The effective treatment of disease
and illness depends upon patients actually adhering to prescribed treatment regimens (Ead,
1998) and begins with acquiring antihypertensives to treat hypertension (American Heart
Association, 2007). Special emphasis is placed on the acquisition of prescribed
antihypertensives, as approximately two-thirds of Medicare elders over 65 years of age and
approximately 76% of those 75 years of age and older are affected by hypertension
(American Heart Association, 2007; Centers for Disease Control and Prevention, 2005;
White, 2002). The ability to acquire antihypertensives is essential for reducing health
disparities for aging populations increasingly afflicted with hypertension and other health
complications (Centers for Disease Control and Prevention, 2007).
This study specifically examined those factors, which might influence legal methods
of acquisition for antihypertensives to include: (a) doctor prescribed and purchased, (b)
obtained through physician-supplied samples, (c) prescription drug plan mail order
(Centers for Medicare and Medicaid Services, 2005).
When acquired and taken as prescribed, antihypertensives have the ability to reduce
hypertension related morbidity and mortality (Benson & Britten, 2002). Often Medicare
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Acquistion behaviors are defined as any method utilized to acquire antihypertensives
through legally approved methods.

2

elders under-use (Voelker, 2004) and may not acquire all needed prescription drugs2,
including those for hypertension (Robeznicks, 2004). While treatable, under-use of
antihypertensives adversely affects morbidity and mortality rates (American Heart
Association, 2007) and under-treated or untreated hypertension has the potential to
adversely affect cognitive, cardiovascular, renal and other functions (Blustein, 2000;
Rosendorff et al., 2007) and accounts for approximately 1.2 million hospitalizations
annually (Middleton, Hing & Xu, 2007).
Since Medicare Modernization Acts' (MMAs) full implementation on January 1,
2006, approximately 22 million Medicare elders have enrolled in Part D plans (both standalone prescription drug plans and Medicare Advantage plans with and without
prescriptions) which provides a prescription drug benefit to Medicare elders previously
lacking coverage (Henry J. Kaiser Family Foundation, 2008). The Medicare Modernization
Act of 2003 (MMA) was implemented to increase access to affordable prescription drugs
for Medicare beneficiaries by reducing out-of-pocket costs, but little has been done to
examine the extent to which the policy has actually increased prescription drug acquisition,
specifically for antihypertensives (Henry J. Kaiser Family Foundation, 2006; Neff, 2004;
O'Brien, 2003).
Proposed methods for understanding antihypertensive acquisition include the
development of a model that builds upon the enhanced Health Belief Model (HBM). This
study tested an enhanced version of the HBM (Bandura, 1986; Rosenstock, Strecher, &
Becker, 1988;) to determine if it accurately identifies factors that influence acquisition

-Drugs were use in place of medications or antihypertensives when interacting with
Medicare elders regarding their prescription drug plans and drug behaviors.

3

behaviors for antihypertensives of Medicare elders better than the proposed
Pharmaceutical Acquisition Model for Medicare Elders (PAMME). The enhanced HBM
was augmented with select components of the Medication Adherence Model (MAM)
(Johnson, 2002) to explore usage (adherence) decisions and with constructs from the
Consumer Choice Theory (Friedman, 1990) to assess the influence of price on
antihypertensive acquisition behavior. The proposed model that was tested is named the
Pharmaceutical Acquisition Model for Medicare Elders (PAMME).
Background
Demographics of the Elderly Population
Increasing Elderly Population
The increase in the number of elderly contributes to markedly higher incidence of
treatable chronic disease and illness (American Heart Association, 2007b). An examination
of factors that enable Medicare elders to acquire prescriptions, especially
antihypertensives, is important as the number of elderly in the United States is expanding
rapidly, with approximately 37 million elders residing in the U.S. in 2005 (U.S. Census
Bureau, 2005) and approximately 39 million in 2006 (Henry J. Kaiser Family Foundation,
2006). The projections for 2010 estimate that more than approximately 40 million people
in the United States population will be older than 65 years of age, with more than
approximately 6 million older than age 85 (U.S. Census Bureau, 2005). The first cohort of
Baby Boomers will reach 65 by 2011, which will expand the elderly population to
approximately 20% of the U.S. population (U.S. Census Bureau, 2005). By 2040, these
Figures are expected to nearly double (U.S. Department of Health and Human Services,
2004). One of the fastest growing segments of U.S. society are those aged 85 years of age
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and older; which accounts for approximately 9% of Medicare elders (U.S. Department of
Health and Human Services, 2004). In Virginia, those Medicare elders 85 years of age and
older are expected to increase five times faster than the state's total population (Virginia
Department for the Aging, 2006).
Gender
Historically, elderly women were disproportionately represented in Medicare
populations due to longevity (U.S. Census Bureau, 2005). While on average men's life
expectancy has increased to approximately 75 years of age, women's average life
expectancy is approximately 86 years of age (U.S. Census Bureau, 2006). According to
the U.S. Census Bureau (2006), the majority (67%) of Medicare elders older than 65 years
of age are women. However, men and women have comparable levels of hypertension
(approximately 27%) of those adults living with chronic disease or illness (Centers for
Disease Control and Prevention, 2007). Additionally, more women than men experience
incidences of uncontrolled hypertension (Reinberg, 2008). However, the gap between
elderly men and women is expected to narrow by 2025 with 18% more men reaching
advanced ages (U.S. Census Bureau, 2006).
Ethnicity and Health Disparities
Ethnicity for the approximately 300 million people in the United States varies
slightly from the state of Virginia's 8 million people (U.S, Census Bureau, 2008).
According to the U.S. Census Bureau (2008), the U.S. is comprised of approximately 80%
white, 13% black, 1% American Indian and Alaskan Native, 15% Hispanic, and 4% Asian
whereas Virginia has approximately 73% white, 20% black, less than 1% American Indian
and Alaskan Native, 6% Hispanic, and nearly 5% Asian. Ethnicity is an important
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consideration as black, Hispanic and others are increasingly identified with hypertension as
health care disparities continue to be addressed (U.S. Census Bureau, 2006). Research
indicates that hypertension disproportionately affects blacks (57%) and other minorities
(16%) who increasingly present with blood pressure levels well above acceptable levels
(Reed, Hargraves, & Cassil, 2003). Additionally, treatment of hypertension in non-whites
has been and continues to be inadequately addressed in the health-care setting (Clinical
Drug Investigation, 2000; James, Thomas, Lillie-Blanton, & Garfield, 2007).
Education and Health Literacy Status
Education attained and literacy level influences the ability to comprehend complex
health care directives (Wilson, Schoen, & Neuman, 2007). Health literacy may be a serious
concern in this population. In a study by Prudential Center for Health Care Research,
researchers recently found that 34% of English-speaking and 54% of Spanish-speaking
respondents in their study of elders more than 65 years of age lacked health literacy
(Gazmararian et al., 2008).
Currently, 23% of elders have less than a high school education while one-quarter
have completed a minimum of high school education and 47% have completed some
college and advanced degrees (Centers for Disease Control and Prevention, 2007).
Income and Poverty Status
More than one-third of elders are considered low income (Centers for Medicare
and Medicaid Services, 2006). Affordability issues for prescription drugs that improve lives
or prevent disease have become critical due to 36% of those aged 65 years or more and
58% of those aged 85 or greater are living in poverty (Moran & Simon, 2005; U.S.
Department of Health and Human Services, 2004). Low-income Medicare elders often
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lack the income or resources necessary to prevent or treat chronic disease and illness,
including hypertension (Piette, Heisler, & Wagner, 2004). The prevalence of multiple
chronic illnesses is greater for low-income Medicare elders than for those who are more
affluent (Federman, Halm, Zhu, Hochman, & Siu, 2006). In addition, the ability to acquire
supplemental health insurance is affected by income status (Stuart, Simoni-Wastila, &
Chauncey, 2005)
Poverty status also affects access to health care by making it less affordable (U.S.
Department of Health and Human Services, 2004). The gap between access to prescription
drugs for low-income elderly and those more affluent elders is a specific area of concern
(World Health Organization, 2002). Additionally, women and minorities have
disproportionately higher incidences of poverty (Agnew, Halprin, & Lipton, 2003; Moran
& Simon, 2005). However, Medicare elders below 150% of the federal income poverty
level are eligible for both Medicaid and Medicare and are considered Dual Eligible
(Centers for Medicare and Medicaid Services, 2006; U.S. Government Accounting Office,
2007). Medicaid provides an income supplement that includes food stamps, payment of
Medicare Part B and automatic qualification for Extra Help. Extra Help pays Medicare
Part D premiums, eliminates the deductible, and lowers co-pays at the drug store (Centers
for Medicare and Medicaid Services, 2006; U.S. Government Accounting Office, 2007).
Chronic Health Conditions
The proper medical management of almost all chronic illnesses requires the
ongoing use of prescription drugs (Brewer, Chapman, Brownlee, & Leventhal, 2002; Ead,
1998; Loeb, Penrod, Falkenstern, Gueldner, & Poon, 2003; McCloskey, 2002; Sherer,
2003; Stuart, 2004). Approximately 80% of all elderly have at least one chronic health
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condition, with approximately 50% having two or more (U.S. Census Bureau, 2005) with
approximately 36% of elderly Medicare elders having three or more chronic conditions to
manage (Agency for Healthcare Research and Quality, 2002; Henry J. Kaiser Family
Foundation, 2007b). With chronic illness comes the need for affordable prescriptions to
treat or prevent adverse health events (Benson & Britten, 2002; Weschler, 2004; Wilson,
Schoen, & Neuman, 2007). Through consistent, affordable prescription drug acquisition
and usage, the possibility of a better quality of life may be attained through reductions in
preventable morbidity and mortality (Soumerai et al., 2006; U.S. Department of Health
and Human Services, 2004).
Underuse Decisions: Intentional or Unintentional
Prescription drug underuse may be either intentional or unintentional (Cooper,
Love, & Raffoul, 1982; Corrigan, 2002; Lehan & McCarthy, 2006). The choice to
underuse prescription drugs may stem from beliefs about effectiveness or safety (Vik,
Maxwell, Hogan, Patten, Johnson, & Romonko-Slack, 2005) of the prescription drugs as
well as unpleasant side effects (George et al., 2006). Intentional underuse may reflect
acquisition decisions by marked decreases in the need to refill prescriptions (Vik et al.,
2005). Intentional acquisition or underuse of necessary prescription drugs may also be
influenced by perceived needs for various prescription drugs (Benson & Britten, 2002;
Cooper, Love, & Raffoul, 1982; George, Munro, McCaig, & Stewart, 2006). Conversely,
research also indicates that multiple dosing and multipharmacology often contribute to
unintentional adherence problems due to the number of pills, busy schedules and
remembering (Haynes, McDonald, & Garg, 2002; Kirking, Lee, Ellis, Briesacher, &
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McKercher, 2006; Lehan & McCarthy, 2004). However underuse occurs it, is necessary to
understand the potential influence that may be exerted on acquisition decisions and healthseeking behaviors (Yagoda, 2004).
Cost Considerations
Rising prescription drug prices affect both overall healthcare expenditures and
perceived affordability of prescription drugs, especially for low-income Medicare elderly
(Families USA, 2003,2006). Rising prescription drug prices adversely affect Medicare
elders due to higher co-pays and higher out-of-pocket expenditures, especially when
coverage gaps occur (Centers for Medicare and Medicaid Services, 2006; Crystal,
Johnson, Harman, et al., 2000; Families USA, 2004; Klein, Turvey, & Wallace, 2004;
Stuart, Simon-Wastila, & Chauncey, 2005). As of 2004, prescription drug costs accounted
for more than 10% of Medicare elders' incomes and constituted 56% of Medicare elders'
health-care costs, with average out-of-pocket costs approximately $2,500 per year
(Gregory, 2004; Sloane, 2004; U.S. Department of Health and Human Services, 2005).
While approximately 9% of elderly had no prescription drug costs, 91% of Medicare elders
filled an average of 30 prescriptions annually (U.S. Department of Health and Human
Services, 2004). Medicare elders with incomes of $10,001-$20,000 had the lowest average
with coverage (73%) due to Medicaid eligibility (U.S. Department of Health and Human
Services, 2004).
Cost is a significant barrier to acquiring necessary drugs for the elderly (Ganguli,
2003; James et al., 2007; LeBuono, 2004; Vik, Hogan, Patten, Johnson, Romonko-Slack,
& Maxwell, 2006). For those with chronic health conditions, 18% of U.S. adults indicated
that cost-related drug underuse occurs at least once per year (Piette, Heisler, & Wagner,
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2004). Additionally, those elderly with high out-of-pocket expenses of $ 100 or more and
annual incomes of less than $20,000 were more likely to have cost-related underuse
(Piette, Heisler, & Wagner, 2004; Stuart & Briesacher, 2002). Ethnicity also affects costrelated usage with approximately 17% of black Medicare elders reporting prescription
drug underuse due to affordabiliry concerns as compared to 9% of whites (Gaskin,
Briesacher, Limeangeo, & Brigantti, 2006; Reed, Hargraves, & Cassil, 2003).
Preventable Cost and Health Consequences of
Prescription Drug Non-use and Underuse
In order for prescription drugs to provide beneficial outcomes (reducing morbidity
and mortality), prescribed guidelines must be followed (Williams, 2002). When
prescription drugs are not taken as prescribed the therapeutic benefits or prevention efforts
are less than optimal (American Medical Association, 2002; Gottlieb, 2000; Mojatabai &
Olfson, 2003). The implications for underuse or improper usage of prescription drugs have
been linked to increases in emergency department visits (Lu et al., 2006; Piette, 2005;
Prendergast, Marquez, Jr., Schilichting, & Figuroa-Pal, 2007) and doctor visits (Piette,
Heisler, & Wagner, 2004). The costs of preventable readmissions attributable to underuse
of prescription drugs range from approximately $1.4 billion to more than $374 billion, with
increases of approximately 19% each year (Friedman & Basu, 2004). Research studies that
track patient readmissions indicate that inappropriate prescription drug usage accounts for
approximately 14 to 20% of emergency department visits and accounts for approximately
35% of doctor visits annually (Budnitz, Shehab, Kegler, & Richards, 2007; Wofford,
Schwartz, Timerding, Folmar, Ellis, & Messick, 1996). However, overall, adherence to
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prescription drugs ranges from 17 to 70% depending upon type of medication and disease
state (National Institutes of Health, 2003).
Hypertension
Hypertension (see Table 1) is defined as having persistent blood pressure levels
above 140/90 (American Heart Association, 2007b). Current recommendations are to
begin treatment in the pre-hypertension stage to prevent adverse consequences of damage
that occurs at higher blood pressure levels (National Health Lung and Blood Institute,
2006). Therefore, the need for antihypertensives that treats as well as prevents adverse

Table 1
Hypertension Levels
Adult Blood Pressure Levels
Category

Systolic (mmHg)

Diastolic (mmHg)

(Top Number)

(Bottom Number)

Result

Normal

Less than 120

Less than 80

Good

Pre-hypertension

120-139

80-89

May lead to
Hypertension

Hypertension
Stage 1

140-159

90-99

Need Rx to Control

Stage 2

160 or higher

100 or higher

May need
additional Rx

Note. From data acquired from the National Heart Lung and Blood Institute, 2006 and the
U.S. Department of Health and Human Services, 2003.
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complications of hypertension is expected to continue to be a concern for the aging U.S.
population (American Heart Association, 2007b; Chobanian, 2007; Ma, Lee, & Stafford,
2006).
Complications
In 2004, cardiovascular disease accounted for approximately 22% of deaths
(Minino, Heron, & Smith, 2006). Antihypertensives, when taken as prescribed, have the
potential to prevent stroke and other cardiovascular complications (Andrawes, Bussy, &
Belmin, 2006). However, left untreated, hypertension poses increased risk for heart disease
and stroke (Centers for Disease Control and Prevention, 2005; Pinto, 2007).
Antihypertensive underuse significantly influences preventable complications for
hypertension and contributes to premature morbidity (American Heart Association, 2007b;
Ryan, 1991).
Antihypertensives
Hypertension Treatment
This study focused upon the acquisition of antihypertensives that have been shown
to reduce hypertension and prevent further disease related complications (Centers for
Disease Control and Prevention, February 2007a). The ability to treat and prevent adverse
health outcomes depends upon continuous prescription drug acquisition and usage of
antihypertensives to reduce preventable hypertension related morbidity and mortality
(Field, Gilman, Subramanian, Fuller, Bates, & Gurwitz, 2005; Soumerai et al., 2006; U.S.
Department of Healm and Human Services, 2004). In addition to use of one or more
antihypertensives, hypertensive treatment also may include diet (Appel, Brands, Daniels,
Karanja, Elmer, & Sacks, 2006), and lifestyle modifications (Schwartz & Sheps, 2006).
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The classification of prescription drugs designated as antihypertensives and designed to
prevent or treat hypertension, includes five main categories: ACE inhibitors, ACE II
inhibitors, diuretics, beta-blockers, and calcium blockers (American Heart Association,
2007b). The purpose of each targets a specific area that influences management of
hypertension (high blood pressure) by regulating blood flow to increase heart efficiency
(American Heart Association, 2007b).
Current Use/Underuse ofAntihypertensives
Antihypertensives are prescribed for more than half of Medicare elders; with lowlevel diuretics often used as the first line of treatment (Al Khaja, Sequeira, & Mather,
2000; Nickolaus & Becker, 2000). After initial diagnosis, additional antihypertensives may
be added to treat hypertension and prevent further complications related to the protection
of the heart, liver, brain, eyes, and blood vessels (National Heart Lung and Blood Institute,
2006). Initially, adherence for antihypertensives is high (approximately 87%) for the first
few months after diagnosis, with sharp declines in usage within 6 months of diagnosis
(American Heart Association, 2007b; Raehl, Bond, Woods, Petry, & Sleeper, 2006).
Antihypertensive Costs
The cost of antihypertensives have been rising approximately 19% annually while
Medicare elders' incomes have remained relativelyfixed(Blustein, 2000). Prescription
drug costs are often indicated as reasons for underuse (Piette, Wagner, Potter, &
Schillinger, 2004). Patients often indicate that prescription drug costs play an important
role in underuse, which contributes to preventable readmissions (Fischer & Avorn, 2003;
Lynch, 2006). Hypertensive Medicare elders, without prior prescription drug coverage,
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faced immense difficulty in acquiring their antihypertensives due to cost considerations and
were at greater risk for increased morbidity and mortality (RAND, 1999).
Antihypertensive Prescription Drug Prices
Table 2 provides examples of commonly prescribed antihypertensives (name brand
and generic equivalent) using 2005 average costs (U.S Government Accounting Office,
2005).

Table 2
Antihypertensive Prescription Drugs
Antihypertensives
ACE inhibitors

Diuretics
Beta-blockers

Calcium Channel
Blockers

Name Brand

Generic

Average Monthly Cost

Lotesin

Benazepril

$43

Vasotec

Enalapril

$39

Accupril

Quinapril

$51

Lasix

Furosemide

$38

Lopressor

Metoprolol Tartrate

$35

Corgard

Nadolol

$59

Inderal

Propranolol

$44

Toprol XL

Metoprolol Succinate

$32

Norvasc

Amlodipine

$55

Cardizem CD

Diltiazem

$58

Procardia XL

Nifedipine

$94

Calan SR

Verapamil

$66

Note. Adapted from Consumer Reports, 2005.
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Pre-Medicare Modernization Act (MMA)
Prior to the passage of the Medicare Modernization Act of 2003 (MMA),
Medicare elders without prescription drug coverage had affordability issues due to the lack
of coverage (Agnew, Halpin, & Lipton, 2003). The main consideration was cost due to the
rapid increases in prescription drug prices (Centers for Medicare and Medicaid Services,
2005c). In 2000, prescription drug costs on average amounted to approximately $1,340
per elderly person with 17% having costs of $2,000 or more (U.S.. Department of Health
and Human Services, 2004). In 2001, prescription drugs were 11% of health care costs
and approximately 5% of elderly reported delays in health care needs due to cost
considerations (U.S. Department of Health and Human Services, 2004).
Overall out-of-pocket expenditures for prescription drugs accounted for
approximately 56% of health care service spending for elderly Americans for 2000-2001
(U.S. Department of Health and Human Services, 2004). Medicare elders without prior
prescription drug coverage often had to choose between prescriptions or other basic
support needs such as food or utilities (Conway-Welch, 2000; Crystal, Johnson, Harman et
al., 2000; Poisal & Chulis, 2000; Sarver, Sudano, & Baker, 2000). In 2002, nearly one-half
(48%) of those aged 65 and older took three or more prescriptions monthly, spending
approximately $3 billion annually on prescription drugs (Williams, 2002). The high out-ofpocket costs were especially difficult for one-third of Medicare elders, who, without prior
prescription drug coverage, paid 45% of the cost of prescriptions (Meyer, 2002). In 2004,
out-of-pocket expenses were approximately 42% with 35% covered by private insurance
and public programs covering 23% of prescription drug costs (U.S. Department of Health
and Human Services, 2004).
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The goal to provide community-based health education and outreach for basic
health services to underserved populations is highlighted by Healthy People 2010 (U.S.
Department of Health and Human Services, 2000). The Medicare Modernization Act
(MMA) prescription drug benefit was designed to address this goal by increasing access to
affordable prescription drugs for the more than 44 million U.S. Medicare elders through
education and outreach efforts (Agnew, Halpin, & Lipton, 2003; World Health
Organization, 2002) to include approximately 947,000 Virginians (Virginia Department for
the Aging, 2005). Current research indicates that despite MMA's best efforts to increase
access to affordable prescription drugs for Medicare elders, cost related problems remain
(Bowman, 2007; Hsu, Fung, Price, Huang, Brand et al., 2008). Additionally, since the
MMA of 2003 was implemented to increase access to affordable prescription drugs by
reducing out-of-pocket costs (Henry J. Kaiser Family Foundation, 2006; Neff, 2004;
O'Brien, 2003) little has been done to examine the extent to which the policy has actually
increased prescription acquisitions, specifically for antihypertensives.
Highlights of Medicare Modernization Policy
Medicare Modernization Act Implementation
The Medicare Modernization Act of 2003 (MMA) was implemented in several
stages and open enrollments periods differ depending upon Part D product (Centers for
Medicare and Medicaid Services, 2007). The full-scale implementation of the MMA began
January 1, 2006, following an initial, voluntary two-year (FY2004 and FY 2005) Medicare
Approved Drug Discount card with an annual credit (up to $600) qualifying, low-income
Medicare enrollees (Centers for Medicare and Medicaid Services, 2005c).
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Timeline
Older Americans Act (OOA) of 1965 - Excluded Prescription Drug Coverage
Legislation to amend OAA to include prescription drugs passes December 8,2003
Transitional Program (Medicare Approved Drug Discount Card [MDC]) FY 2004 FY 2005
Part D Implementation - Fully implemented January 1,2006
Open Enrollment completed December 31,2006, for Prescription Drug Plans (PDPs)
Open Enrollment completed March 15,2007, for Medicare Advantage Plans (MA &
MA-PDs)
Open Enrollment completed December 31,2007, for Prescription Drug Plans (PDPs)
Open Enrollment completed March 31,2008, for Medicare Advantage Plans (MA &
MA-PDs)
The MMA of 2003 was enacted to reduce disparities due to prescription drug affordability
(Matthews, 2004). The MMA expanded Medicare to provide a prescription drug benefit
previously lacking in the original Older Americans Act of 1965 and subsequent revisions
(Centers for Medicare and Medicaid Services, 2005c; Klein, 2003; Swartz, 2003; Weeks,
2004).
Medicare Modernization Act: Voluntary Options (FY 2004 - FY 2005)
Medicare Approved Drug Discount Card Program
The two-year voluntary Medicare Approved Drug Discount Card program (MDC)
in FY 2004 - FY 2005 was a transitional program, which provided 40% discounts and
monetary credits (up to $1,200) for qualifying low-income Medicare elders (Centers for
Medicare and Medicaid Services, 2005a; U.S. Department of Health and Human Services,
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2004). Monetary credit approval was determined by annual gross income and excluded
assets (Centers for Medicare and Medicaid Services, 2005c). The MDC program's
intentions were to reduce prescription drug costs, especially for those previously without
prescription drug coverage (Centers for Medicare and Medicaid Services, 2005a). For FY
2004, Medicare elders had 28 nationwide and 19 regional Medicare Approved prescription
discount card (MDC) choices (Barlas, 2004). For FY 2005, Medicare elders in the state of
Virginia had 39 plans to choose from in making their enrollment decisions (Centers for
Medicare and Medicaid Services, 2005a). Medicare elders who enrolled in 2004 were able
to change cards in 2005, if the card selected did not meet their drug discount needs;
however, premiums varied by program enrollment, wraparound coverage and drug plan's
formularies that could be frequently changed or not used (Barlas, 2004). Approximately
187,000 Medicare elders in southeastern Virginia were screened for this benefit (Virginia
Department for the Aging, 2005).
Medicare Modernization Act: Part D Implementation (FY 2006- FY 2008)
Medicare Part D
The MDC program was phased out as of January 1,2006, when the Medicare
Modernization Act (MMA) became fully implemented (Centers for Medicare and Medicaid
Services, 2006). Since MMA's full implementation, 19 million Medicare elders have
enrolled in Part D plans (both stand-alone prescription drug plans and Medicare Advantage
plans with prescription coverage) thereby providing a prescription drug benefit to
Medicare elders previously lacking coverage (Centers for Medicare and Medicaid Services,
2005e). Additionally, as of 2006, only 8% of Medicare elders were without coverage, as
opposed to 33% in 2005 (Kaisernetwork.org, 2007). For FY 2006, the number of
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Medicare approved plans from which Virginia Medicare elders had to choose was 41. That
number increased to more than 51 for FY" 2007 and more than 53 for FY 2008 (Centers for
Medicare and Medicaid Services, 2008). Since MMA's full implementation in FY 2006,
open enrollment has been completed for FY 2007 and FY 2008 (Centers for Medicare and
Medicaid Services, 2008).
Medicare Advantage Plans
Medicare elders who decide to bundle Part A, B, and D benefits may choose a
Medicare Advantage plan (Centers for Medicare and Medicaid Services, 2005d). Medicare
Advantage plans were formerly called Part C or Medicare + Choice (Centers for Medicare
and Medicaid Services, 2005d). Medicare elders may choose to enroll in a Medicare
Advantage plan if they perceive them as providing the best benefit (maximum utility) since
these plans are expected to result in increased savings (Centers for Medicare and Medicaid
Services, 2006). Another possible reason for selecting a Medicare Advantage plan is that
the premium is paid by Medicare while the Medicare elders' health care provision is
managed by approved coverage providers (Centers for Medicare and Medicaid Services,
2005c). Medicare elders must continue to pay their Part B premium, with the exception
being those Medicare elders who also have Medicaid, which will pay their Part B premium
(Henry J. Kaiser Family Foundation, 2006). However, Medicare elders without Extra Help
who select Advantage plans may experience unexpected higher co-pays at both the
doctors' office and at the pharmacy (Hoadley, Thompson, Hargrave, Merrell, Cubanski, &
Neuman, 2007). For Dual Eligibles (with both Medicare and Medicaid) who automatically
qualify for the Extra Help benefit, Advantage plans have fixed co-pays for prescription
drugs and have no deductible or coverage gap (Elam, 2006).
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Complexity of the Part D Decision-making Processes
Creditable Coverage Status
Medicare elders' decision to participate in the Medicare Modernization Act
(MMA) implementation often depends upon creditable coverage3 status. Medicare elders
with creditable coverage are not required to participate in MMA. However, Medicare
elders without creditable coverage must enroll in a Medicare prescription drug discount
plan or pay a late enrollment penalty when they later decide to participate (Centers for
Medicare and Medicaid Services, 2005a).
Medicare elders with creditable coverage may choose to explore their MMA
options to determine if they may be able to reduce their current prescription drug costs by
selecting a cost-effective alternative (utility maximizing) to employer-based plans (Folland,
Goodman, & Stano, 2004). In addition, those with employer-based plans who are able to
isolate the prescription drug portion may elect to utilize MMA to reduce their out-ofpocket expenditures (Centers for Medicare and Medicaid Services, 2006). Lastly,
employees with creditable coverage who retire or turn 65 are increasingly losing coverage
when become eligible for Medicare (Henry J. Kaiser Family Foundation, 2007b).
Extra Help Decision-making Processes
Extra Help (i.e., Low-Income Subsidy [LIS]) approval status may influence Part D
enrollment decisions since Extra Help eliminates plan deductibles and premiums, and
subsidizes co-pays for qualifying Medicare beneficiaries (U.S. Government Accounting
Office, 2007). Medicare elders are screened for Extra Help eligibility, which has income
(150% of poverty level), and assets (less than $11,700) requirements (Elam, 2006).
^Creditable coverage is defined as previous insurance that is considered "as good or better"
than Medicare (Centers for Medicare and Medicaid Services, 2004).
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The three methods by which Medicare elders may apply for the Extra Help benefit
are as follows: (a) at Social Security Administration, (b) by mail, or (c) via an online
submission process (Centers for Medicare and Medicaid Services, 2005a). Medicare elders
who are denied Extra Help may appeal the decision with an independent qualifying agency
(Centers for Medicare and Medicaid Services, 2005a; U.S. Government Accounting
Office, 2007). Medicare elders who are ineligible or denied Extra Help may choose to
participate in an MMA benefit plan to avoid the late or non-enrollment penalty (Centers for
Medicare and Medicaid Services, 2005a). Since the full implementation of the MMA on
January 1,2006, there remain Medicare elders who are still unaware of Part D or Extra
Help (Henry J. Kaiser Family Foundation, 2007b). For this study, only Medicare elders
who are aware of Extra Help, have been screened for it, and who are currently enrolled in
an MMA plan will be included.
Part D Decision-making Processes
Part D Enrollment
Medicare elders without previous prescription drug coverage may utilize the
Medicare prescription drug discount plan finder through the Medicare website to narrow
the choices by deductible, co-payments, and annual expected out-of-pocket costs (Centers
for Medicare and Medicaid Services, 2005d). Medicare elders who perceive enrollment as
potentially beneficial in reducing their out-of-pocket costs for prescription drugs and know
that a non-enrollment penalty may be imposed will usually join a Part D plan (Henry J.
Kaiser Family Foundation, 2005).
Figure 1 illustrates the different choices involved in application and enrollment
decisions. Dual Eligible (both Medicare and Medicaid) automatically qualify for the Extra
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Help benefit and usually are automatically enrolled in a prescription drug discount plan.
For those eligible who apply, they may either be approved or denied. For those who are
denied, an appeals process is available. Based upon Extra Help status, they may choose to
either enroll or not enroll. Some Medicare elders are eligible but prefer not to apply for
Extra Help or to enroll in a Part D plan, despite their knowledge of a penalty.
The Part D enrollment decision-making process (see Figure 2) allows making
informed decisions regarding the selection of a best plan for a given coverage year

Extra Help (Low Income Subsidy "LIS") Status

Part D Status

Auto
Enrolled
Appeals Process
Apply

Appeal

vA

Approved

Eligible
Enroll
Denied

Ineligible

Do Not Apply

Not Enroll

Figure 1. Influence of Extra Help (Low-Income Disability or LIS) and Part D Enrollment
Decisions.
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(Centers for Medicare and Medicaid Services, 2005b). Medicare participation in MMA is
expected to result in savings of up to 40% for those Medicare elders who elect to enroll in
a prescription drug discount plan (Centers for Medicare and Medicaid Services, 2005a).
The plan finders utilize the generic costs where requested to estimate the annual
prescription drug costs. Medicare elders with Extra Help are able to save money by not
having a deductible, low co-pays, and Medicare paying Part D premiums. Medicare elders
with Dual Eligibility automatically qualify for Extra Help with Medicare paying Part D
premiums and Medicaid paying Part B premiums. Medicare elders without Extra Help are

Perceived
Benefits
Individual
Perceptions
Adhere to
treatment
Decrease Disease
Related
Complications

Perceived
Barriers
Late Enrollment
Penalty

Enrollment
Status

Health
Improved
Reduce Annual
Out-of-Pocket
costs for Rx

Number of Plan
Choices

Enroll in
PartD

Premiums
Co-pays
Coverage gaps
Rxnoton
Formulary
Extra Help
Approval

Figure 2. Part D Enrollment Decision-Making Process.

Do Not
Enroll in
PartD
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subject to periods when they are responsible for 100% of their prescription drug costs
versus Extra Help elders who never reach the gap.
The acquisition decision-making process may lead Medicare elders to participate in
the MMA prescription drug benefit depending upon their perceptions of the benefits and
the barriers that may ultimately influence their ability to acquire antihypertensives. MMA
decisions apply only to the current year and Medicare elders may rollover their Part D plan
(Centers for Medicare and Medicaid Services, 2006); however, Medicare encourages
Medicare beneficiaries to reevaluate plan choices each year as plan choices are updated
and health status may have changed (Centers for Medicare and Medicaid Services, 2005a).
Various Methods Utilized to Solve the MMA Benefit Dilemma
For those who do not qualify for the Extra Help benefit, the decision is the
verification that the prescription drug plan's formulary includes the drugs that are taken
with no or a low deductible and the monthly premium costs are affordable. For Medicare
elders who take no prescription drugs, they are advised to enroll in the plan with the least
expensive premiums to avoid a late enrollment penalty.
To illustrate the complexity of the MMA decision-making process the following
three representative scenarios highlight individualized approaches to addressing the
MMA's health care decisions. The first scenario explores Medicare Part D without Extra
Help. The second scenario describes Medicare Part D using a prescription drug discount
plan with Extra Help. Lastly, the third scenario discusses the decision to choose a
Medicare Advantage plan (previously called Medicare Part C) to solve the health care and
prescription drug dilemma. Each case has its own unique benefits and drawbacks.
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MMA Decision-making Process Scenario I: Medicare Part D without Extra Help
The MMA's prescription drug discount plan benefit process often starts with Mr.
Green (not his real name) receiving correspondence from the Centers for Medicare and
Medicaid Services (CMS) when he becomes eligible for Medicare (up to three montiis
before his 65th birthday). Initially, Mr. Green has seven months to select a MMA plan (three
months before, the month of, and three months after his 65* birthday) if he is not covered
by an equitable (creditable coverage) plan. Mr. Green's Welcome Package from the CMS
indicates that Medicare beneficiaries without creditable coverage (employer- or militarybased insurance plan) must enroll in the Medicare prescription drug benefit or be subject to
a late enrollment penalty (Centers for Medicare and Medicaid Services, 2005). Those who
must participate are directed to their local SSA or the website (www.ssa.gov) to apply for
their Medicare card and be screened for Extra Help (Medicare also provides their website
and toll-free number for further assistance. Often callers are referred to their local State
Health Insurance Programs [SHIPs] or Agency on Aging). Mr. Green learned that
Medicare elders who met the assets and income requirements for Extra Help might apply
to be screened through their local SSA office or SHIP office (Centers for Medicare and
Medicaid Services, 2006).
In addition, while Mr. Green had creditable coverage with his employer, his
benefits department informed him that he would lose this coverage when he turns 65 years
of age and encouraged him to choose a Medicare prescription drug discount plan. Mr.
Green is angry and disappointed to learn that he will have to find his own health plan that
includes a prescription drug plan. He is overwhelmed by the amount of correspondence
that he has been receiving from the CMS, the SSA and numerous Medicare approved and
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non-approved health insurance companies providing health coverage both with and
without prescription drugs. The information that Mr. Green received from CMS indicates
that there are 53 stand-alone prescription drug discount plans (PDPs), 21 Advantage (MAPD & MA only) as well as 2 Special Needs plans in southeastern Virginia (Centers for
Medicare and Medicaid Services, 2007).
Mr. Green started by calling CMS's 800 number and navigating through the
numerous prompts. The expected wait time for the next available representative was
approximately 25 minutes. A recording indicated that he cold hold, call back, or use the
Medicare website to receive assistance. After about 20 minutes, Mr. Green became tired of
waiting and called his brother, Mr. Lane (not his real name), who went through this
process last year. Mr. Green learned that Senior Services of Southeastern Virginia, the
local VICAP (Virginia Insurance Counseling Assistance Program) office, could assist by
simplifying the enrollment process and answering questions about his options. Mr. Green
brought the mailings that he received, his prescription drug bottles, and a copy of the
insurance information from his employer's group plan to his appointment. He hoped to get
similar coverage under the MMA that he had with his employer's group-based plan. Mr.
Green was screened for Extra Help, but did not qualify because his assets were more than
the limit (more than $11,750) and greater than the income (less than $12,675 for a single
person) to qualify for the benefit. Additionally, Mr. Green believed that he would get
approximately $30,000 annually (after taxes) and wanted a Medicare plan that minimized
his annual out-of-pocket expenses for health insurance and prescription drug costs.
Mr. Green had been taking three prescriptions each day that cost him
approximately $230 per month in co-pays. For 2007, Mr. Green selected a Medigap
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supplement and a stand-alone prescription drug discount plan (PDP) with approximately
$7,700 estimated annually to cover his health insurance expenses. Annually, Mr. Green has
estimated out-of-pocket expenses for prescription drugs were approximately $2,695
including premiums and co-pays. Mr. Green selected a PDP that did not have gap
coverage, so during five months his out-of-pocket expenses were expected to be
approximately $275. However, when he reached the coverage gap (donut hole) he found
he was paying $678 per month for the same three prescriptions. After Mr. Green
discovered how much more he would pay in the coverage gap, he stopped taking one of
his prescriptions and asked his doctor about free samples for another one. During open
enrollment (November 15 - December 31) for the next year Mr. Green considered
switching his PDP but did not want to go through the aggravation of selecting another
plan especially when gap coverage was not widely available for any of the plans.
Medicare Part D Decision-making Process Scenario 2: Medicare Part D and Extra Help
Ms. Smith (not her real name) wanted to retire and researched the possibility of
affording health insurance when she stopped working. She had worked for 25 years as a
night auditor for a well-known chain store. Her benefits were good, but her wages were
modest. She was unable to accumulate much retirement savings ($9,000) and would not
receive more than $1,025 monthly from her retirement and Social Security. Ms. Smith was
recently hospitalized. She takes seven prescription drugs that cost $90 in co-pays with her
employer-based health plan. Her health plan covered all her hospital expenses except
$2,000, for which she has arranged to make payments.
Ms. Smith contacted her local VICAP to discuss her retirement options. She
received information about discounted senior housing that can help her to reduce her living
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expenses. Ms. Smith also discovered that applying for Medicaid would pay her Part B
premium (upon approval) and that when she stopped working she would become eligible
for Medicaid. As a Dual Eligible (having both Medicare and Medicaid) Ms. Smith would
automatically qualify for Extra Help (i.e., Low-Income Subsidy) and automatically be
enrolled in a Medicare Part D plan.
Ms. Smith retired, was approved for Medicaid, and got her Medicare Part D plan.
However, Ms. Smith found that the plan that was randomly chosen for her did not cover
three of her prescription drugs. Ms. Smith contacted her local VICAP office and assisted
with selecting another plan whose formulary included the prescription drugs she was
currently taking. Since she qualified for Extra Help, Ms. Smith has no deductible, no
premium, and low co-pays (approximately $2.40 for generics and $5.00 for name brands)
for her prescription drugs. Ms. Smith is satisfied with her new plan and will keep it for the
upcoming year. Ms. Smith will re-evaluate her plan as her health care provider prescribes
new prescription drugs.
Medicare Decision-making Process Scenario 3: Medicare Advantage Plan
Mr. and Mrs. Brown (not their real names) live in a senior citizens' housing
complex where an insurance presentation was offered for the Medicare Modernization Act
(MMA) benefit. Pizza and drinks were served during the presentation and the Browns
were asked to sign-in to prove that they had attended the event. Mr. and Mrs. Brown got a
welcome package, approximately a week later, and learned that they had been enrolled in a
Medicare Advantage plan. They did not understand why they were placed into this plan,
but as there was no premium, they decided that they would keep the plan and see how it
worked. When Mrs. Brown went to the doctor two months later, she was informed that
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her doctor did not accept her Medicare Advantage plan and she would have to pay out-ofpocket for the visit.
As Mr. and Mrs. Brown are over the limit for Extra Help, they are not able to
change their plan except during their annual enrollment period. Mr. and Mrs. Brown's
previous health insurance had been employer-based with affordable monthly premiums and
co-pays. However, upon being enrolled in the Medicare Advantage plan, Mr. and Mrs.
Brown lost this coverage. While the Brown's appreciated not having to pay a premium, the
Advantage plan did not offer comparable coverage and they were forced to seek a doctor
who would accept their plan.
The couple contacted their local VICAP office to see what could be done to assist
them with getting their former coverage back. The Medication Education Counselor tried
to contact the agent who had given the presentation and a fraudulent enrollment complaint
was submitted to Medicare Complaints. Within a day, the assigned caseworker contacted
the Browns for a follow-up. Mr. and Mrs. Brown explained that they did not agree to have
their plan switched and they were never told that their doctor does not have to accept their
Medicare Advantage plan. The caseworker was willing to switch the them back to their
previous plan; however, the employer-based plan was not willing to do so. The caseworker
dis-enrolled them from the Advantage plan and placed them back into original Medicare.
The couple then discussed their options with the VICAP counselor who assisted
them with obtaining a stand-alone PDP and a Medigap supplement, which works with
original Medicare (Advantage plans do not). The Browns each selected a PDP based upon
their different prescription drugs, but were able to select the same Medigap supplement.
The Browns were happy that they could continue to see their same doctor and their overall

29

out-of-pocket health care expenses were less than before, even with having higher monthly
premiums. The Browns were satisfied with their choices. They were advised to re-evaluate
their plan choices annually to insure that they had the most affordable coverage given the
revised plans each year.
Out-of-Pocket Expenses
Out-of-pocket expenses influence acquisition abilities and include those items that
Medicare elders pay out-of-pocket to meet their healthcare needs (Centers for Medicare
and Medicaid Services, 2005a). Part D enrollment and Extra Help (Limited Income
Subsidy [LIS]) approval status may reduce out-of-pocket expenses possibly influencing
antihypertensive acquisition decisions. These out-of-pocket expenses include the
premiums, deductibles, and prescription drug co-pays as well as gap {donut hole) expenses
and may influence Medicare elders' decisions to enroll in a Part D plan that may ultimately
influence antihypertensive acquisitions.
Premiums
Part D premiums (see Table 3) vary by covered prescription drug and the amount
of gap coverage offered by each plan (Blum, Bowman, & White, 2005; Centers for
Medicare and Medicaid Services, 2006). The average monthly premium for PDPs rose by
approximately 17% as contrasted widi the Medicare Part B premium that experienced only
a 3.1% increase from 2006 to 2007 (Hoadley, Thompson, Hargrave, Merrell, Cubanski, &
Neuman, 2007). For 2008, the average monthly Part D premium is approximately $25 with
annual increases expected (Henry J. Kaiser Family Foundation, 2008). Part D premiums
may influence Medicare elders' decisions to enroll in a Part D plan and may affect their
ability to acquire antihypertensives.

30

Table 3
Part D Premiums, Deductibles, Co-pays, Gap ("Donut Hole "), and
Catastrophic Coverage Limits
Out of Pocket Expenditures

2006

2007

2008

Monthly Premiums (Range)

$8.81 - $56.50

$13.51-$92.30

$15.10-$64.80

$250

$265

$275

Vary by plan

Vary by plan

Vary by plan

$2,400

$2,510

$2,525

$5,451

$5,726

$5,754

Annual Deductibles
Co-pays (per Rx)
Annual Donut Hole ("Gap")
Annual Catastrophic
Coverage Limits

Note. Adapted from Medicare Prescription Drug Discount Plans, 2006,2007,2008.

Deductibles
The decision to acquire a plan with a deductible lowered the monthly premium
(Centers for Medicare and Medicaid Services, 2006). For those Medicare elders with LIS,
deductibles were not applicable (Centers for Medicare and Medicaid Services, 2007). The
deductibles (see Table 4) for Part D are subject to annual increases and vary by plan.
Currently, Part D plan deductibles range from $0 to $275 for 2008. In 2007, the deductible
ranged from $0 to $265 for those plans with a deductible and was slightly lower at $250
for 2006 (Henry J. Kaiser Family Foundation, 2006,2007a).
Gap or Donut Hole Coverage
Coverage in the gap or donut hole is offered on a plan-by-plan basis; coverage is
extremely limited (Centers for Medicare and Medicaid Services, 2006,2008; Wilensky,
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Table 4
Medication Education Database
Secondary Dataset Fields
Randomly
Assigned Number

Marital Status

• Emergency
I Contact Name

Last Contact Date

Spouse Name

Initial Contact Year

Home Address

j Emergency
| Contact Phone
•+
I Emergency
I Contact Type

Counselor

Home City

j Extra Help
. Apply Status

Type of Contact

Home State

| Extra Help
j Apply Date

Referred From

Ethnicity

Home Telephone

I Extra Help
I Application Status

Referred To

1

±__

I
Gender

Title

First Name

Alternative
Telephone

i

Part D Status
1
I Part D Date
I
1
Part D Plan Name

I

Birth Date & Age

r
Alternative Mailing
Plan Finder
Address
j
Alternative City

Insurance Status

Stimulus Package

1 Mental Health

I Plan Finder Date

_L
Middle Initial

Alternative State

Last Name

Alternative Zip Code Hypertensive Status

Health Status

I

New to Medicare

I
New to Area
E-mail Address
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2004). In FY 2006, coverage gaps occurred when Medicare elders reached out-of-pocket
costs of approximately $2,400 until catastrophic coverage began at $3,051 (with total outof-pocket expenditures of $5,451). In 2006, several plans offered gap coverage for both
name brand and generics. However, for FY 2007 only one plan provided full gap coverage
and discontinued that benefit for FY 2008. Often, plan providers have limited gap
coverage (generics only) with six companies offering that benefit. For 2008, once
Medicare members have paid more than $5,754 out-of-pocket costs, their co-pays will be
5% and Medicare will assume the other 95%. In die donut hole or coverage gap, Part D
premiums are collected even though prescription drug discounts are minimal (Centers for
Medicare and Medicaid Services, 2008).
Since the implementation of the Medicare Modernization Act (MMA), Medicare
elders unwilling to pay higher premiums for minimal gap coverage {donut hole) may
experience periods where they are responsible for 100% of prescription drug costs despite
having a prescription drug discount plan (Centers for Medicare and Medicaid Services,
2006; Families USA, 2006). While in the coverage gap, Medicare elders may eliminate
costly prescription drugs or reduce those perceived as nonessential without telling their
physicians (Wilson, Schoen, & Neuman, 2007). The implications for these benefit limits are
that Medicare elders are using fewer prescriptions with higher hospitalizations and
decreased clinical outcomes (Hsu et al., 2008).
Bridging the Coverage Gap or Donut Hole
The ability to obtain coverage in the donut hole or coverage gap is extremely
limited and currently applies to select generics (Centers for Medicare and Medicaid
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Services, 2008). Methods utilized to save money may include pharmaceutical assistance
programs covered by state funding (SPAPs), pharmaceutical assistance programs (PAPs)
offered by individual prescription drug manufacturers, and charitable programs (national
and community) that may provide discounted or free drugs. Additionally, switching to
over-the-counter (OTC) or lower-cost generics or store brands may reduce out-of-pocket
costs (Centers for Medicare and Medicaid Services, 2008). However, using the Medicare
prescription drug plan throughout the year allows the appropriate accumulation of
prescription drug spending to apply toward the catastrophic coverage amounts (Centers
for Medicare and Medicaid Services, 2008).
Recent research (Madden, Graves, Zhang, Adams, Briesacher, Ross-Degnan et al.,
2008) indicates that proposed donut hole or coverage gap solutions are minimally effective
as not all Medicare elders know about the options and often only generics are available
while the more expensive, name-brand drugs are excluded. Approximately 20% of
Medicare elders continue to struggle when acquiring their prescription drugs.
Prescription Drug Co-pays
Prescription drug co-pays are based upon the negotiated prices offered under
specific plans and are not the same at all drug stores (Centers for Medicare and Medicaid
Services, 2006). Co-pays affect the total out-of-pocket costs and may influence Medicare
elders' ability to acquire their prescription drugs with Medicare elders opting out of having
prescription drugs refilled if they perceive that plan premiums and prescription drug copays (approximately $2.35 for generics and approximately $5.35 for name brands) are too
high (Williams, 2002). Medicare elders with Extra Help (LIS) premiums are paid by
Medicare and their co-pays are much lower (Centers for Medicare and Medicaid Services,
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2008). While seemingly affordable, often Medicare elders with approved Extra Help are
still unable to acquire their prescription drugs despite the financial assistance (Centers for
Medicare and Medicaid Services, 2008; Kanavos & Gemmill, 2004; Williams, 2002).
Name Brands versus Generics
Research (Federman et al., 2006; Spence, Hui, & Chan, 2006) indicates that
Medicare elders could greatly reduce their out-of-pocket expenses by switching to
generics. Medicare's plan finder (www.medicare.gov) uses generic prices, where available,
to calculate expected annual plan costs for the prescription drug benefit (Gavin, 2007).
Additionally, Medicare elders are instructed to ask their doctors to switch their brand name
prescriptions to generics in effort to lower out-of-pocket expenses, as well as to help
bridge coverage gaps (Centers for Medicare and Medicaid Services, 2008). Cost savings
of approximately 73% are expected for Medicare beneficiaries who switch from brand
name prescribed drugs to generic versions (Centers for Medicare and Medicaid Services,
2005c). However, research to determine if income influenced generic prescription drug use
indicated that slightly more low-income Medicare elders were more likely to use generics
as opposed to those who were more affluent (Federman et al., 2006).
Mail Order and Reimportation Options
Two cost-saving methods being used by Medicare elders to save money on
prescription drugs include mail order and reimportation (Reed, 2005). Mail order offered
by PDPs may legally save Medicare elders on prescription drug costs (Centers for
Medicare and Medicaid Services, 2005a). However, Medicare elders must consider the
availability of mail order under plans and its costs to acquire prescription drugs; of special
concern to Medicare elders when using mail order are the perceived costs (90-day supply)
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and shipping costs (Centers for Medicare and Medicaid Services, 2006). Additionally, in
their efforts to save money Medicare elders may choose to acquire prescription drugs
through reimportation from Canada, Mexico, or European countries {American Journal of
Nursing, 2004; Weschler, 2004a). Although Medicare elders believe savings are being
realized, reimportation is a grey area with some plans recognizing prescription drugs
acquired from abroad, while other plans provide no cost incentive to pursue reimportation
(American Journal of Nursing, 2004; Weschler, 2004a).
Understanding Health Behavior
To address health behaviors and propose solutions for overcoming health-related
barriers, researchers developed models to examine these phenomena (Johnson, 2002;
Rosenstock, Strecher, & Becker, 1988). These models have been used to develop
intervention methods for improving health outcomes. They attempt to explain healthrelated behaviors with the intent of developing interventions to improve health outcomes
(Johnson, 2002; Rosenstock, Strecher, & Becker, 1988). The Health Belief Model (HBM)
and the Medication Adherence Model (MAM) are two models designed to examine health
beliefs and behaviors that influence whether individuals will overcome barriers necessary to
practice healthier behaviors or adhere to prescribed treatment regimens (Bandura, 1986;
Janz & Becker, 1984; Johnson, 2002). However, antihypertensive acquisition decisions,
due to their complex nature, require integrated multidisciplinary approaches to understand
decision-making strategies and processes used by Medicare elders.
Theory and Models
The intent of this study was to develop and test an integrated multidisciplinary
theoretical model that accurately depicted antihypertensive acquisition behaviors. This
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study tested the enhanced Health Belief Model (HBM), which includes self-efficacy
(Bandura, 1997; Janz & Becker, 1984), against the proposed Pharmaceutical Acquisition
Model for Medicare Elders (PAMME) to determine whether the proposed model is better
at explaining Medicare elders' antihypertensive acquisition behaviors. The proposed
PAMME was tested to determine if it could explain which factors influence
antihypertensive acquisition by Medicare elders, accounting for cost and usage intentions.
In particular, it explored the attitudes and beliefs of Medicare elders as they specifically
relate to health insurance, hypertension, antihypertensives, and adherence decisions to
determine what influences they have on antihypertensive acquisition. This study examined
those attitudes and behaviors that influence antihypertensive acquisition to determine
predictability from the various influencers that may contribute to antihypertensive
acquisition. By understanding the health beliefs and behaviors that lead to acquisition
behavior, utilizing consumer choices, and adherence decisions for Medicare elders, it may
be possible to improve prediction for antihypertensive acquisition and adherence behaviors.
Assumptions
In an examination of Medicare elders' acquisition of antihypertensives several
assumptions were made, namely:
1. Medicare elders are capable of rational decision making with respect to
antihypertensive acquisitions.
2. Medicare elders who enroll in a Part D plan do so with the belief that they will
reduce their out-of-pocket acquisition costs for antihypertensives.
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3. Medicare elders who apply and are approved for Extra Help believe that they
will reduce their out-of-pocket acquisition costs for antihypertensives.
4. Medicare elders were honest about their antihypertensive acquisitions.
Limitations
Several limitations to this study were indicated. They are as follows:
1. Administered survey responses are self-reported and may not accurately reflect
antihypertensive acquisition experiences.
2. The telephone may not be the best method of communication for Medicare
elders due to hearing or comprehension concerns.
3. The study is limited to English-speaking, hypertensive, consenting Medicare
elders. Their experiences may differ from those not consenting to participate.
4. Medicare elders who are not competent to make their own health-care decisions
were excluded from the study.
5. Medicare enrollment data to be utilized excludes disabled and those not subject
to Medicare Part D enrollment (military or government retirees or other individuals with
creditable coverage).
Research Questions
1. To what extent do Medicare elders actually acquire antihypertensives as
prescribed?
2. To what extent does the enhanced Health Belief Model (HBM) overall explain
antihypertensive acquisition behavior for hypertensive Medicare elders?
2a. Do individual perceptions about disease severity influence Medicare elders'
decision to acquire antihypertensives?
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2b. Do perceived benefits of antihypertensives influence Medicare elders' decision
to acquire antihypertensives?
2c. Do perceived barriers to acquiring antihypertensives influence Medicare elders'
decision to acquire antihypertensives?
2d. Does perceived seriousness of hypertension influence Medicare elders' decision
to acquire antihypertensives?
2e. Do cues to action influence Medicare elders' decision to acquire
antihypertensives?
3. To what extent do constructs from other models (Medication Adherence Model
and Consumer Choice Theory Model) help to explain antihypertensive acquisition behavior
for Medicare elders?
3a. Are Medicare elders confident that they can overcome antihypertensive out-ofpocket cost barriers in order to acquire antihypertensives?
3b. Do Medicare elders perceive other barriers to acquiring antihypertensives?
4. Does the integrated Pharmaceutical Acquisition Model for Medicare Elderly
(enhanced Health Belief Model with constructs from Consumer Choice Theory and
Medication Adherence) explain antihypertensive acquisition behavior for Medicare elders
better than the enhanced Health Belief Model?
Significance of the Study
This study examined underuse as it related to antihypertensive acquisitions.
Prescription drug underuse has been a concern for healthcare providers who want to
improve patients' health (Ead, 1998; Gottlieb, 2000; Kirking et al., 2006). Through
treatment regimens that include regular access to and refill acquisitions by Medicare elders,
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healthcare providers may assist in controlling or preventing adverse health events (Ead,
1998; Mojatabai & Olfson, 2003; Vik et al., 2006). However, despite the implementation
of the Medicare Modernization Act (MMA) of 2003 to reduce prescription drug costs,
acquisition decisions and related underuse continue to affect Medicare elders (Bowman,
2007; Henry J. Kaiser Family Foundation, 2007; Hsu et al., 2008). Acquisition of
affordable prescriptions, including antihypertensives, is necessary so mat Medicare elders
can take antihypertensives as prescribed (Bardel, Wallander, & Svardsudd, 2007).
Understanding low-income, Medicare elders' antihypertensive acquisition behaviors
has important implications for future prescription drug treatment and health
implementation efforts. The acquisition of antihypertensives has the potential to reduce
hypertension-related complications by reducing preventable doctor and emergency
department visits, thereby reducing hypertension-related mortalities and health-care costs
(Cutler et al., 2007; Malhotra, Karan, Pahdhi, & Jain, 2001; Mojatabai & Olfson, 2003;
Nilsson, 2005). For this study, antihypertensive acquisition specifically was examined as an
outcome to analyze Medicare elders' beliefs about hypertension. Medicare elders' Part D
enrollment decisions and behaviors were examined to determine which factors influenced
legal antihypertensive acquisitions. Understanding what decision-making and consumer
processes Medicare elders follow to decide whether to be screened for Extra Help,
participate in a Part D plan, and ultimately acquire their antihypertensives may help in
forming or refining policy. Thesefindingsalso may have multiple applications for other
services and products designed to benefit the health of Medicare elders.
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Chapter 2
LITERATURE REVIEW
Theoretical Framework: Models Used to Explain Health Behaviors
Health Belief Model (HBM)
The original Health Belief Model (HBM) was designed to explain general healthrelated behavior (Janz & Becker, 1984; Rosenstock, Strecher, & Becker, 1988). The
Health Belief Model (HBM) (Janz & Becker, 1984) (see Figure 3) may be useful in
determining which antihypertensive perceptions and beliefs have an influence on
antihypertensive acquisition behaviors for Medicare elders.

Perceived
Susceptibility
of the
Disease or
Disability
Health-Seeking
Behavior

Perceived Benefit
of Health
Improving
Behavior

Figure 3. Health Belief Model (HBM).
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Constructs of the Health Belief Model
Thefiveconstructs of the original Health Belief Model are as follows: perceived
susceptibility, perceived severity, perceived benefit, perceived barrier, and health-seeking
behaviors) (Janz & Becker, 1984; Rosenstock, Strecher, & Becker; 1988). Perceived
susceptibility of a disease or illness relates to Medicare elders' perceptions about the
disease; i.e., what they know about their chances of being diagnosed with the disease
(University of Maryland, 2003). Perceived severity for the disease often depends upon the
severity of symptoms or severity of an illness (Balkrishnan, 1998). Perceived benefits may
include feeling better by controlling hypertension and preventing adverse health
complications (Home & Weinman, 1999). Perceived barriers to antihypertensive
acquisitions may include the cost, pharmacy location, and insurance status (Bowman,
2007; George et al., 2006; Home & Weinman, 1999). Additional perceived barriers may
include transportation (Klein, Turvey, & Wallace, 2004), the ability to open bottles, health
literacy level, and remembering to refill prescriptions (Grymonpre, Didur, Montgomery, &
Sitar, 1998; Spiers & Kutzik, 1995). Health-seeking behaviors may include acquiring
prescribed prescription drugs and taking them as directed in support of health-seeking
behaviors for chronic disease control (Antonacci, 2002).
Enhanced Health Belief Model
The enhanced Health Belief Model (see Figure 4) adds Bandura's self-efficacy
theory (Bandura, 1986) to the original Health Belief Model (HBM) (Janz & Becker,
1984), which examines an individual's perceived abilities with regard to performing healthseeking behaviors and actions (Bandura, 1986). The enhanced HBM is useful for exploring
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behavior changes and using motivation as a function of action to achieve a specified
outcome (Bandura, 1986; Janz & Becker, 1984; Rosenstock, Strecher, & Becker, 1988).

Individual
Perceptions

Self-efficacy

Perceived
Susceptibility/
Seriousness of
Disease

Modifying
Factors

Age, Gender, Ethnicity
Personality
Socioeconomics
Knowledge

Perceived threat of
disease

Likelihood of Action

Perceived Benefits
Versus Barriers to
Behavioral Change

Likelihood of
Behavioral Change

Cues to Action
•Education
•Symptoms
• Media Information

Figure 4. Enhanced Health Belief Model.

Constructs of the Enhanced Health Belief Model
The enhanced Health Belief Model (HBM) has three constructs (individual
perceptions, modifying factors, and likelihood of action) that influence levels of health
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Individual Perception
Individual Perceptions includes self-efficacy, perceived susceptibility, and
seriousness. Individual perceptions were explored to determine if self-efficacy has an
influence on perceived susceptibility and perceived seriousness of hypertension has an
influence on Medicare elders' ability to make decisions for antihypertensive acquisitions.
Self-efficacy is an individual's perception of being able to complete the desired task
or health behavior (Bandura, 1997). Including self-efficacy in the enhanced Health Belief
Model strengthens the willingness to change or perform an action by an individual
believing that he or she has the ability to perform the desired health behavior (Bandura,
1997). Without the ability to perform the behavior, while the desire may be there, the
action will remain incomplete (Bandura, 1997). However, attitudes and beliefs alone may
not be sufficient to motivate an individual to perform the health action if he or she
perceives the barriers as too great to accomplish the task (Rosenstock, Strecher, & Becker,
1988)
Perceived susceptibility refers to the likelihood that an individual may be diagnosed
with the disease. Medicare elders may or may not perceive that they are susceptible for
hypertension.
Perceived seriousness of disease may influence individual perceptions about the
threat of disease. Individual perceptions may lead to behavioral changes if the perceived
seriousness and perceived threat of the disease lead to health-seeking behaviors. As
hypertension often is a "silent killer," asymptomatic Medicare elders may not perceive
hypertension as a real threat. Medicare elders not experiencing adverse hypertensive
symptoms may not perceive the need for treatment (American Heart Association, 2007b).
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Modifying Factors
Modifying factors include demographics (age, gender, ethnicity, and marital status)
and socioeconomic variables (e.g., income level, social support systems) (Balkrishnan,
1998).
Age continues to be a factor as Medicare elders are increasingly diagnosed with
hypertension (American Heart Association, 2007a). Gender may also be a factor since both
men and women are equally affected by the hypertension. Ethnicity is important, as African
Americans are more prone to hypertension while Hispanics and Asians are increasingly
being afflicted, as their dietary conditions resemble Western society (University of
Maryland, 2003). Marital Status has an influence, as married Medicare elders are more
likely to have their hypertension under control (U.S. Department of Health and Human
Services, 2003).
Income level has an influence as lower-income Medicare elders are increasingly
diagnosed with hypertension in comparison with their more affluent peers (Federman et al.,
2006; Sarver, Sudano, & Baker, 2000). Social support systems may provide some benefit
in both friends and relatives helping to reduce hypertension and in monitoring
antihypertensive usage (University of Maryland, 2003). Perceived threat of disease may
depend upon Medicare elders' knowledge and perception about the seriousness of their
illness, and their perceptions about taking prescription drugs (Home & Weinman, 1999).
Cues to action may include media coverage of antihypertensive issues via television or
radio announcements, talk shows, newspaper articles, and health fairs (Mattson, 1999).
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Likelihood of Action
Perceived benefits to behavioral change include a greater likelihood that an
individual will obtain and use a antihypertensive as prescribed if it is perceived that it is
effective for treating hypertension (Piette, Heisler, & Wagner, 2004a). Acquisition and
adherence decisions may be influenced by the number of prescriptions, dosage frequency,
and beliefs about the benefits of specific prescription drugs (Graupner, Frost, Weinman,
Wright, & Hankins, 2004; Osterberg & Blaschke, 2005; Ostrosky, 2003; Piette, 2005).
Perceived barriers to behavioral change for antihypertensive acquisition may
include the cost, pharmacy location, insurance status (George et al, 2006; Home &
Weinman, 1999; Klein, Turvey, & Wallace, 2004), or their effectiveness and safety, which
may influence adherence motivations (Cooper, Love, & Raffoul, 1982).
The likelihood of behavioral change, in the likelihood of action component of the
enhanced HBM would be following treatment guidelines through the acquisition of
antihypertensives as prescribed. The likelihood of behavioral change also may depend upon
the perceived threat of hypertension and perceptions of elders' ability to obtain prescribed
antihypertensives (Jackson, Doescher, Saver, & Fishman, 2004).
Empirical Support for the Health Belief Model
The Health Belief Model (HBM) utilizes behavioral change theories in an attempt
to explain and predict health behaviors by examining individual attitudes and beliefs that
prompt the individual to take a specific health action (Foley, Vasey, Berra, Alexander, &
Markson, 2005; Glanz, Lewis, & Rimer, 1990). The HBM has been used to explain health
promotion and prevention behaviors utilizing individual perceptions and beliefs for disease
states and treatment approaches. The enhanced HBM, with the inclusion of self-efficacy,
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has applications to research that explore individual perceptions about access and the
perceived ability to overcome barriers necessary to achieve a desired health outcome
(Bandura, 1986; Rosenstock, Strecher, & Becker, 1988). Previous research studies have
effectively used the HBM to understand change within patient populations (Al-Ali &
Haddad, 2004; Aquino, Fyfe, MacDougall, & Remple, 2004; Atta, 1994; Carroll, 2003;
Mattson, 1999; Nex^e, Kragstrup, & SjEgaard, 1999; Vernon, 1999). The HBM also has
been used to develop the Osteoporosis Health Belief Scale (Kim, Horan, Gendler, & Patel,
1991) to examine breast and other cancer-screening programs (Barnes & Thomas, 1990;
Brown & Williams, 1994; Lasbley, 1987) as well as explore bodily changes of illness in
older adults (Haug, Musil, Warner, & Morris, 1998).
The Health Belief Model (HBM) has been used to study patient compliance for
congestive heart failure (Lacey, 1988) and hypertension (Leeser, 1989). The perceived
seriousness of the illness and perceptions individuals have about a specific disease or illness
may reflect their need to adhere to prescription drug regimens (Balon, 2002; Bardel,
Wallander, & Svardsudd, 2007; Jackson et al., 2004). However, the impetus to change a
situation must be present to achieve a desired outcome (Janz & Becker, 1984). Often,
multiple and complex decision-making processes exist for specific prescription drug
acquisitions decisions including those for antihypertensives (Morrow, Leirer, & Sheikh,
1988), and individuals may choose to discontinue specific prescription drugs (for
cholesterol and high blood pressure) that they believe to be no longer necessary, especially
when they are feeling better (Vik et al., 2005).
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Review of Studies that Use Health Beliefs to Predict
Prescription and Other Health Behaviors
Health Belief-related Research
Studies that examine perceptions about disease state are necessary to
understanding hypertension-related perceptions and health-seeking behaviors. Several
studies have specifically addressed prescription drugs (Xu, Smith, & Borders, 2003).
Research to study health-seeking behaviors for myocardial infarction, based upon elders'
perceptions of symptoms, found that four factors (symptom, attribution, severity and
duration, attribution to comorbid and chronic conditions) as well as previous experience
may influence treatment-seeking behaviors (Ryan & Zerwic, 2003). Medicare elders with a
family history of hypertension or with friends or family members with disease-related
complications may perceive the hypertension as more threatening than Medicare elders
who have not experienced adverse symptoms or previous disease-related experience(s)
(Schlomann & Schmitke, 2007). Family members, caregivers, or social support systems
also may contribute to Medicare elders' decision to acquire antihypertensives with usage
intentions (Jackson et al., 2004).
Research has shown that individuals who perceive barriers to affordability or do
not perceive that their illness is that severe may use rationing methods to extend
prescriptions through pill splitting, skipping dosages, and delays in refilling prescriptions or
sharing prescriptions with friends or family members (Hughes, 2004). Other barriers
explored in research include individual perceptions about the effectiveness and safety of
antihypertensives, which have influenced adherence motivations (Cooper, Love, & Raffoul,
1982; Gohar, Greenfield, Beevers, Lip, & Jolly, 2008). Low self-efficacy for acquisition
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and adherence to prescription drug regimens has been shown to influence adversely
acquisition and usage (Resnick, Wehren, & Orwig, 2003).
Attitude and Behavior-based Research for Prescription Drugs
Research gathered prior to the Medicare Modernization Act (MMA) with Medical
Expenditure Panel Survey data for Medicare elders used an access-based approach to
examine prescription drugs (i.e., determinants of realized, perceived, and potential access)
and found that perceptions about overcoming illness without assistance was linked to
lower odds of taking prescription drugs (Xu, Smith, & Borders, 2003). Other research
studies have indicated that higher acquisition and adherence rates may be linked to beliefs
about health-care providers (MacLaughlin, Raehl, Treadway, Sterling, Zoller, & Bond,
2005). The level of relationship that patients have with their doctors, specifically
supportive relationships, reflects improvement in adherence levels (Piette, 2005;
Rosenblatt, Wright, Baoldwin, Chan, Clitherow, Chen, et al., 2000). Other hypertensive
research has focused upon nutrition education programs (Klinedinst, 2005) to reinforce
health-promoting behavior and beliefs such as losing weight, controlling salt intake, and
working out at a fitness club also may reflect health-seeking behaviors (Antonacci, 2002).
The conscious decision to acquire or adhere to specific prescription drugs often
reflects patients' attitudes about their effectiveness and safety (Home & Weinman, 1999)
and varies by ethnicity (Reed, Hargraves, & Cassil, 2003), disease states (Jackson et al.,
2004) and income levels (Bowman, 2007). Medicare elders with knowledge about
hypertension's possible symptoms, signs, and complications may perceive that
hypertension is more threatening than those who are not as knowledgeable (Schlomann &
Schmitke, 2007) and may be more likely to perceive antihypertensive acquisition as
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necessary to their health (American Heart Association, 2007a). Perceived benefits also may
be the perception of an improved quality of life through chronic disease control that may
include the reduction in emergency room visits, increased disease control or the prevention
of disease-related complications derived from following treatment regimens by acquiring
antihypertensives as prescribed (Andrawes, Bussy, & Belmin, 2006; Benson & Britten,
2002; Meyer, 2002). Additionally, acquiring antihypertensives according to prescribed
guidelines may have the potential to improve health outcomes through increased adherence
(Schwartz & Sheps, 2006). If Medicare elders perceive that hypertension is a serious
disease with preventable complications, or if they perceive there is a chance of
experiencing adverse disease-related complications, then they may be more likely to seek
and adhere to treatment (University of Maryland, 2003).
However, Medicare elders may not always refill prescription drugs regularly due to
cost considerations (Bowman, 2007). Individuals who perceive barriers to affordability or
do not perceive that their illness is that severe may use rationing methods to extend
prescriptions through pill splitting, skipping dosages, and delays in refilling prescriptions or
sharing prescriptions with friends or family members (Hughes, 2004). However, barriers to
antihypertensive drug usage may include affordability issues, the ability to open bottles,
literacy levels, as well as remembering (Grymonpre et al., 1998; Piette et al., 2004; Spiers
& Kutzik, 1995).
Components Added to the Enhanced Health Belief Model
While the Health Belief Model (HBM) has proved useful for explaining the
behavioral and cognitive factors related to health beliefs and behaviors, the components for
understanding consumer acquisition decisions and specific antihypertensive usage as
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influenced by cost considerations is still lacking. The specific model components to be
added to the enhanced HBM include consumer decision-making factors (Consumer Choice
Theory) and medication adherence-related (Medication Adherence Model) health
behaviors and attitudes Medicare elders exhibit with respect to acquisition of
antihypertensives. The focus of this examination was upon antihypertensive drug
acquisition; specifically, how price (Part D plan premiums and prescription drug co-pays)
influence Medicare elders' consumer acquisition decisions and health-seeking behaviors.
The Consumer Choice Theory
The Consumer Choice Theory (see Figure 5), as adapted from Friedman (1990),
was used to examine to what extent premium price influences plan enrollment and whether
Extra Help status influences antihypertensive acquisition decisions in the construct of the
enhanced HBM. The Consumer Choice Theory attempts to explain the behavior of rational
consumers in maximizing acquisition opportunities given their budget constraints (Folland,
Goodman, & Stano, 2004). Medicare elders often subsist on fixed or limited incomes such
that budget constraints and price are often factors considered in antihypertensive
acquisition decisions and behaviors (Gaskin et al., 2006).
Constructs for Consumer Choice Theory
To examine consumer acquisition decisions, constructs from the Consumer Choice
Theory (Friedman, 1990) are employed to understand what factors influence an
individual's decision to acquire antihypertensives with usage intentions. Consumer Choice
Theory extends the behaviors of individuals to acquiring decisions that are designed to
maximize their utility while reducing costs (Friedman, 1990). Consumer Choice Theory is
based upon economic theory that looks at the relationship between the price and the value
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Purchase Decisions
•
•
•
•

Budget Constraints
Price Considerations
Perceived Benefit
Availability of Substitutes

•
•
•

Cost Benefit Trade Off
Cost versus Value of
Perceived Benefit

Purchase

Not
Purchase

Economic Considerations
Best Value
Perceived Need
Perceived Benefit

Satisficing - Partial Knowledge
versus Complete Knowledge
Figure 5. Consumer Choice Theory.

that consumers place on select goods (Friedman, 1990). The cost-benefit tradeoff decisionmaking behaviors for antihypertensive acquisitions were examined to determine whether
price is a good indicator of acquisition decision (Winter et al., 2006). Satisficing requires
trade-offs with Medicare elders making informed choices by researching plan information,
prescription drug costs, and estimating their expected annual out-of-pocket expenditures
(Folland, Goodman, & Stano, 2004). Consumer choices are satisficing; if complete
information had been available, then the decision might have been different (Folland,
Goodman, & Stano, 2004). The Consumer Choice Theory is incorporated into the
enhanced H B M by adding select components under Cues to Action. The assumptions that
the Consumer Choice Theory makes is that consumers are rational and make acquisition
decisions to maximize utility (Friedman, 1990). As resources are limited, cost-benefit
trade-offs that maximize consumer utility makes rational sense (Friedman, 1990). The
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Consumer Choice Theory (see Figure 6) as it relates to the Medicare Modernization Act of
2003 (MMA) includes various options to be included in the complex decision-making
process.
Empirical Support for the Consumer Choice Theory
Recently, researchers have attempted to develop an understanding of consumers'
choices, predictions, judgments, and outcomes (Fonseca & Zeidan, 2004; Lynch &
Zauberman, 2007). A correlated research study looks at construing consumer decision
making to understand "how consumers represent outcomes and weigh different decision
criteria" (Lynch & Zauberman, 2007, p. 107). The decision to acquire often involves
complex decision making for which consumers may not have enough information to make
an informed decision (Thull, 2007). However, understanding the decision-making
processes, as well as the cost benefit trade-offs that are used when selecting a Part D
prescription drug plan or applying for Extra Help, may lead to a better understanding of
Medicare elders' perceptions of the barriers to and benefits of acquiring antihypertensives.
Previous research in 1996 was conducted to understand long-term care choices and
personal decision-making styles that outlined four decision-making style categories
(scramblers, reluctant consenters, wake-up call, and advance planners) that highlighted
trade-offs given long-term care decision-making scenarios (Maloney, Finn, Bloom, &
Andresen, 1996). A more recent study examined media interaction between the ageism
message and elderly perceptions of health care needs (Hodgetts, Chamberlain, & Bassett,
2003). Additionally, research conducted to understand consumer health plan switching has
been studied for quality effect with results showing low satisfaction for those with chronic
illness (Abraham, Feldman, Carlin, & Christianson, 2006).

53

Choices:
Creditable Coverage: Yes/No
IF No - Need Part D or will pay late
enrollment penalty
Enrollment in Part D Plan
•
Choose either Prescription
Drug Discount or Advantage
Plan with Prescription Drugs

Perceived Need:
Willingness to Pay to:
•

•

Reduce
Antihypertensive
Costs

•

Reduce Healthcare
Costs

•

•

•

Treat Hypertension

•

Acquire
Antihypertensives
as Prescribed

Cost of Monthly Premium
for Plan vs. Benefit
Cost of Co-pays for Rx vs.
Perceived Benefit
Rx on Plan Formulary vs.
Barrier to Access

Purchase Decisions:
•

o Leave Pharmacy
with all Prescribed
Rx
o Leave Pharmacy
with Partial
Prescribed Rx
•

Extra Help Status:
•
Eligible
o
Income and Assets
o
Dual Enrollment Status
(Medicaid/Medicare)
o
SSDI
•

Ineligible

Evaluation of Decision(s)
• Successfully Purchase all Rx with Part D Plan
• Rx Costs Different than Anticipated
If EH Approved o Was EH status recognized for
antihypertensive acquisition?
o Were cost-savings achieved?
o Acquire antihypertensives by means other
than purchase

Figure 6. Consumer Choices -Acquiring Antihypertensives.

Purchase Rx

Not Purchase any Rx
o Leave Pharmacy
without Prescribed
Rx
o Leave Pharmacy
with OTC
Alternatives
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Willingness to Pay
The ability to pay is often based upon income and wealth, while the willingness to
pay is the value that an individual places upon a good or service and the price he or she
is willing to pay to get it (Donaldson, Thomas, & Torgerson, 1997). The ability to test for
willingness to pay is difficult if the question is phrased too broadly; whereas, if a choice
between two items is offered (i.e., "Would you rather pay $10 to go the circus or would
you rather go to a movie?") specific preferences may be identified (Donaldson, Thomas, &
Torgerson, 1997). In the case of healthcare, willingness to pay may be determined by the
perceived need for the procedure or treatments (e.g., spend $5,000 for liposuction versus
putting a down payment on a new car or spend $300 to have a mole removed and biopsied
versus having dental work).
Economics-based Medicare Prescription Drug Research
A 1978 study of perception of risk for generically prescribed drugs showed concern
among consumers for generic drugs that indicates a shift in perceptions in more recent
research that shows increased acceptance of generics for certain socioeconomic status and
based upon reflected cost savings (Bearden & Mason, 1978). Another study, which used
the RAND Elderly Health Supplement to the 1990 Panel Study of Income Dynamics
(PSID) demand model of drugs, examined insurance status and the effects on
expenditures. Results revealed significant findings for out-of-pocket expenditures for
hypertension as well as proposing the addition of the prescription drug benefit to Medicare
to reduce significantly out-of-pocket costs (Lillard, Rogowski, & Kington, 1999).
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The Medication Adherence Model
The Medication Adherence Model (MAM) (see Figure 7) was developed to
understand medication-taking behaviors and to explain prescription drug adherence
decision-making processes for treating hypertension (Johnson, 2002). Understanding how
Medicare elders perceive the effectiveness, safety, and benefits of antihypertensives will
require components of the MAM (Johnson, 2002), which may influence antihypertensive
acquisitions. The MAM also may be useful in examining acquisition behaviors for
antihypertensives.

Purposeful Action
•
•
•

Patterned Behavior

Perceived Need
Perceived Effectiveness
Perceived Safety

•
•
•

Feedback
Appraisal Process
• Information
• Prompts
• Events

Figure 7. Medication Adherence Model.

Remembering
Access
Routines
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Constructs of the Medication Adherence Model (MAM)
The Medication Adherence Model (MAM) has three constructs that include
purposeful action, patterned behavior, and feedback (Johnson, 2002). Purposeful action
encompasses individual decisions to use prescription drugs based upon perceived
effectiveness and safety. Patterned behavior includes access, routines, and remembering.
Feedback includes an individual's use of events, information, or prompts, which influence
levels of purposeful action and patterned behavior.
Select components of the Medication Adherence Model (MAM) were added to the
enhanced Health Belief Model (HBM) to test these constructs as well. These factors were
included in the enhanced HBM with a special emphasis on interaction between behaviors
and beliefs, cost considerations, and actual reported usage resulting from decisions to
acquire antihypertensives. The beliefs and perceptions that Medicare elders have about
antihypertensives, as well as Medicare elders' perceptions about the effectiveness and
safety of antihypertensives, may influence decisions to acquire antihypertensives with
usage motivations (Lehan & McCarthy, 2006). Acquisition with intention to use decisions
are important when exploring the decisions and behaviors related to antihypertensive
acquisitions, as acquisition of antihypertensives would not be perceived as necessary if
Medicare elders had no intention of taking them once acquired.
Constructs adapted from the MAM (see Figure 8) were used; specifically the
perceptions about need, effectiveness, and safety of antihypertensives, based upon health
beliefs and behavior components (Johnson, 2002) that were included in the proposed
Pharmaceutical Acquisition Model for Medicare Elders (PAMME).
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Patterned Behavior

Purposeful Action

Establish Antihypertensive-taking Patterns

Perceived Need for
Antihypertensives

Access - Regular Doctor Visits & Rxs

Perceived Effectiveness of
Antihypertensives

Routines - Taking Antihypertensives as
Prescribed

Perceived Safety of
Antihypertensives

Remembering - To Refill Antihypertensives

X ^
\
\
\

:

Feedback - Appraisal Process
Information - Learning more about Hypertension and
Treatment Methods
Prompts - Family Reminders
Events - Feeling 111, Poor Blood Pressure Control

Figure 8. Medication Adherence Model for Antihypertensives.

Empirical Support for the Medication Adherence Model
Research that examines adherence for Type 2 Diabetes Mellitus has been studied to
develop interventions that will improve health treatment behaviors (Vermeire, Wens,
Roy en, Biot, Hearnshaw, & Lindenmeyer, 2008). Several other studies have been
conducted to develop interventions for adherence to oral hygiene instructions (Renz, Ide,
Newton, Robinson, & Smith, 2008), lipid-lowering medication (Schedlbaurer, Schroeder,
Peters, & Fishey, 2008) as well as high blood pressure treatment (Schroeder, Fishey, &
Ebrahim, 2008). The studies reviewed for high blood pressure found that simplified dosing
and complex reminder systems were effective in improving adherence; however, the
studies did not report education to be effective (Schroeder, Fishey, & Ebrahim, 2008).
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Limitations of Current Theories
Understanding the complexity of adherence to treatment regimens has been heavily
researched, but the interaction of acquisition, price, and intention to use is lacking. While
the current health behavior theories have proven quite useful in understanding healthrelated behaviors for prenatal care (Atta, 1994), oral hygiene (Carroll, 2003), exercise
participation (Ali-Ali & Haddadd, 2004), and chronic health behaviors (Home & Weinman,
1999), they lack a utility component related to acquisition. Often health behavior and
health belief theories are individualized. They exclude external monetary aspects of the
cost of acquiring health care. The influence of price and the effect that price has on health
beliefs and behaviors are missing from the current theories. In an attempt to incorporate
economic and nursing theory into the existing enhanced Health Belief Model
multidisciplinary approach an integrated model to understand the complexity of Medicare
elders' decision-making process for the acquisition of antihypertensives was necessary.
Pharmaceutical Acquisition Model for Medicare Elders (PAMME)
As no model currently exists that incorporates beliefs, decision-making strategies,
consumer behaviors (with respect to cost and underuse factors) specific components of the
enhanced Health Belief Model (HBM), which includes self-efficacy (Bandura, 1997) and
constructs from the Consumer Choice Theory (Friedman, 1990) were used to develop the
Pharmaceutical Acquisition Model for Medicare Elders (PAMME) (see Figure 9). For the
purpose of this examination the five factors of the enhanced HBM (Janz & Becker, 1984),
with constructs from the Consumer Choice Theory (Friedman, 1990) and the Medication
Adherence Model (Johnson, 2002) were used to develop a new multidisciplinary
theoretical model to predict the processes that Medicare elders undergo when making
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Figure 9. Proposed Model of the Pharmaceutical Acquisition Model for Medicare Elders
(PAMME)
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antihypertensive acquisition decisions. Perceptions that Medicare elders have regarding
their health status may influence their willingness to acquire prescription drugs designed to
prevent or treat health conditions, specifically hypertension. Understanding what influences
Medicare elders' MMA participation, Extra Help application, and antihypertensive
acquisition decisions requires a complex decision-making process that involves trade-offs
among the competing barriers and benefits.
The proposed Pharmaceutical Acquisition Model for Medicare Elders (PAMME)
incorporates components from the enhanced Health Belief Model (HBM) with select
components from Consumer Choice Theory and the Medication Adherence Model. The
performance of this proposed model against the enhanced HBM was tested to determine if
Medicare elders' antihypertensive acquisition behaviors can be predicted using the
developed new model. The influence of multiple factors were examined to determine
which, if any, of the variables may be used to predict acquisition behaviors for Medicare
elders under various model conditions.
This study examined the linkage between individual perceptions and beliefs about
hypertension, including self-efficacy of acquiring antihypertensives, to try to understand
what decision-making processes Medicare elders engage in when deciding to acquire
antihypertensives. Ultimately, this study attempted to determine whether the enhanced
HBM or the proposed PAMME were useful frameworks for examining elderly Medicare
elders' antihypertensive acquisition decisions and behaviors.
PAMME Constructs
The proposed PAMME examines various components of consumer decision
making (Friedman, 1990) that have been found to effect antihypertensive acquisitions for
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Medicare elderly (perceived health status, price of individual prescription drug, Part D plan
premiums, Extra Help status, perceived antihypertensive side effects, perceived
effectiveness of antihypertensives, beliefs about antihypertensive safety, and benefits of
acquiring antihypertensives among others).
Demographic Factors
Demographic factors include age, gender, marital status, income, and ethnicity.
Treatment, adherence, and disease control may vary by ethnicity, age, and marital status
(Bardel, Wallander, & Svardsudd, 2007).
Age may influence antihypertensive acquisitions as hypertension becomes more
prevalent as the population ages (American Heart Association, 2007b). Gender may
influence antihypertensive acquisitions as approximately one-fourth of Medicare-aged men
and women have been diagnosed with hypertension (Centers for Disease Control and
Prevention, 2007b). Marital status might influence whether Medicare elders acquire their
antihypertensives. Married couples may be concerned for each other's health and remind
each other to acquire and take their antihypertensives as prescribed (Davis & Srivastava,
2003). Income level may have an influence on treatment affordability and antihypertensive
acquisitions as lower-income Medicare elders may have more difficulty acquiring their
prescribed antihypertensives and other prescription drugs (Blustein, 2000; Bowman, 2007;
Federman et al., 2006). Ethnicity influences acquisition of health care and prescription
drugs for African-American Medicare elders who are not equally able to acquire their
prescription drugs (Center for Studying Health System Change, 2003).
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Individual Perceptions
Individual perceptions include self-efficacy, perceived threat of disease, perceived
susceptibility/seriousness of illness, perceived barriers versus benefits of acquiring
antihypertensives, perceived benefit versus cost of prescription plan and antihypertensives
cost as well as perceived need, effectiveness and safety of antihypertensives.
Self-efficacy is the perception or belief that an individual has about his or her ability
to complete a desired task (Antonacci, 2002). Sell-efficacy with respect to acquiring
antihypertensives includes an individual's belief in his or her ability and the desire to
overcome the barriers to acquiring antihypertensives as prescribed by a physician.
Willingness to pay is the value perception that an individual places upon items
(includes health) and the price he or she is willing to pay. Often, with the Medicare Part D
premiums and co-pays, willingness to pay may be influenced by the range of premiums, the
number of prescription drugs taken, and the individual's perceptions about the cost benefit
trade-offs of coverage for one plan when compared to another (e.g., Advantage plan with
zero premium versus a stand-alone drug plan with a $ 14.40 monthly premium).
Perceived health status is an individual's perception of his or her health, which may
differ from his or her health care provider's perception related to the clinical diagnosis.
Perceived threat of disease includes how real a threat a Medicare elder perceives
hypertension to be for him or her. If Medicare elders have been diagnosed with prehypertension or hypertension, then they may perceive the threat as greater than that
perceived by elders not diagnosed (Pinto, 2007).
Perceived susceptibility/seriousness of illness may be affected by a lack of
symptoms or signals from the body that something is wrong, which may, in turn,
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incorrectly influence an individual's perceptions about his or her chances of having
hypertension or his or her perceptions about the severity of disease state and the need for
treatment (Balkrishnan, 1998; Leeser, 1989). Asymptomatic hypertensive Medicare elders
may delay obtaining medical care or treatment if they perceive that they are not susceptible
to hypertension or that hypertension is a mild disease that has little adverse health effects
(Leeser, 1989).
Perceived barriers versus benefits of acquiring antihypertensives may be influenced
by distance to the pharmacy, availability of transportation, or the adverse consequence of
not obtaining the prescribed antihypertensives (Balkrishnan, 1998; Cooper, Love, &
Raffoul, 1982). The desire to acquire antihypertensives must be strong enough to
overcome the barriers of cost, beliefs about health status, hypertension beliefs, and
attitudes about prescription drugs as well as other perceived barriers.
Perceived need, effectiveness, and safety of antihypertensives may have an
influence on antihypertensive acquisitions. Examining Medicare elders' beliefs about a
prescription drug's effectiveness (McDonald-Miszczak, Maris, Fitzgibbon, & Ritchie,
2004) and beliefs about the severity of their illness or effectiveness of prescription drugs
designed to prevent illness or treat chronic diseases are important in determining to what
extent these perceptions influence their acquisition behaviors (Home & Weinman, 1999;
Okonofua, Cutler, Lackland, & Egan, 2005). Adherence also may be influenced by
perceived need, effectiveness, and safety, which could affect whether an individual
perceives antihypertensives as essential for the treatment of hypertension or chronic illness
(Balkrishnan, 1998; Cooper, Love, & Raffoul, 1982; Lehan & McCarthy, 2006).
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Modifying Factors
Modifying Factors include knowledge of their condition, cognitive ability, social
support, and cues to action (symptoms, side effects, information, and media events).
Knowledge about hypertension and methods to improve disease control may have an
influence on Medicare elders' antihypertensive acquisition by understanding what is
required to prevent adverse health outcomes (Esposito, 1992; Hsu et al., 2008).
Cognitive ability is influenced by both the aging process and hypertensive
treatment (Terrera, Matthews, & Brayne, 2008; Wang, Alexander, & Stafford, 2007).
Antihypertensive acquisition may possibly be influenced by cognitive impairment for
hypertensive Medicare elders for whom additional screening and treatment may be
required (van Uffelen, Chin, Hopman-Rock, & van Mechelen, 2007). Cognitive ability may
be affected by stroke or the development of dementia (McGuinness, Todd, Passmore, &
Bullock, 2006; Yaan, Fischer, Gamat, Bagwell, & Thai, 2006).
Social Support could influence antihypertensive acquisitions if friends, family, and
health care providers are actively involved monitoring the health-seeking behaviors of
parents, neighbors, or patients (Centers for Medicare and Medicaid Services, 2006).
Additionally, physicians and pharmacists taking an active interest in their patients'
treatment and acquisition abilities may have an influence on treatment adherence
(Mojatabai,2005).
Cues to Action may include symptoms, side effects, information, and media events.
Symptoms may not be recognized by Medicare elders as related to an illness, but may be
erroneously attributed to non-threatening conditions such as the aging process (Ryan &
Zerwic, 2003). Side effects of antihypertensives may influence Medicare elders' willingness
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to acquire them as prescribed (Benson & Britten, 2002). If side effects are more
unpleasant then the benefits derived from specific antihypertensives, Medicare elders may
choose not to acquire their prescriptions (Benson & Britten, 2002). Information about
hypertension may allow Medicare elders to choose dietary methods for hypertension
prevention and treatment (Appel et al., 2006). Learning about preventing adverse
cardiovascular events (Andrawes, Bussy, & Belmin, 2006) may influence antihypertensive
acquisitions and provide information for making informed choices (Benson & Britten,
2002). Media events may have an influence on antihypertensive acquisitions as direct
marketing to Medicare elders may induce them to visit their physician to discuss treatment
options (Datti & Carter, 2006).
Access Behavioral Methods
Access Behavioral Methods includes acquisition of antihypertensives by legal
methods, by other than purchase, and not acquired. Acquisition of antihypertensives by
legal methods may be influenced or dependent upon perceptions of affordability. Dual
Eligible (Medicare elders with both Medicare and Medicaid) with PDPs may perceive that
they are able to acquire affordable antihypertensives (Elam, 2006). Medicare elders who
are able to afford prescribed drugs may be able to take dosage amounts as prescribed
(Gottlieb, 2000). Increases in adherence through improved access may improve an
individual's quality of life through better disease control (Meyer, 2002).
Acquisition of antihypertensives other than purchase may include free samples
from the doctor's office (Montemayer, 2002). Additionally, the availability of nonprescription drug alternatives may influence antihypertensive acquisitions (Balkrishnan,
1998). Not acquired by any method is an option for Medicare elders who either do not
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believe that antihypertensives are necessary to treat their hypertension (Home & Weinman,
1999) or are unable to afford their antihypertensives despite having a prescription drug
plan (Blustein, 2002; Bowman, 2007).
Outcome
Outcome includes (a) acquired prescribed supply of antihypertensives by legal
methods, (b) did not acquire prescribed supply of antihypertensives, and (c) did not
acquire any antihypertensives. Acquired prescribed supply of antihypertensives by legal
methods includes purchase through pharmacy or by mail order utilizing the Medicare Part
D plans or obtaining samples in prescribed amounts from doctors' offices or clinics. Did
not acquire prescribed supply of antihypertensives includes any non-legal method, which
may include sharing, skipping, or utilizing reimportation from non-U.S. countries. Did not
acquire any antihypertensives includes use of herbal treatment remedies or not acquiring
any of the prescribed treatments by a health care professional.
Empirical Support for the Proposed Pharmaceutical Acquisition
Model for Medicare Elders (PAMME)
This study tested the proposed Pharmaceutical Acquisition Model for Medicare
Elders (PAMME) against the enhanced Health Belief Model (HBM), thereby providing an
initial assessment of the proposed PAMME's usefulness predicting antihypertensive
acquisition behaviors. Testing the proposed model against the time-tested enhanced HBM
was expected to provide information previously lacking for Medicare elders'
antihypertensive acquisition behaviors.
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Chapter 3
METHOD
Overview
The purpose of this study was to test the usefulness of the proposed
Pharmaceutical Acquisition Model for Medicare Elders (PAMME). This model expanded
upon the constructs from the enhanced Health Belief Model (HBM) (Janz & Becker,
1984), Consumer Choice Theory (Friedman, 1990), and the Medication Adherence Model
(Johnson, 2002) with respect to decision making for antihypertensive acquisitions. The
various components of the PAMME were tested to determine which factors, if any, exert
influence upon decision making for antihypertensive acquisitions. The performance of the
proposed PAMME was compared to that of the enhanced HBM to determine if it a better
predictor of antihypertensive acquisition behavior by Medicare elders.
This study employed a quasi-experimental, retrospective, mixed-methods design. A
combination of primary and secondary data was used to examine the various factors that
may influence antihypertensive acquisitions. The population of interest in this study was
low-income, Medicare elders in southeastern Virginia (see Appendix I). Low-income was
assessed at 150% of the poverty level (Centers for Medicare and Medicaid Services,
2005a). A Medicare elder is a beneficiary who has attained at least 65 years of age
(Centers for Medicare and Medicaid Services, 2006). Antihypertensive Acquisition (Yes/
No) was assessed based upon whether Medicare elders legally obtained the prescribed
amounts of antihypertensives with the intention of taking them as directed by their
physician.
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Human Subjects Review
This study complied with all Human Subjects Review guidelines and was approved
by the Institutional Review Board (IRB) prior to the beginning of data collection. Copies
of the sample consent letters are included in Appendix V.
Target Population
The target population of this study was Medicare elders who were prescribed at
least one antihypertensive and who were assisted by Senior Services of Southeastern
Virginia (SSSEVA) to enroll in the Medicare prescription drug discount or Advantage
plans. Medicare elders were screened for Extra Help (i.e., Low Income Subsidy or LIS).
SSSEVA is the local Agency on Aging (AoA), the Virginia Insurance Counseling
Assistance Program (VICAP), and the local State Health Insurance Program (SHIP) for
southeastern Virginia.
Sample Size Selection
Sample size calculations were made using the formula (see Appendix II) for
statistical power and optimal sample size to obtain a power of alpha = .05. It was
necessary to select an appropriate sample size sufficient to identify a meaningful difference
between elderly Medicare elders who acquire prescription drugs as prescribed and those
who do not. The formula was used to calculate the correct sample size for the power
selected: too much power (or too large a sample) might decrease the ability to identify
appropriate statistical significance (Creative Research Systems, 2003; Israel, 2003; Sigma
Six, 2007). Conversely, too small a sample had the potential to identify incorrectly a
difference that might exist (Creative Research Systems, 2003; Israel, 2003; Sigma Six,
2007).
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Approximately 1,179 Medicare elders (65+ years of age) could be contacted using
complete contact data. Of the Medicare PDP enrollees, 96 had applied for the Extra Help
program (i.e., Low Income Subsidy or LIS). Closer examination of the database records
revealed that not all 1,179 were eligible to be contacted. A portion of this sample was
taking prescription drugs for the treatment of mental health (e.g., dementia, Alzheimer's,
among others) or was lost to follow-up (e.g., moved, in a nursing home, living with
relatives). These Medicare elders were excluded from the research study for obvious
reasons. A total of 868 Medicare elders were eligible to participate. They were sent
invitations with study materials and consent forms. All research materials were mailed to
Medicare elders with self-addressed and postage-paid return envelopes to facilitate return
mailing.
Not all of the invited Medicare elders consented to participate. Additional
invitation letters were sent to those who had not been contacted during the first mailing.
Initially, 670 Medicare elders were contacted for interviews. A second, then a third mailing,
was sent to those Medicare elders who had not previously been invited. The revised
calculations for statistical power indicated that a sample size of 67 completed surveys was
necessary for an alpha of .05 significance. The number of Medicare elders consenting was
81; however, not all were able to complete the survey for reasons explained in Chapter 5.
Medication Education Database Information
The information collected in the Medication Education Database (see Table 4 in
Chapter 1) contains information about the clients who were assisted by SSSEVA with
insurance and health care needs. The Medication Education Access database contains 44
fields of information collected for health insurance contacts. This database has been
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continuously maintained and updated for the past five years (October 2004 to the present)
and originated with the Medicare Modernization Act of 2003 implementation efforts. The
portions of the database that are relevant to Medicare Part D and this study are Last
Contact Date, Type of Contact, Age, Ethnicity, Marital Status, Home City, Emergency
Contact Type, Extra Help-related, Hypertensive Status, Health Status, Insurance Status,
Part D-related and New to Medicare. The other information, while not directly related,
might be useful if the referral was from either a doctor (or other health professional) or an
elder's pharmacist.
Hypertensive Status was indicated separately from Health Status to identify elders
who were prescribed at least one antihypertensive. Health Status differs from Hypertensive
Status as it identifies Disability Status as well as hospitalizations and any other chronic
illness(es). Insurance Status is used to identify whether a contact has Creditable Coverage
or is Enrolled in Part D or a Medigap supplement with prescription drugs.
Participant Selection Criteria
Inclusion Criteria
Participants were selected from consenting Medicare elders assisted by Senior
Services of Southeastern Virginia (2006, 2007, 2008) for MMA enrollment and LIS
screening for whom complete contact information (name, age, address, and telephone) was
available. Age as of last birthday was used in place of birth date. Identification of age was
necessary, as only those at least 65 years of age were included in this study. An elder's
eligibility for Medicare was based upon being 65 years of age versus elders who were
medically diagnosed with a disability and meeting the 24-month waiting period (Centers
for Medicare and Medicaid Services, 2005a). All income levels were included in this study;
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however, the focus was upon low-income elders since they were identified previously as
having acquisition problems for prescription drugs (Elam, 2006; Klein, Turvey, & Wallace,
2004). Low income was defined as 150% of poverty level income. Those elders not
classified as having a low income were above the poverty level and were screened not
eligible for Extra Help (Centers for Medicare and Medicaid Services, 2005b).
Additionally, Medicare Modernization Act enrollees' records were screened for the
prescription drug discount plan status enrollment (PDP or Advantage) and Extra Help
status (application and approval). The inclusion of those enrolled during the full
implementation of the MMA's prescription drug discount card program provided historical
data for those continuously enrolled.
Exclusion Criteria
Medicare elders with creditable coverage (employer- or military-based insurance
that is equivalent or better than Medicare) who are not required to participate in MMA
were excluded. Database records of Medicare elders with incomplete or missing
demographic or contact data were excluded from this study. In addition, Medicare elders
were excluded from this study if they were unable to speak or understand English because
the survey instrument was not available in other languages. Medicare elders who were not
able to use a telephone or who were not mentally capable and/or unable to make their own
decisions related to their health or health options were excluded (i.e., those elders whose
files included a Power of Attorney to a caregiver). The administered survey instrument
included questions from the Short Portable Mental Status Questionnaire (SPMSQ).
Medicare elders who were unable to respond successfully to the initial four questions (i.e.,
if they failed the mental portion of the questionnaire) also were excluded from this study.
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Data Collection
Data collection included information from primary (administered surveys) and
secondary data sources (Senior Services of Southeastern Virginia [SSSEVA] enrollment
databases). Data collection forms and surveys were randomly assigned numbers to
facilitate data entry into SPSS (Version 16.0 for Windows). Approval by the Chief
Executive Officer and the Board of Directors of SSSEVA was granted to access the
necessary Medicare enrollee databases and to contact those clients required to conduct this
study (see Appendix VI).
Screening and Data Collection Instruments
A combination of quantitative and qualitative information was collected using three
types of data-screening and collection instruments. The first was the master screening
document that was used to compile the master record of hypertensive Medicare elders,
including demographic data such as name, age, address, and telephone number. The
second was the screening of plan enrollment and Extra Help, which recorded hypertension
status and Extra Help status of Medicare elders. Lastly, the administered survey log was
used to contact selected Medicare elders for the study.
Screening and Random Sample Data Collection Instruments
A records review was conducted to identify current enrollment information such as
Medicare Part D enrollment status, Extra Help status, demographic information,
antihypertensive usage, and any notable acquisition experiences. The framework for the
collection of data from the master dataset included an assessment tool that allowed data
matching with individual enrollment and application records collected from 2006 to
present.
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Identification of Medicare elders with hypertension who were prescribed at least
one antihypertensive (see Table 5 and Table 6) was necessary so that invitations were sent
only to those individuals meeting the inclusion criteria for the target population.

Table 5
Master Screening to Collect Demographic Information
Random
Database

Number

Number

Assigned

Name

Phone

Age

Gender

Ethnicity

HBP

M/F

White
Black
Asian
Hispanic
Other

YES/NO

(65+)
Last,
First

(757)
XXXXXXX

Data screening of Medicare elders' hypertension status and their prescription drug
plan and Extra Help status was conducted. This screening instrument (see Table 6)
includes age (65+) and hypertension (HBP) with at least one blood pressure medicine
prescribed. Additionally, the Medicare elders selected were those who had been assisted
with Part D enrollment and Extra Help application. The data-screening instrument for
hypertension and insurance status was used to select those Medicare elders from a
secondary dataset who had been prescribed at least one antihypertensive and were assisted
with enrollment into a Medicare Part D or Advantage plan for FY 2006, FY 2007, and/or
FY 2008. All screening documents were securely maintained (i.e., password and key
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protected) in a locked room within a locked filing cabinet. Additionally, Table 7 was used
to match Extra Help and Part D for FY2006, FY2007, and FY2008.

Table 6
Data Screening for Hypertension and Insurance Status
Number

Name

Phone

Age

HBP

(65+)
Random

Last,
First

(757)
XXX-

HBP

MMA

EH

RX

Status

Status

YES/NO

YES/NO

YES/NO YES/NO

xxxx

Table 7
Survey Data Collection: Part D and Extra Help Status
Number

Name

Random
Number
Assigned

Last,
First

2006
Extra
Help
Approved

2007
PDP
or
ADV

Extra
Help

2008
PDP
or
ADV

Extra
Help

PDP
or
ADV

The Data Collection List for Consent Results (see Table 8) includes the random
numbers assigned to the Medicare elders selected randomly from the Preliminary Data
Screening Master List. The random numbers and contact information were used to send
the invitation to participate in the research study. The Survey Data Collection List for
Consenting Responses recorded the responses from Medicare elders who consented to
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participate in administered interviews. Medicare elders had two methods for consent:
signing and returning the invitation letter or verbal consent via the telephone.

Table 8
Survey Data Collection: Consent Response
Number

Name

Phone

Address

Age

Mailed

Consent

Date
Random
Number
Assigned

Last,
First

(xxx)
xxxxxxx

City,
ST Zip

>65

Date

Time

Yes

No

Table 9 includes the random numbers of consenting Medicare elders. The
administered survey instruments utilized to contact Medicare elders contained only the
random number assigned, name, and administered number. Three attempts were made to
contact Medicare elders from those randomly selected from among the Medicare elders
agreeing to participate.

Table 9
Survey Data Collection: Medicare Elders'Administered Interview Results
Number

Random
Number

Name

Last,
First

Phone

(xxx)
xxxxxxx

Attempt

Attempt

Attempt

1

2

3

Date

Tune

Date Time

Complete

Date Time Yes No
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Data Collection: Medicare Elders 'Administered Interview Results
The survey instrument was a modified version of the Henry J. Kaiser Family
Foundation's Medicare Elders Experiences with Part D, a nationally administered survey
that obtained good results for Medicare beneficiaries. Approval was granted via e-mail and
administered from the Henry J. Kaiser Family Foundation to use select portions of the
Seniors' Early Experiences with Their New Drug Plan - June 2006 survey with the
provision that a copy of the results would be forwarded to the Foundation upon
completion of this study. The survey instrument comprised the Medicare section of the
survey (Henry J. Kaiser Family Foundation, 2006b). Initial questions from the administered
survey were taken from the Short Portable Mental Status Questionnaire (SPMSQ) to
screen for mental deficiencies that would prevent Medicare elders from effectively
completing the survey. Additionally, the survey contained Questions to Identify Patients
Experiencing Medication Cost Problems (California Healthcare Foundation, 2005);
Medication Adherence - Morisky Scale (Vik et al., 2005) as well as the SSSEVA's Access
& Acquisition of Prescription Drugs Survey (Senior Services of Southeastern Virginia,
2005). The modifications include additional questions relating to adherence (Morisky
Scale) and acquisition decisions relating to affordability and adherence (Questions to
Identify Patients Experiencing Medication Cost Problems). Overall, the survey questions
were designed to elicit responses that might improve our understanding of prescription
drug discount plan enrollment and usage experiences, as well as identify affordability or
health beliefs related to antihypertensive acquisition with usage intentions.
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Seniors' Early Experiences with Their New Drug Plan-June 2006
The Henry J. Kaiser Family Foundation (2006b) was instrumental in conducting
research to determine if the new MMA's implementation was beneficial for Medicare
elders. The survey was administered nationwide to Medicare beneficiaries. The survey
instrument has a demonstrated reliability of .927 for gathering Medicare beneficiaries'
prescription drug plan experiences.
The Short Portable Mental Status Questionnaire
The Short Portable Mental Status Questionnaire has been used successfully (.738)
with aging populations to measure cognitive impairment and to detect early stages of
dementia (Eissa, Andrew, & Baker, 2003).
Morisky Scale
The Morisky Scale was developed to assess prescription drug adherence and has
been used successfully for chronic disease medication-taking behaviors (Vik et al., 2005).
The Morisky Scale has been used previously with hypertensive elders (Val, Amoros,
Martinez, Fernandez, & Leon, 1992) and has a demonstrated reliability of .640 when used
with elders who are similar to the target population of this study (Val et al., 1992; Vik et
al., 2005).
California Medication Affordability Survey
The California Medication Affordability Survey has been used to determine how
affordability influences medication acquisition. This survey instrument has been utilized
successfully (.744) with populations with chronic illness and disease, including Medicare
elders (California Healthcare Foundation, 2006).

78

SSSEVA: Access & Acquisition of Prescription Drugs Survey
The SSSEVA: Access & Acquisition of Prescription Drugs Survey has been useful
(.854) in determining how the MMA affected prescription drug access and acquisition
(SSSEVA, 2006). Table 10 summarized the reliability coefficients for each of the surveys
and scales used in this research.

Table 10
Summary of Reliability Coefficients
Survey Instruments

Reliability
Coefficients

Senior's Early Experiences with Their New Drug Plan - June 2006

.927

Short Portable Mental Status Questionnaire (SPMSQ)

.738

Morisky Scale

.640

California Medication Affordability Survey

.1AA

The Senior Services of Southeastern Virginia (SSSEVA)
Access and Acquisition of Prescription Drugs Survey

.854

Survey Administration
The survey was administered by trained interviewers (approximately 25 to 30
minutes in-person and approximately 45 minutes by telephone). The instrument included
research variables (see Table 11) and questions about experiences with prescription drug
plan enrollment, Extra Help approval status, demographics, health status, prescription drug
insurance status, and antihypertensive acquisitions (including affordability and usage

Table 11
Research Variables Linked to Model

Variables

Label

Constructs

Measurement

Data

Instrument

Source

Model
Components

Acquire
Antihypertensive
(Yes/No)

Nominal

Individual
Survey

Administered
Survey

Likelihood of
Action:
Likelihood of
Behavioral
Change

Age on Last
Birthday

Ratio

Access
Database/
Individual
Survey

Data
Collection
Form/
Administered
Survey

Demographics
Age

Gender

Male
Female

Nominal

Access
Database

Data
Collection
Form

Demographics
Gender

Marital Status

Married
Separated
Divorced
Widowed
Single

Nominal

Access
Database/
Individual
Survey

Data
Collection
Form/
Administered
Survey

Demographics
Marital Status

Ethnicity

Caucasian
AfricanAmerican
Asian
Hispanic
Other

Nominal

Access
Database/
Individual
Survey

Data
Collection
Form

Demographics
Ethnicity

Gross Monthly
Income

Self-Reported
Amount

Ratio

Access
Database/
Individual
Survey

Data
Collection
Form/
Administered
Survey

Demographics
Income

Annual
Income

Gross Monthly
Income x 12
mos.

Ratio

Access
Database/
Individual
Survey

Data
Collection
Form/
Administered
Survey

Demographics
Income

Outcome
Variable

Independent
Variables
Demographic/
Socioeconomic
Age
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Table 11 (continued)
Variables

Label

Measurement

Data

Instrument

Source

Model
Components

Education
Level

Highest Level
Completed

Ordinal

Self-Reported

Administered
Survey

Demographics
Education

Self-Efficacy

Very
Confident-Not
Confident

Ordinal

Self-Reported

Administered
Survey

Individual
Perceptions:
Self-Efficacy

#
Antihypertensive
Prescribed by
Doctor

Ratio

Self-Reported

Administered
Survey

Individual
Perceptions:
Perceived
Severity

Decision of #
Antihypertensives
to Take

#
Antihypertensive
Taken

Ratio

Self-Reported

Administered
Survey

Likelihood of
Taking Action

Decision of #
Antihypertensive
Not Taken

#
Antihypertensive
Not Taken

Ratio

Self-Reported

Administered
Survey

Individual
Perceptions:
Barriers

Decision to
acquire
Antihypertensive
(which per
month)

Name
Antihypertensive
Acquired

Nominal

Self-Reported

Administered
Survey

Likelihood of
Taking Action

Ratio

Self-Reported

Administered
Survey

Likelihood of
Taking Action

Medication
Taking
#
Antihypertensive
Prescribed

Decision to
obtain
Antihypertensive
other than
acquisition

Antihypertensives
Obtained By
Other than
Acquisition

Perceived
Health Status

Diseases
taking Rx to
treat or
Prevent

Nominal

Self-Reported

Administered
Survey

Individual
Perceptions;
Perceived
Health

Perceived
Need for
Antihypertensive

Hypertension:
Serious/Not
Serious

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Cost vs.
Benefit

Perceived
Barriers for
Antihypertensive

Easily
Acquire/Not
Easily Acquire
Antihypertensives

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Barriers
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Table 11 (continued)
Variables

Label

Measurement

Data

Instrument

Model
Components

Source
Believe
Antihypertensive
helps prevent/
control disease
(Yes/No)

Nominal

Self-Reported

Administered
Survey

Individual
Perceptions:
Perceived
Effectiveness

Sharing
Skipping
Free Samples
NonRx
Alternatives
Other

Nominal

Self-Reported

Administered
Survey

Likelihood of
Action:
Acquisition
other than
Purchase

Enrolled
(Yes/No)

Nominal

Database &
Self-Reported

Data
Collection
Form/
Administered
Survey

Likelihood of
Action: Part D
Enrolled

Part D Usage

Used to
Acquire Rx
(Yes/No)

Nominal

Self-Reported

Administered
Survey/Plan
Quarterly
Report

Likelihood of
Action: Rx
Acquisition

Extra Help
Applied Status

Applied
(Yes/No)

Nominal

Database &
Self-Reported

Data
Collection
Form/Phone
Survey

Likelihood of
Action: Extra
Help Applied

Extra Help
Approved
Status

Approved
(Yes/No)

Nominal

Database &
Self-Reported

Data
Collection
Form/Phone
Survey

Likelihood of
Action: Extra
Help Approved

Prescription
Drug
Enrollment
Confusion

Confusion
Enrolling in
Part D: Not
Confusing/
Very
Confusing

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Barriers

Perceived
Effectiveness
of
Antihypertensive

Prescription
Drug
Acquisition
Behaviors
What other
methods used

Plan
Experiences
Part D Status
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Table 11 (continued)
Variables

Label

Data

Measurement

Model

Instrument

Source

Components

PartD
Monthly
Premiums

Monthly
Premiums
Affordable/Not
Affordable

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Cost vs.
Benefit

PartD
Co-Pays

Co-Pays
Affordable/Not
Affordable

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Cost vs.
Benefit

Prescription
Drug
Acquisition
Problems

Difficulty
Using Part D
to Acquire Rx:
No Difficulty/
Very Much
Difficulty

Scale

Self-Reported

Administered
Survey

Individual
Perceptions:
Barriers

intentions). The survey used existing valid and reliable survey instruments to address the
hypotheses and research questions posed by this study.
Seven-day pillboxes were given to those consenting Medicare elders who
participated and completed the survey. Medicare elders who consented but were unable to
participate also received the seven-day pillboxes.
The administered survey items are linked with the variables for the enhanced
Health Belief Model (see Table 12) and the proposed Pharmaceutical Acquisition Model
for Medicare Elders (see Table 13).
Table 14 maps the administered survey (including question source) to the PAMME.
The questions reflect the addition of the Consumer Choice Theory and the Medication
Adherence Model to the enhanced HBM. The inclusion of these additional questions
enabled the researcher to compare the two models to determine if increased predictability
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Table 12
Administered Survey Items Matched to the Model Variables for the Enhanced Health
Belief Model (HBM)
Type of Variable

Survey

Measurement

Item#

Level

Dependent Variable(s)
Outcome
Acquired prescribed supply of antihypertensive(s)
Did not acquire prescribed supply of antihypertensive(s)
Did not acquire any antihypertensive(s)

33
34
9B,35

Nominal
Nominal
Nominal

32A, 32D
32E
9B, 38B, 38C

Nominal
Nominal
Nominal

SPMSQ3
Dl
D2
D3
D4
D5
D6

Ratio
Nominal
Nominal
Nominal
Ratio
Ordinal
Ordinal

5

Nominal

9A-9H
17
18

Nominal
Ordinal
Ratio

Access Behavioral Method
Acquire antihypertensive(s) from pharmacy
Acquire hypertensive(s) other than purchase
Not acquired by any method
Independent Variable(s)
Demographic and Socioeconomic
Age
Gender
Ethnicity
Marital status
Monthly gross income
Annual income
Educational level
Antihypertensives

Self-Efficacy

Feel confident to acquire blood pressure Rx as prescribed
Perceived Barriers: Antihypertensive Acquisition
Medicare plan and acquiring Rx
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Table 12 (continued)
Type of Variable

Survey

Measurement

Item#

Level

Difficulties with Plan

38A-38G

Nominal

Problems?

44

Nominal

Perception of policy?

52

Nominal

Taking Antihypertensives?

22

Ratio

# Antihypertensives prescribed?

33,34
22

Nominal
Ratio

# Antihypertensives taken?

31A

Ratio

Antihypertensives taken: Name

31B

Nominal

Antihypertensive-taking behavior

30

Nominal

Perceived health status

16

Nominal

Perceived need for antihypertensives

13,14

Nominal

Perceived effectiveness of antihypertensives

12

Nominal

Perceived safety of antihypertensives

15

Nominal

Social support

23
24A-24J

Nominal
Nominal

Doctor

25

Nominal

Cues to Action - Symptoms

26C, 26D

Ordinal

Cues to Action - Side Effects

27A-27J

Ordinal

Cues to Action - Information

28A-28E

Nominal

Cues to Action - Media Events

29A-29E

Nominal

Perceived Benefits: Antihypertensive Acquisition
Antihypertensive regular usage status

Modifying Factors
Knowledge
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Table 13
Model Variables Matched to the Pharmaceutical Acquisition Model
for Medicare Elders (PAMME)
Type of Variable

Survey

Measurement

Item#

Level

Dependent Variable(s)
Prescription Drug Acquisition
Acquired Antihypertensive with plan?

33
32A-32B

Nominal
Nominal

Decision to Acquire Antihypertensives - Doctor

241, 25

Nominal

Decision to Acquire Antihypertensives - Pharmacist

24J

Nominal

How Many Antihypertensives Acquire Regularly?

33

Ratio

Decision to obtain - other than purchase

32E

Ordinal

Gender

SPSMQ 3
Dl

Ratio
Nominal

Marital Status

D2

Nominal

Ethnicity

D3

Nominal

Monthly Gross Income

D4

Ratio

Annual Income

D5

Ratio

Education Level

D6

Ordinal

What are the date, month, and year?

SPMSQ 1

Nominal

What is the day of the week?

SPMSQ 2

Nominal

How old are you?

SPMSQ 3

Ratio

When were you born?

SPMSQ 4

Nominal

Impression of Benefit

39

Nominal

Knowledge of Late Enrollment Penalty?

46

Nominal

Independent Variable(s)
Demographic & Socioeconomic
Age

Cognitive Ability

Plan Experiences
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Table 13 (continued)
Type of Variable

Extra Help Benefit?
Difficulty of Enrollment
Choosing a Plan - Importance
Decisions About Choosing Plan
Plan Experience - Better/Worse
Type of Medicare Plan
Plan Choice Satisfaction
Plan Acquisition w/ Plan?
Difficulties getting card?
Rx not covered by plan
Billing Mistake by plan
Switching plan
Coverage gap? (write in comments)
Message to policy makers

Survey

Measurement

Item*

Level

37
42
44,45
46,47
48A-48D
36
39
34,35
38A
38D
38F
47
—

52

Self-Efficacy
Confidence in ability to acquire
Affordability
Saving Money w/ Plan?
Saving a lot/a little?
Paying a lot /a little"
Help paying for Rx
Find assistance to pay for Rx
Ask whether could afford Rx
Where to get less expensive

Nominal
Ordinal
Nominal
Nominal
Nominal
Nominal
Ordinal
Ordinal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal

Nominal

49
50
51
20A
20E
20C
20D

Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
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Table 13 (continued)
Type of Variable

Survey

Measurement

Item#

Level

Willingness to Pay
Pay for better health?
Pay for Rx drug plan?
Pay for Antihypertensive Rx

17
18
19

Ordinal
Ratio
Ratio

Health Status
Perceived Health Status

16

Nominal

Hypertensive Status
When Diagnosed with HBP?

31

Nominal

Health-Care Decisions
Social Support
Doctor Assistance

24A-24J
25

Nominal
Nominal

Antihypertensives
Number of Antihypertensives prescribed
Decision of Number Antihypertensives Taken
Antihypertensives Actually Take by Name
Switched Rx Effective
Perceived Need for Antihypertensives
Perceived Safety of Antihypertensives
Antihypertensive Usage Status
Perceived Barriers to Antihypertensive Acquisitions
Rx not covered by plan
Couldn't afford
Transportation problems
Problems Acquiring
NotfilledRx or Skipped

35
37
38
47
33
32
34
22,41,46
20D
20C, 20E
46
20B
26C

Ratio
Ratio
Nominal
Ordinal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
Nominal
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Table 14
Pharmaceutical Acquisition Model for Medicare Elders (PAMME) Mapped to
Administered Survey and Survey Question Sources
Survey
Question
Number(s)

Survey
Question(s)
Source

Education

Dl
D2
D3
D4
D5
D6

2006 SE Dl
2006 SE D3
2006 SE D4
2006 SE D5
2006 SE D6
2006 SE D7

Independent
Independent
Independent
Independent
Independent
Independent

Variable
Variable
Variable
Variable
Variable
Variable

Cognitive Ability
Date, Month, Year
Day of Week
How old
When born

1
2
3
4

SPMSQ 1
SPMSQ 2
SPMSQ 5
SPMSQ 6

Independent
Independent
Independent
Independent

Variable
Variable
Variable
Variable

Individual Perceptions
Self-Efficacy

5

Catz, Kelly, Bogart,
Benotsch, & McAuliffe
(2000)

Independent Variable

Health Status

16

2006 SE 39

Independent Variable

Willingness to Pay

17
18
19

Donaldson, Thomas, &
Torgerson (1997)

Independent Variable
Independent Variable
Independent Variable

Perceived threat of hypertension

7

Gohar, Greenfield, Beevers:, Independent Variable
Lip, & Jolly (2008)

Perceived susceptibility/
seriousness of hypertension

6
8
36
26A

Gohar, Greenfield, Beeversi, Independent Variable
Lip, & Jolly (2008)
Independent Variable
Independent Variable
Morisky
Independent Variable

Perceived barriers vs.
perceived benefits of
acquiring antihypertensives

11
7
8
9
9A

2006 SE 8
2006 SE 10
2006 SE 11
2006 SE 12

Demographic Factors
Gender
Marital Status
Ethnicity
Income

Relating to the Model

Independent
Independent
Independent
Independent

Variable
Variable
Variable
Variable
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Table 14 (continued)
Survey
Question
Number(s)

Survey
Question(s)
Source

9B
9C
9D
12

2006 SE 12
2006 SE 12
2006 SE 12

Perceived need,
effectiveness, and safety
of antihypertensives

13
14
33
34
37
38

Relating to the Model

Independent
Independent
Independent
Independent

Variable
Variable
Variable
Variable

Independent
Independent
Independent
Independent
Independent
Independent

Variable
Variable
Variable
Variable
Variable
Variable

Modifying Factors
Knowledge
Social Support

23
24A - 24J

2006 SE 9

Independent Variable
Independent Variables

Doctor Assistance

25

SSSEVA

Independent Variable

Cues to Action: Symptoms
Cues to Action: Side Effects
Cues to Action: Information
Cues to Action: Media Events

26C-26D
27A-27J
28A-28J
29A-29F

Independent
Independent
Independent
Independent

32A, 32D

Dependent Variable

32E
38B, 38C

Dependent Variable
Dependent Variable

33

Dependent Variable

34

Dependent Variable

35

Dependent Variable

Access Behavioral Method
Acquire antihypertensive(s)
from pharmacy
Acquire anti-hypertensive(s)
other than purchase
Not acquire by any method
Dependent Variable
Outcome
Acquired prescribed supply
of antihypertensive(s)
Did not acquire prescribed
supply of antihypertensive(s)
Did not acquire
any antihypertensive(s)

Variable
Variable
Variable
Variable
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was possible given the added constructs. The inclusion of the cognitive ability questions
allowed for exclusion of any consenting Medicare elders who were not mentally competent
to answer the survey questions. The only demographic variable that was included in the
cognitive ability portion was age. Age was not asked any other place in the survey
instrument and was readily verifiable with database records.
Research Hypotheses
Ho 1: Medicare elders do not legally acquire 100% of prescribed antihypertensive.
Hal:

Medicare elders legally acquire at least 70% of their prescribed antihypertensives.

Ho2: The enhanced Health Belief Model overall does not explain Medicare elders'
antihypertensive behaviors.
Ha2: The enhanced Health Belief Model overall explains less than 60% of
antihypertensive behaviors for antihypertensive Medicare elders.
Ho2a: Individual perceptions for disease severity have no influence on Medicare
elders' decision to acquire antihypertensives.
Ha2a: Medicare elders who perceive their hypertension as serious may be more
likely to acquire their antihypertensives.
Ho2b: Perceived benefits of antihypertensives have no influence on Medicare
elders' decision to acquire antihypertensives.
Ha2b: Medicare elders who perceive the benefits of taking antihypertensives will
be more likely to acquire legally their antihypertensives.
Ho2c: Perceived barriers have no influence on Medicare elders' acquisition of
antihypertensives.
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Ha2c: Medicare elders' perceptions about out-of-pocket expenditures will have a
statistically significant influence on their decision to acquire
antihypertensives.
Ho2d: Perceived seriousness of hypertension will have no influence on Medicare
elders' decision to acquire antihypertensives.
Ha2d: Medicare elders who perceive hypertension as serious will be more likely to
acquire antihypertensives than those who do not perceive hypertension as
serious.
Ho2e: Cues to action has no influence on Medicare elders' decision to acquire
antihypertensives.
Ha2e: Medicare elder's decision to acquire their antihypertensives is influenced by
education and hypertension symptoms.
Ho3: Constructs from the both the Medication Adherence Model and Consumer Choice
do not significantly explain Medicare elders' antihypertensive acquisition behaviors.
Ha3:

Constructs from both the Medication Adherence Model and Consumer Choice
significantly explain Medicare elders' antihypertensive acquisition behaviors.
Ho3a: Constructs from the Medication Adherence Model added to the enhanced
Health Belief Model does not help to explain antihypertensive acquisition
behavior for Medicare elders significantly greater than the enhanced Health
Belief Model.
Ha3a: Constructs from the Medication Adherence Model helps to explain
Medicare elders' antihypertensive acquisitions significantly greater than the
enhanced Health Belief Model.
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Ho3b: Constructs from Consumer Choice added to the enhanced Health Belief
Model do not help to explain Medicare elders' antihypertensive acquisition
behaviors significantly greater than the enhanced Health Belief Model.
Ha3b: Constructs from Consumer Choice added to the enhanced Health Belief
Model does help to explain Medicare elders' antihypertensive acquisition
behavior significantly greater than the enhanced Health Belief Model.
Ho4: The proposed Pharmaceutical Acquisition Model for Medicare Elder (enhanced
Health Belief Model with constructs from Consumer Choice Theory and
Medication Adherence) does not explain antihypertensive acquisition behavior for
Medicare elders significantly better than the enhanced Health Belief Model.
Ha 4: The proposed Pharmaceutical Acquisition Model for Medicare Elderly (enhanced
Health Belief Model with constructs from Consumer Choice Theory and
Medication Adherence) explains antihypertensive acquisition behavior for Medicare
elders significantly better than the enhanced Health Belief Model.
Data Analyses
Once data collection was completed, data were entered into SPSS (Version 16.0 for
Windows) for analyses. Statistically appropriate methods using bivariate and multivariate
methods were conducted (see Tables 10 and Table 11). Odds ratios were calculated for the
dichotomized variables (acquire/not acquire). Chi-square calculations were employed on
nominal, categorical data. Logistic regression was used to determine those factors that
exerted influence upon the likelihood of antihypertensive acquisitions, including enrollment
and application decisions. Confirmatory factor analysis was conducted on the survey
response data to determine if the questions captured the intended constructs (Meyers,
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Gamst, & Guarino, 2006). Model-fitting techniques were used to examine specific
hypothesized relationships as well as model comparison (Meyers, Gamst, & Guarino,
2006) between the enhanced HBM and the proposed PAMME. Table 15 summarizes the
types of analyses by research hypothesis.

Table 15
Hypotheses and Type ofAnalyses
Hypotheses Number

Type of Analyses

HI

Logistic Regression

H2

Multiple Regression

H2a

Multiple Regression

H2b

Multiple Regression

H2c

Chi-Square

H2d

Chi-Square

H2e

Chi-Square

H3

Model Comparison

H3a

Model Comparison

H3b

Model Comparison

H4

Model Comparison

Data Management
To prevent unauthorized access, Medicare elders' enrollment records and database
files were properly safeguarded via password protection. All materials were kept in a
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locked file cabinet in a locked office. The computer was accessible by password only, and
only the primary researcher had access. Records will be destroyed within five years of the
completion of the study, and the information filed on the research computer will be
reformatted to make retrieval impossible after aggregate analyses and reporting has been
completed.
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Chapter 4
FINDINGS
Overview
The purpose of this study was to test the usefulness of the proposed
Pharmaceutical Acquisition Model for Medicare Elders (PAMME) which was expanded
using constructs from the enhanced Health Belief Model (HBM) (Janz & Becker, 1984),
Consumer Choice Theory (Friedman, 1990) and the Medication Adherence Model (MAM)
(Johnson, 2002) with respect to decision making for antihypertensive acquisitions. The
various components of the PAMME were tested to determine which factors, if any, exerted
influence upon antihypertensive acquisition decisions. The performance of the PAMME
compared to that of the enhanced HBM was slightly better at predicting antihypertensive
acquisition behavior by Medicare elders using this target population.
Data Collection
Target Population
The target population was selected from the Senior Services of Southeastern
Virginia's (SSSEVA) Medicare Medication Management database. Initially, data and file
review identified 1,079 individuals identified with hypertension. Further evaluation
eliminated 181 individuals. Although Medicare eligible, they did not meet the qualifications
set by the research protocol (65 years of age and older).
Informed Consent
Initially invitation letters (N= 858) were sent to potential participants to provide
them with study details and to request their written consent for follow-up contact for the
purposes of completing the administered survey. The individuals who consented were
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contacted by the researcher and trained volunteers. Several attempts were made to contact
the consenting Medicare elders. Follow-ups included site visits to three congregate meal
sites to administer the survey at the consenting Medicare elders' request.
Survey Administration
Those who were contacted were able to complete the administered survey usually
within one hour (approximately 45 minutes by telephone and approximately 25 minutes in
person). The time of 45 minutes was under ideal conditions without Medicare elders
relating additional healthcare experiences. The consenting Medicare elders were allowed to
describe briefly their health care-related experiences. Their remarks were recorded by the
trained interviewers. Rural Medicare elders were unable to be contacted by telephone as
easily as urban dwellers due to attendance at congregate meal sites. Three site visits were
scheduled to Isle of Wight, Suffolk, and Franklin to reach those consenting Medicare
elders. The site directors and staff arranged appointment times for Medicare elders to meet
with a trained interviewer. The Medicare elders explained that they preferred to see the
interviewer face-to-face so that they could decide whether to complete the survey. Several
participants explained that they screened their calls and do not answer surveys by
telephone because they do not know if they can trust the person calling them.
Description of Results of Consumer Choice Theory
and the Medication Adherence Constructs
Willingness to Pay
Table 16 shows the responses for willingness to pay as they relate to better health,
Medicare Part D, and Medicare elders primary blood pressure drug.
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Better health. When asked, How much would you be willing to pay (per year) to
have better health? the majority (53.7%) of respondents either "refused" (35.8%) or did
not know (17.9%) how much they would be willing to pay. For those Medicare elders who
responded to this question, less than one-quarter (23.9%) were "willing to pay between
$101 and $500" with slightly more than 10% (10.4%) "willing to pay between $501 and
$1,000." Less than 5% were either "willing to pay up to $100" (3%) or "over $1,001 or
more" (4.5%). Additional comments by respondents indicated that they would be "willing
to pay whatever was necessary if they could afford it" to have better health.
Medicare Part D Plan. When asked, How much would you be willing to pay (per
month) for a Medicare Part D plan? less than one-third (29.9%) of Medicare elders were
willing to pay nothing ($0) for their Medicare plan or willing to pay from $1 to $35 per
month (31.3%). Less than one-fifth (16.4%) were willing to pay from $36 to $50 per
month to obtain a Medicare Part D plan with more than one-fifth (22.4%) willing to pay
from $51 to $295 for their Medicare Part D plans. As some Advantage plans offered
during the 2008 enrollment year had no premiums due from the member or Medicare
elders who received Extra Help (monthly premium paid by Medicare), it really was
possible to pay nothing ($0) for a plan.
Primary blood pressure drug. Approximately 12% of Medicare elders were not
willing to pay ($0) out-of-pocket expenses for their primary blood pressure drug.
Approximately 49.2% were willing to pay from $1 to $20 per month and more than onethird (31.3%) were willing to pay between $36 and $50. Only 7% were willing to pay
from $51 to $250 out-of-pocket per month for their primary blood pressure drug.
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Table 16
Willingness to Pay for Better Health, Medicare Part D, and Primary Blood Pressure
Drug
Willingness to Pay
Better Health

n

%

67

Nothing

3

4.5

Up to $100

2

3.0

Between $101 and $500

16

23.9

Between $501 and $1000

7

10.4

Over $1001 or More

3

4.5

Don't Know

12

17.9

Refused

24

35.8

Medicare Part D Plan

67

Nothing ($0)

20

29.9

Between $1 and $35

21

31.3

Between $36 and $50

44

16.4

Between $51 and $295

15

22.4

Primary Blood Pressure Drug
Nothing ($0)

67

8

11.9

Between $1 and $20

33

49.2

Between $21 and $50

21

31.3

Between $51 and $250

5

7.6
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Affordability
Table 17 outlines Medicare elders' responses to the survey question that asked, In
the past 12 months, did someone ever? . . . (a) arrange assistance to pay for blood
pressure drugs, (b) talk about which blood pressure drugs definitely not to skip, (c) discuss
the affordability of prescribed blood pressure drugs, (d) provide information about less
expensive blood pressure drugs, and (e) provide information about programs to pay for the
blood pressure drugs.
Arrange assistance to pay for blood pressure drugs. A majority (82.1%) of
Medicare elders responding to questions about assistance from a social worker or other
professional indicated that they had received no assistance. Approximately 18% had
received some assistance.
Blood pressure drugs definitely not to skip. More than two-thirds (73.2%) of those
answering the question about whether anyone in the past 12 months had talk(ed)...
about which blood pressure drugs you definitely should not skip responded "No." More
than one-quarter (26.9%) of Medicare elders responded in the affirmative.
Afford blood pressure drugs when prescribed. The majority (85.1%) of the
Medicare elders responded that they had not been asked whether they could afford blood
pressure prescriptions. Approximately 14.9% indicated that they had been asked.
Information about less expensive blood pressure drugs. Medicare elders also were
asked whether anyone had given them information about where to purchase less expensive
blood pressure drugs. About two-thirds (65.7%) of the respondents indicated that they had
not received information about where to purchase less expensive blood pressure drugs.
Slightly more than one-third (34.3%) answered affirmatively (Yes).
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Information about programs to pay for blood pressure drugs. Medicare elders also
were asked if anyone had given them information about programs that assist individuals
with paying for blood pressure drugs. Less than two-thirds (64.2%) had not received
information; more than one-third (35.8%) had received such information (Yes).

Table 17
Affordability of Blood Pressure Drugs
N=61

No
n (%)

Yes
n (%)

Arrange Assistance to Pay for Blood Pressure Drugs

55 (82.1)

12 (17.9)

Blood Pressure Drugs Definitely Not to Skip

49 (73.2)

18 (26.9)

Afford Blood Pressure Drugs when Prescribed

57 (85.1)

10(14.9)

Information About Less Expensive
Blood Pressure Drugs

44(65.7)

23(34.3)

Information about Programs to Pay for
Blood Pressure Drugs

43(64.2)

24(35.8)

Medication Adherence Model (MAM)
Adherence
To address adherence behaviors, Medicare elders were asked to think about the
blood pressure drugs PRESCRIBED to them by their respective doctors and to respond to
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these questions: Do you ever forget to take your blood pressure drugs? and Are you
careless at times about taking your blood pressure drugs'? Their responses are summarized
in Table 18.
Forget to take. Less than one-half (41.8%) indicated that they never forget to take
their blood pressure drugs. More than one-third (35.8%) responded that they rarely
forgot. Less than 10% (9%) sometimes forgot, and less than 2% (1.5%) forgot either often
or always to take your blood pressure drugs.
Careless about taking blood pressure drugs. Less than two-thirds (61.2%)
indicated that they were never careless at times about taking blood pressure drugs. More
than one-quarter (26.9%) responded that they rarely were careless. Less than 10% (9.0%)
sometimes were careless. Less than 2% (1.5%) were careless at times either often or
always about taking blood pressure drugs.
Stop taking blood pressure drugs: Feel better or feel worse. Medicare elders also
were asked how they felt while taking blood pressure drugs. Some respondents indicated
(see Table 18) that they stopped taking their blood pressure medication when they felt
better. Others indicated that they stopped medicating when they felt worse. More than
three-quarters (85.1%) of respondents do not stop taking blood pressure drugs when they
feel better while more than 10% (10.4%) rarely stop taking the medication when they feel
better. However, approximately 5% (4.5%) admitted to not taking blood pressure
medication sometimes when they feel better. More than three-quarters (85.1%) indicated
that they do not stop taking their blood pressure drugs when they feel worse. However,
more than 10% (11.9%) rarely stopped while 3% sometimes stopped taking them when
they felt worse.
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Table 18
Adherence to a Blood Pressure Drug Regimen
Never

Rarely

Sometimes

Often

Always

AT =67

n(%)

n(%)

n (%)

n (%)

Forget to Take

28(41.8)

24(35.8)

14(20.9)

1(1.5)

Careless about Taking 41(61.2)

18(26.9)

6(26.9)

1(1.5)

Feel Better

57(85.1)

7(10.4)

3(4.5)

—

—

FeelWorse

57(85.1)

8(11.9)

2(3.0)

—

—

n(%)
—
1(1.5)

Access Behavioral Method
Table 19 summarizes the responses of Medicare elders when asked where they
usually acquire their primary blood pressure drugs. The majority (83.6%) always acquire
medication from a local pharmacy. Less than 10% either always receive free samples (6 %)
or acquire their prescription through mail order (9%).
Free Samples
Approximately one-third of Medicare elders who responded received no free
samples (zero) from their doctor or health care provider. Having received no assistance
was not one of the response categories; the answer was a written comment in the margin
of the survey form to indicate that response (see Table 20). Approximately 3% do not
know if they received any free samples. However, more than one-third of Medicare elders
have received either a little help (35.8%) or some help (31.3%) with free samples from
their doctor or health care provider. However, many indicated that free samples were
offered less frequently than in years past.
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Table 19
Method of Acquisition of Primary Antihypertensive (HBP Rx)
Acquisition of

Never

Rarely

Sometimes

Often

Always

Primary HBP Rx:

n(%)

n(%)

n(%)

n(%)

n(%)

Local Pharmacy

4 (6.0)

3 (4.5)

—

4 (6.0)

56 (83.6)

Receive free samples 46 (68.7)

7 (10.4)

8(11.9)

2 (3.0)

4 (6.0)

Share with someone 66 (98.5)

—

1 (1-5)

—

—

From Mail Order

57 (85.1)

1 (1-5)

2 (3.0)

1 (1-5)

6 (9.0)

Other

65 (97.0)

1 (1.5)

1 (1.5)

—

—

Table 20
Free Samples of Prescription Drugs from Physician
Receive Free Samples:

%

No Help (write in response)

20

29.9

A Little Help

24

35.8

Some Help

21

31.3

Don't Know

2

3.0

Antihypertensives Prescribed
Table 21 summarizes the prescribed antihypertensives that respondents indicated as
those prescribed for them. Of the 138 drugs prescribed, approximately one-third (29.9%)
of respondents indicated that they were prescribed Lisinopril. The majority (72.5%) of
respondents were prescribed generics rather than name brand antihypertensives.
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Table 21
Prescribed Antihypertensives
Antihypertensive

%

Lisinopril

21

29.9

Furosemide

18

13.0

Atenolol

10

7.2

HCTZ

8

5.8

Diovan

7

5.1

Metoprolol

7

5.1

Cozaar

5

3.6

Norvasc

5

3.6

Clonidine

4

2.9

Coreg

4

2.9

Other

40

29.0

Generic

00

72.5

Name Brand

38

27.5

Medicare Part D and Extra Help Status
The majority (50.7%) of Medicare elders have a stand-alone prescription drug
plan while less than one-quarter (23.9%) have been approved for Extra Help. Less than
one-half (43.3%) have a favorable view of Medicare Part D, while nearly one-third
(28.9%) indicated an unfavorable view. Approximately 26.9% indicated neutral or do not
know. These responses are listed in Table 22.
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Table 22
Medicare Part D and Extra Help Status
Medicare Part D

n

%

Prescription Drug Plan (stand-alone)

34

50.7

Medicare Advantage Plan w/ Rx

20

29.9

Other (Medigap w/ PDP)

13

19.4

No

51

76.1

Yes

16

23.9

Favorable

29

43.3

Unfavorable

20

28.9

Neutral

13

19.4

5

7.5

Extra Help

View of Part D

Don't Know

Medicare Part D Plan Experiences
Medicare elders' were asked about their experiences obtaining an enrollment card
and using their Medicare Part D plan (see Table 23). The majority (65.7%) have had to
switch from a name brand to a generic drug. The majority have not had difficulty getting
their enrollment card or had to switch to another drug because it was not covered by their
plan. More than one-fourth (28.4%) have had to pay costs they had not expected for a
drug or a premium. The majority (71.6%) of Medicare elders indicated that they believe
that the generic works just as well as the name brand drug (see Table 24).

106

Table 23
Medicare Part D Plan Experiences
Medicare Part D Plan Experiences (N = 67)

% Have

% Have Not

3.0

97.0

Left Pharmacy w/o Rx - not covered by plan

20.9

79.1

Left Pharmacy w/o Rx - not able to afford

13.4

86.6

Switched Rx - not covered by plan

28.6

71.6

Switched from name brand to generic

65.7

34.4

Billing mistake for a Rx or a Premium

7.5

92.7

28.4

71.6

Had difficulty getting enrollment card

Costs hadn't expected for Rx or a Premium

Table 24
Impressions of Generics versus Name Brand Antihypertensives
Generics vs. Name Brand (N = 67)

n

%

Works better

2

3.0

Just as well

48

71.6

7

10.4

10

14.9

Not as well as name brand
Don't know

Enhanced Health Belief Model (HBM)
The demographic characteristics of the respondents are as follows: the majority of
respondents were women (74.6%) who were at least 75 years of age or older (86.6%).
Respondents were either currently married (32.8%) or widowed (44.8%) with a high
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school education (25.4%) or greater (41.8%). The ethnicity of respondents was
approximately one-half Caucasian/white (50.7%) or African-American/black (49.3%).
Those consenting to participate did not indicate any other ethnicity.
Only 57 of the 67 respondents answered the income-related questions. The other
respondents declined to answer those financially sensitive questions. Of those who chose
to respond, 68% had monthly gross incomes of $2,850 or less and 57.9% had annual
family incomes of $20,000 or less. Assets were not surveyed as all participants had been
screened for Extra Help and assets information was available in the Medication Education
database. More than one-third of respondents had assets below $11,750. Table 25
summarizes the demographic information for the survey respondents.
Individual Perceptions
Tables 26 through 29 present information about Medicare elders' perceptions
regarding issues such as the benefits and barriers to acquiring prescribed antihypertensive
drugs. Table 28 indicates that approximately 18% of the respondents are paying more than
$50 in monthly out-of-pocket costs for their antihypertensives. While transportation is not
perceived as a barrier by the majority (95.5%) of respondents, for those unable to obtain
their antihypertensives as prescribed due to transportation barriers it is necessary to assist
in minimizing this barrier. Possibly the use of pharmacies that deliver or Medicare elders'
enrollment in the mail-order option of their prescription drug plans may provide a more
reliable method of acquisition. Some respondents who indicated "No" had additional
comments that their children or a neighbor took them to the pharmacy (often not exactly
when their refills became available, but that they "eventually" were able to obtain their
prescriptions).
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Table 25
Demographics
n

%

Age (Mean = 76.5 years, SD = 6.9 years)
65-74 years old
75-84 years old
85-93 years old

67
26
32
9

Gender
Male
Female

67
17
50

25.4

Ethnicity
Caucasian/white
African-American/black

67
34
33

50.7

Marital Status
Married
Divorced
Separated
Widowed
Never Been Married

67
22
10
2
30
3

Education
None, or grade 1-8
High School Incomplete (9-11)
High School Graduate (12 or GED)
Technical/Trade/Vocational AFTER High School
Some College, no 4-year degree (includes AA/AS)
College Graduate (BS, BA, or other 4-year degree)
Post-graduate or professional schooling
(Master's, PhD, JD, or MD)

67
7
15
17
8
11
5

38.8
47.8
13.4

74.6

49.3

32.8
14.9

3.0
44.8

4.5

10.4
22.4
25.4
11.9
16.4

7.5
6.0
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Table 25 (continued)
n

%

Income - Gross Monthly (Mean = $2,084, SD = $1,506)
$0-$1,250
$1,251 -$2,580
$2,581 -$4,080
$4,081 - $7,250

57
26
13
13
5

45.6
22.8
22.8
8.8

Income - Family
$10,000 or less
$10,001 - $15,000
$15,001 -$20,000
$20,001 - $30,000
$30,001 - $50,000
$50,001 - $75,000
$75,001 - $100,000

57
12
14
7
5
11
5
3

21.0
24.6
12.3
8.8
19.2
8.8
5.3

Modifying Factors
Table 30 summarizes the responses for (a) time since first diagnosed, (b) time
started taking blood pressure drugs, (c) number of different antihypertensives prescribed,
and (d) knowledge of blood pressure effects.
Time since first diagnosed. The Medicare elders who responded had first been
diagnosed from one to 51 years ago. Slightly more than one-third (34.3%) have been
diagnosed with hypertension for 10 years or less. Those Medicare elders who have been
diagnosed with hypertension between 11 years to 25 years are slightly more than
approximately two-fifths (41.8%) and those 26 years to 51 years are less than one-quarter
(23.9%).
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Table 26
Individual Perceptions
n

%

Health Status: In general, would you say your health is?
Excellent
Very Good
Good
Only Fair
Poor

2
11
27
23
4

3.0
16.4
40.3
34.3
6.0

Self-Efficacy: How confident are you that you can get
blood pressure Rx as prescribed by doctor?
Very Confident
Somewhat Confident

50
17

74.6
25.4

Perceived Susceptibility: To your knowledge,
can you avoid getting high blood pressure?
Yes
No
Don't Know

11
43
13

16.4
64.2
19.4

Perceived Threat: How dangerous do you perceive
that high blood pressure is to your health?
(0 = Not Dangerous to 10 = Extremely Dangerous)
(Mean = 8.164, SD = 2.247)
1-8
9-10

29
38

43.3
56.7

Perceived Seriousness: On a scale from zero to 100,
how likely is it that your blood pressure would be high
if you didn't take your blood pressure drugs?
(0 = No Chance to 100 = Extremely Likely)
(Mean = 89, SD = 15.798)
1-60
61-89
90-100

6
14
47

9.0
20.9
70.1

Ill

Table 27
Perceived Barriers (i.e., Cost) to the Acquisition of a Primary Blood Pressure Drug
Never
Acquire Primary HBP Rx? (N = 67)

Rarely

Sometimes

Often

Always

%

%

%

%

%

Take fewer pills or a smaller dose?

68.7

17.9

10.4

3.0

0

Not fill a prescription at all?

82.1

9.0

7.5

1.5

0

85.1

7.5

7.5

0

0

95.5

1.5

3

0

0

stretch out the time before a refill?

83.6

9.0

6.0

1.5

0

Split pills to help them last?

88.1

3.0

6.0

1.5

1.5

Shared pills with anyone else?

98.5

1.5

0

0

0

Someone shared pills with you?

97.0

3.0

0

0

0

Put off or postpone getting
a prescription drug

filled?

Use herbal medicines or vitamins
when you felt sick rather than
take your prescription drug?
Take the drug less frequently
than recommended;
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Table 28
Perceived Barriers to Acquiring Blood Pressure Drugs

Perceived Barriers - Out-of-Pocket Costs
Not counting the costs paid by your insurance, how much do your blood pressure drugs
cost you and your family each month? In other words, how much do you pay out-ofpocket per month? (in dollars)
n
1-10
11-25
26-50
51-100
101-300

67
35
10
10
8
4

%

52.2
14.9
14.9
12.0
6.0

Perceived Barriers - Transportation
In the past 12 months, have you ever not filled your blood pressure drugs because you did
not have transportation to get to the pharmacy?

Yes
No

n

%

67
3
64

4.5
95.5

Time started taking blood pressure drugs. Medicare elders were asked, How soon
after your doctor prescribed a blood pressure drug didyou start taking it? The majority
of respondents started taking their medication either immediately (43.3%) or right away
(29.9%). Approximately 10% (10.5%) started taking it the same day or no later than the
next day ([6.4%).
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Table 29
Perceived Benefit, Need, and Safety of the Acquisition of a Primary Blood Pressure Drug
Perceived Benefit
On a scale from zero to 100, how likely is it that your
BP drugs lower your blood pressure?
(0 = No Chance to 100 = Complete Cure)
(Mean = 84.970, SD = 22.336)
n
"24
43

%
35^8
64.2

Perceived Need
How much do you believe that the BP drugs are
needed to control your HBP?
A little necessary
Somewhat necessary
Very necessary
Extremely necessary
Don't know

n
1
12
23
30
1

%
1.5
17.9
34.3
44.8
1.5

Are you currently taking any prescribed HBP Rx, or not?
Yes

n
67

%

Perceived Safety
How much do you believe that the BP drugs
are needed to control your HBP?
A little necessary
Somewhat necessary
Very necessary
Extremely necessary
Don't know

n
1
12
23
30
1

0 to 85
86 to 100

Note. N = 61.

100

%

1.5
17.9
34.3
44.8
1.5
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Number of different antihypertensives prescribed. The number of different
antihypertensives prescribed for this sample population ranged from one to four different
antihypertensives. Slightly more than one-third (35.8%) have been prescribed at least one
antihypertensive. Those Medicare elders who have been prescribed two different
antihypertensives account for more than approximately one-quarter (28.4%) of the
respondents, with slightly more than one-fifth (22.4%) prescribed three different
antihypertensives. More than 10% (13.4%) of the Medicare elders were prescribed four
antihypertensives.
Knowledge of blood pressure effects. The majority of Medicare elders interviewed
had high levels of knowledge regarding blood pressure effects. Approximately 12% were
extremely knowledgeable about blood pressure and its effects on the body, and 43.3% had
very much knowledge about the effects of blood pressure. Approximately one-fifth had
some (19.4%) or very little (20.9%) knowledge about high blood pressure. Less than 5%
(4.5%) were not at all knowledgeable about the effects of high blood pressure.
Social Support
When asked, How much support do you get in making blood pressure drug
decisions? respondents indicated a reasonably high level of support from doctors and
pharmacists. Considerable variation exists among responses to the other answer categories
to the question (see Table 31).
Spouse. More than three-quarters (80.6%) of Medicare elders interviewed
indicated that they received no support (none) from a spouse. Respondents said that they
received support from a spouse less than 10% for each of the following response
categories: a lot (9.0%), some (7.5%) and very little (3.0%).
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Table 30
Modifying Factors
%

Factors
Time Since First Diagnosed
(Mean = 19 years; SD - 12.9 years, Range: 1-51 years)
Less than 10 years
11 years to 25 years
26 years or more

23
28
16

34.3
41.8
23.9

Number of Different Antihypertensives Prescribed
(Mean = 2 prescribed; SD = 1 prescribed, Range: 1-4 prescribed)
One Antihypertensive
24
Two Antihypertensives
19
Three Antihypertensives
15
Four Antihypertensives
9

35.8
28.4
22.4
13.4

Time Stated Taking Blood Pressure Drugs
How soon after your doctor prescribed
a BP Rx did you start taking it?
Immediately
Right Away
Same Day
Next Day

29
20
7
16.4

43.3
29.9
10.5
16.4

Knowledge of Blood Pressure Effects
Are you knowledgeable of the effect high blood pressure
has on your health?
Not At All
Very Little
Some
Very Much
Extremely Much

3
14
13
29
8

4.5
20.9
19.4
43.3
11.9

Note. N= 67.
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Children. More than one-half (56.7%) of Medicare elders indicated that they
received no support (none) from their children in making blood pressure drug decisions.
Medicare elders who received very little support accounted for 10.4% of respondents.
Approximately 14.9% of Medicare elders received some support, while those who
received a lot of support accounted for 17.9%.
Siblings. The majority of Medicare elders (83.6%) received no (none) support
from their siblings in making blood pressure drug decisions. According to the respondents,
their siblings provided very little support (9.0%), some support (1.5%), and a few received
a lot (6%) of support in making blood pressure drug decisions.
Friend. Less than three-quarters (71.6%) of the Medicare respondents relied upon
a friend or friends for support when making blood pressure drug decisions. Slightly more
than 10% (11.9%) received some support from their friend(s) and other respondents
received either a lot (9.0%) or very little (7.5%) support when making blood pressure
drug decisions.
Neighbor. The majority (85.1%) of respondents indicated that they received no
support (none) from a neighbor when making blood pressure drug decisions. Less than 5%
received either very little (4.5%) or a lot (4.5%) of support from their neighbor.
Approximately 6% received some support when making blood pressure drug decisions.
Visiting Nurse. Almost no respondents (92.5%) received support (none) from a
visiting nurse when making blood pressure drug decisions. Medicare elders received less
than 5% of either very little (3%) or a lot (4.5%) of support from a visiting nurse.
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Social Worker. Almost no respondents (94.0%) received support from a social
worker when making blood pressure drug decisions. Medicare elders received less than
5% of very little (1.5%), some (1.5%), or a lot (3.0%) of support from a social worker.

Table 31
Social Support Experienced by Medicare Elders
How much support do you get in making blood pressure drug decisions from each?
None

Very Little

Some

A Lot

n(%)

n(%)

n(%)

n(%)

Spouse

54 (80.6)

2 (3.0)

5 (7.5)

6 (9.0)

Children

38 (56.7)

7 (10.4)

10(14.9)

12(17.9)

Siblings

56 (83.6)

6 (9.0)

1 (1-5)

4 (6.0)

Friend

48(71.6)

5 (7.5)

8(11.9)

6 (9.0)

Neighbor

57(85.1)

3 (4.5)

4 (6.0)

3 (4.5)

Visiting Nurse

62 (92.5)

2 (3.0)

Social Worker

63 (94.0)

1 (1.5)

1 (1-5)

2 (3.0)

9(11.9)

5 (7.5)

20 (29.9)

34 (50.7)

Pharmacist

29 (43.3)

11 (16.4)

10 (14.9)

17 (25.4)

Other

64 (95.5)

—

Doctor

—

3 (4.5)

3 (4.5)

—

Note. N= 61.
Doctor. A slight majority (50.7%) of Medicare elders received a lot of support
from doctors when making blood pressure drug decisions; approximately one-third
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(29.9%) indicated some support. Medicare elders received approximately 10% of either no
support {none, 10.4%) or very little (7.5%) support from a doctor.
Pharmacist. Less than one-quarter (25.4%) of Medicare elders received a lot of
support from a pharmacist while more than two-fifths (43.3%) indicated that they received
no support {none) when making blood pressure drug decisions. More than 10% received
either very little (16.4%) or some (14.9%) support from a pharmacist in making blood
pressure drug decisions.
Other. Almost all respondents (95.5%) did not receive support from any other
individual not previously mentioned {none); however, approximately 5% (4.5%) relied
upon grandchildren, godchildren, daughters-in-law or church members for support when
making blood pressure drug decisions.
Cues to Action
Side Effects
The following responses from consenting Medicare elders are shown in Table 32.
The majority of respondents suffered no side effects {never) when taking high blood
pressure drugs; however, some of the respondents had side effects ranging from
headaches, dry mouth, and insomnia, among others.
Headache. Approximately 79.1% of Medicare elders never experienced a
headache from taking blood pressure drugs. Approximately 6% rarely or sometimes
experienced headaches. One respondent always suffered from headaches while 7.5% do
not know if their antihypertensive was the reason for their headache.
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Nausea. Approximately 83.6% never experienced nausea when taking their
antihypertensives. Approximately 6% rarely or sometimes experienced nausea, and 4.5%
responded do not know when asked about nausea after taking their blood pressure drugs.
Dizziness. Less than three-quarters (70.1%) of respondents never experience
dizziness when they take blood pressure drugs. Approximately 10% experience dizziness
rarely (10.4%) or sometimes (9%). Approximately 3% always experience dizziness while
6% do not know if dizziness occurs when they take blood pressure drugs.
Loss ofAppetite. More than three-quarters (85.1%) of Medicare elders never
experience loss of appetite when they take blood pressure drugs. Approximately 3%
experience loss of appetite rarely or sometimes (6%). Approximately 6% do not know if
loss of appetite occurs when they take their blood pressure drugs.
Insomnia. More than two-thirds (67.2%) of respondents never experience
insomnia after taking their blood pressure drugs. Approximately 10% experience insomnia
rarely (10.4%) or sometimes (9%). Approximately 4.5% often experience insomnia with
approximately 1.5% always experiencing insomnia Approximately 6% do not know if
insomnia occurs when they take their blood pressure drugs.
Dry Mouth. Approximately one-half (50.7%) of respondents never experience dry
mouth after taking their blood pressure drugs. Less than 10% (7.5%) experience it rarely.
Less than one-fifth (19.4%) of the elders surveyed sometimes experience dry mouth.
Approximately 9% often experience it. Approximately 6% always experience dry mouth
while 7.5% do not know if dry mouth occurs when they take their blood pressure drugs.
Incontinence. Less than three-quarters (74.6%) of respondents never experience
incontinence after taking their blood pressure drugs. Approximately 3% experience
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Table 32
Side Effects
Have you ever experienced any of the following side effects after taking your HBP Rx?
Never

Rarely

Sometimes

Often

Always

Don't
Know

n (%)

n (%)

n (%)

n(%)

n(%)

n(%)

1 (1-5)

5 (7.5)

Headache

53(79.1)

4(6.0)

4(6.0)

—

Nausea

56 (83.6)

4 (6.0)

4 (6.0)

—

Dizziness

47(70.1)

7(10.4)

6(9.0)

Loss of Appetite

57(85.1)

2(3.0)

4(6.0)

Insomnia

45(67.2)

6(9.0)

8(11.9)

3 (4.5)

1 (1-5)

4 (6.0)

Dry Mouth

34(50.7) 50(74.6) 13(19.4)

3 (4.5)

6 (9.0)

5 (7.5)

3 (4.5)

1 (1-5)

4 (6.0)

—

1 (1-5)

3 (4.5)

—

1 (1-5)

5 (7.5)

Incontinence

5 (7.5)

2 (3.0)

7 (10.4)

Allergic Reaction

55 (82.1)

5 (7.5)

3 (4.5)

Other (Specify)

56 (83.6)

5 (7.5)

—

1 (1.5)
—

—

2 (3.0)
—

3 (4.5)
4 (6.0)
4 (6.0)

Note. N = 67.

incontinence rarely or sometimes (10.4%). Approximately 4.5% often experience
incontinence while approximately 1.5% always experience incontinence. Approximately
6% do not know if incontinence occurs when they take their blood pressure drugs.
Allergic Reaction. Less than three-quarters (82.1%) of respondents never
experienced an allergic reaction after take their blood pressure drugs. Approximately 7.5%
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experience an allergic reaction rarely or sometimes (4.5%). Approximately 1.5% always
experience allergic reaction while 4.5% do not know if an allergic reaction occurs when
they take their blood pressure drugs.
Other (specified). More than three-quarters (83.6%) of respondents never
experience other side effects after taking their blood pressure drugs. Approximately 7.5%
rarely experience other side effects. Approximately 1.5% always experienced other side
effects, while 7.5% do not know if other side effects occur when they take their blood
pressure drugs. Other side effects indicated by respondents included swelling tongue, dry
cough, ringing in ears, heart issues, and cut down too much so that blood pressure shot
up very high.
Information
Medicare elders when asked, Where do you get your information about high blood
pressure treatment? the majority of respondents relied upon their healthcare provider.
Very few utilized the internet or other when seeking information about high blood pressure
treatment. The responses are summarized in Table 33.
Healthcare Provider. More than one-half (52.2%) always get their information
about high blood pressure treatment from their healthcare provider. More than 10%
obtained their information about blood pressure treatment often (14.9%), sometimes
(13.4%) or rarely (10.4%). Less than 10% never (9%) got information about high blood
pressure treatment from their healthcare provider.
Health Publications. Less than one-half (47.7%) never utilized health publications
when seeking information about high blood pressure treatment. Approximately one-fifth
(19.4%) of Medicare elders sometimes used health publications for information about high
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blood pressure. More than 10% often (14.9%) or rarely (11.9%) relied upon health
publications. More than 5% (6.0%) of respondents always referred to health publications
to provide information about high blood pressure treatment.
Internet. The majority (92.5%) of respondents never browse the internet for
information about high blood pressure treatment. Approximately 6% sometimes use the
internet while approximately 1.5% always consults the internet for information about high
blood pressure treatment.

Table 33
Information Seeking for High Blood Pressure Treatment of Survey Respondents
Where do you get your information about HBP treatment?
Never

Rarely

Sometimes

Often

Always

n(%)

n(%)

n(%)

n(%)

n(%)

Healthcare Provider

6 (9.0)

7 (10.4)

9(13.4)

10(14.9)

35 (52.2)

Health Publications

32 (47.8)

8 (11.9)

13 (19.4)

10 (14.9)

4 (6.0)

Internet

62 (92.5)

—

4 (6.0)

1 (1.5)

—

Friends

46 (68.7)

7 (10.4)

10 (14.9)

4 (6.0)

—

Other

56 (83.6)

2 (3.0)

3 (4.5)

3 (4.5)

3 (4.5)

Friends. More than two-thirds (68.7%) never ask friends for information about
high blood pressure treatment. More than 10% (14.9%) of respondents sometimes or
rarely (10.4%) get information about high blood pressure treatment from friends.
Approximately 6% often ask friends about high blood pressure treatment.
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Other. More than three-quarters (83.6%) never got information about high blood
pressure from anyone other than those previously mentioned. However, approximately 3%
of Medicare elders rarely received information about high blood pressure, while
approximately 4.5% sometimes, often, or always did. The sources of information ranged
from 1.5% each for daughter-m-/aw, daughter, grandson, nurse, newspaper/no computer,
with approximately 6% asking the pharmacist.
Media Events
Table 34 summarizes the percentages of responses to the following question: What
media events have influenced you to learn more about how to get your high blood
pressure drugs ? The majority of Medicare elders never were influenced by Medicare
Mailings, Newspaper Articles, Public Service Announcements, Health Presentations, or
Health Fair Brochures, but sometimes were influenced by a television program.
Bivariate Relationships
Demographics and Acquisition
No significant relationships were found between gender, marital status, family
income, and acquisition (refilled) of prescribed antihypertensives. There was no significant
relationship between acquisition (refill) and out-of-pocket expense. However, while none
of the low-income (less than $20,000) had difficulty acquiring their prescription drugs,
approximately 6% of those in the higher income (20,001 or more) did not legally acquire
(refill) their prescription drugs.
Self-efficacy. There was no significant relationship between self-efficacy and legal
acquisition (refill). Despite the high levels of confidence (very confident and somewhat
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Table 34
Media Events that Influenced Survey Respondents
What influenced you ?
Never

Rarely

Sometimes

Often

Always

%

%

%

%

%

Medicare Mailings

59.7

13.4

13.4

4.5

9.0

Newspaper Article

53.7

16.4

17.9

6.0

6.0

Public Service Announcement

62.7

16.4

7.5

10.4

3.0

Health Presentation

65.7

14.9

14.9

3.0

1.5

Health Fair Brochure

59.7

13.4

23.9

3.0

0.0

Television Program

38.8

6.0

40.3

13.4

1.5

Note. N= 67.

confident) that Medicare elders had about their ability to get their blood pressure drugs,
approximately 6% did not legally acquire (refill) their antihypertensives as prescribed.
Multivariate Relationships
Multivariate relationships include the analyses for principal components factor
analysis. Initial extraction produced 33 factors from the 52 items (including sub-responses)
on the survey instrument. The exclusion criterion was any factor not loading above .675
with eigenvalues lower than 1.0. After elimination of those items not sufficiently loading on
a factor, the final extraction produced 22 factors that were interpretable.
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Principal Component Factor Analyses
The following section summarizes the results of the principal component factor
analyses for the 52 items and their sub-items loading +/- .675 or better on the factors
having an eigenvalue of at least 1.0, the reliability of the factor scores, and the correlations
between each factor and the six demographic items. The sample size of 67 corresponds
with significant factor loadings of .675 (Hair, Jr., Anderson, Tatham, & Black, 1995) which
will be utilized as the cut-off when eliminating variables. The 22-factor matrix accounted
for 82.901 % of the total variance of the data. The factors are interpreted (see Table 35) as
follows:
Factor I: Health Beliefs. This factor comprises the belief about health status
variable. This variable is concerned with beliefs about perceived level of health. The factor
accounted for 9.222% of the total variance.
Factor II: Perceptions about Antihypertensives. The variables that loaded on this
factor are those related to the perceived need for antihypertensives to lower or control
hypertension. Another variable included was the perception of risk that antihypertensives
pose to health. This factor accounted for 8.461% of the total variance.
Factor III: Perceptions about Acquisition of Antihypertensives. The variable that
loaded on this factor was the monthly cost of antihypertensives. This factor accounted for
7.272% of the total variance.
Factor IV: Perceived Influence of Hypertension on Health. The variables in this
factor include avoid getting hypertension or the dangers of hypertension. This factor
accounts for 6.688% of the total variance.
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Factor V: Self-efficacy. This factor includes the confidence in ability to acquire
legally antihypertensives as prescribed. This factor accounts for 4.847% of the total
variance.
Factor VI: Knowledge of Antihypertensives. The variables in this factor include
confidence in the ability to get antihypertensives and accounts for 4.455% of the total
variance.
Factor VII: Perceived Cost Barriers. The variables in this factor include
perceptions of ways to reduce the out-of-pocket costs as well as reducing antihypertensive
monthly costs. Methods of stretching time between refills or not acquiring at all or using
alternatives are variables are included in this factor. This factor accounts for 4.284% of the
total variance.
Factor VIII: Willingness to Pay. Variables loaded in this factor are the out-ofpocket monthly expenses for primary antihypertensive and the willingness to pay monthly
for a Medicare Part D plan. This factor accounts for 3.774% of the total variance.
Factor IX: Affordability. This factor was concerned with whether a healthcare or
social worker provided ways to pay for antihypertensives or whether the healthcare
provider asked if the respondent could afford the antihypertensive before it was prescribed.
This factor accounts for 3.621% of the total variance.
Factor X: Social Support. The variables that loaded on social support for
antihypertensive decision making are siblings, friend, or neighbor for this factor. This
factor accounts for 3.341% of the total variance.
Factor XI: Adherence. Variables that loaded on this factor include whether
respondents forgot to take their antihypertensives. This factor also included variables for
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whether respondents stopped taking their antihypertensives when they felt better or worse
after taking them. This factor accounts for 3.230% of the total variance.
Factor XII: Side Effects. This factor includes variables for side effects experienced
by respondents after taking their antihypertensives. The variables included headache,
nausea, dizziness, loss of appetite, insomnia, dry mouth, incontinence, and allergic
reaction. This factor accounts for 2.836% of the total variance.
Factor XIII: Information. Health publications, friends, and other are variables
loaded on this factor for where respondents sought information about hypertension
treatment. This factor accounts for 2.595% of the total variance.
Factor XIV: Media Events. The variables that loaded upon this factor include
Medicare mailings, newspaper articles, public service announcement, health presentations,
health fair brochures and television programs for this factor. This factor accounts for
2.511 % of the total variance.
Factor XV: Medication Taking. The variables that comprise this factor include the
number of different antihypertensives prescribed, when started taking antihypertensives
and number of antihypertensives taken. This factor accounts for 2.375% of the total
variance.
Factor XVI: Access Methods. The variables that loaded on this factor include local
pharmacy, sharing with someone, and mail order to access their antihypertensives. This
factor accounts for 2.167% of the total variance.
Factor XVII: Insurance. The variables that loaded on this factor include plan type
and whether Extra Help was received. This factor accounts for 2.153% of the total
variance.

128

Factor XVIII: Acquisition with Medicare Part D. The variables that loaded on this
factor include enrollment card experiences, antihypertensives not covered by plan, unable
to afford, billing mistakes, or having to pay unanticipated costs. This factor accounts for
2.041% of the total variance.
Factor XIX: Perception about Choosing a Medicare Part D Plan. The variables that
loaded on this factor included difficulty with choosing a Part D plan and if respondents
made a good choice. This factor accounts for 1.869% of the total variance.
Factor XX: Most Important Variables for Choosing a Medicare Part D Plan. This
factor explores the variables that were most important to the selection of a Medicare Part
D Plan. The variables that loaded on this factor are the amount for each prescription, the
amount of monthly premiums and the specific drugs that were covered by the plan. This
factor accounts for 1.807% of the total variance.
Factor XXI: Decision-making Influence. The variables that loaded on this factor
include whether there was a monthly premium, which prescription drugs were included in
the formulary, and the monthly charge for each antihypertensive. This factor accounts for
1.746% of the total variance.
Factor XXII: Perceptions for Part D Experiences Compared with Pre-Part D. This
factor had loadings of variables for how much respondents paid for antihypertensives
before compared with current out-of-pocket expenditures. The comparison of monthly
premiums as well as whether the respondents were able to obtain antihypertensives as
needed and getting answers to questions. This factor accounts for 1.605% of the total
variance.
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Table 35
Items and Factor Loadings for the Antihypertensive Acquisition Beliefs and Behaviors
Instrument
Factor Items

Factor
Loadings

Factor I: Health Beliefs
16a. Health Status

.858

Factor II: Perceptions about Antihypertensives
8a. Hypertension would be high if not take antihypertensives

.793

12a. Perception that antihypertensives lower hypertension to healthy levels

.773

13a. Need antihypertensives to control hypertension

.812

15a. Perceptions of risk for antihypertensives

.778

Factor III: Perceptions about acquisition of antihypertensives
10a. Monthly cost of antihypertensives

.845

Factor IV: Perceived influence of hypertension on health
6a. Avoid getting hypertension

.770

7a. Danger of hypertension

.796

Factor V: Self-Efficacy
5 a. Confident can acquire antihypertensives as prescribed

.819

Factor VI: Knowledge about antihypertensives
23a. Knowledge of hypertension on health

.839

Factor VII: Perceived Cost Barriers
9b. Not fill antihypertensive at all

.885

9c. Postpone getting antihypertensive filled

.818

9e. Take less frequently - stretch out time before refill

.784
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Table 35 (continued)
Factor Items

Factor
Loadings

Factor VIII: Willingness to Pay
18a. Pay for Medicare Part D
19a. Pay out-of-pocket for primary antihypertensive

.840
.832

Factor IX: Affordability
20a. Professional or social worker provide ways to pay for antihypertensives
20b. Talk about which antihypertensives definitely not skip
20d. Information where to get less expensive antihypertensives
20e. Information about programs that help pay for antihypertensives

.840
.825
.714
.842

Factor X: Social Support
24c. Siblings
24d. Friend
24e. Neighbor

.814
.818
.881

Factor XI: Adherence
26a. Forget to take
26c. Stop taking - feel better
26d. Stop taking - feel worse

.866
.829
.865

Factor XII: Side Effects
21 a. Headache
27b. Nausea
27c. Dizziness
27d. Loss of Appetite
27e. Insomnia
27f. Dry mouth
27g. Incontinence
27h. Allergic reaction

.840
.861
.888
.888
.847
.823
.900
.816
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Table 35 (continued)
Factor Items

Factor
Loadings

Factor XIII: Information
28b. Health publications
28d. Friends
28e. Other

.815
.781
.856

Factor XIV: Media Events
29a. Medicare mailings
29b. Newspaper article
29c. Public service announcement
29d. Health presentation
29e. Health fair brochure
29f. Television program

.898
.870
.832
.858
.817
.767

Factor XV: Medication Taking
22a. Number of different antihypertensives prescribed
30a. Began taking antihypertensives
31a. Number of antihypertensives taken

.835
.808
. 8 84

Factor XVI: Access Methods
32a. Local Pharmacy
32c. Share with someone
32d. Mail Order

.931
.857
.925

Factor XVII: Insurance
36a. Type of Plan
37a. Extra Help status

.808
.757

Factor XVIII: Acquisition with Medicare Part D
38a. Difficulty getting enrollment card
38b. Left pharmacy without antihypertensive - plan not cover

.794
.752
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Table 35 (continued)
Factor Items

Factor
Loadings

38c. Left pharmacy without antihypertensive - can't afford
38d. Switched antihypertensive - not covered by plan
38f. Billing mistake for a premium or antihypertensive
38g. Pay costs had not anticipated

.850
.739
.845
.877

Factor XIX: Perceptions for choosing a Medicare Part D plan
42a. Difficulty in choosing
43a. Made a good choice

.813
.855

Factor XX: Most important to choosing a Medicare Part D plan
44a. Amount for each antihypertensive
44d. The amount of monthly premiums
44e. The specific antihypertensive covered

.828
.773
.748

Factor XXI: Decision-making Influence
45b. Monthly Part D premiums
45c. Antihypertensives covered by plan
45d. Amount of monthly premiums
45e. Specific antihypertensives covered

.873
.899
.853
.790

Factor XXII: Perceptions for Part D Experiences compared with pre-Part D
48a. How much pay for antihypertensives
48b. Cost of monthly premiums
48c. Getting antihypertensives needed
48d. Getting answers to questions

. 845
.767
.849
.757
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Summary Statistics
Means and standard deviations are presented for the 22 interpretable items in Table 36.
The highest mean was found in Factor II: Perceptions about Antihypertensives. Factor XX:
Most Important Variables for Choosing a Medicare Part D Plan had the lowest overall
mean.
Internal Consistency of the 22 Interpretable Factors
Coefficient alphas were computed for each of the 22 factors to assess the internal
consistency of items represented by each factor. The factor scores were calculated by
adding respondents' coded responses for each item. Items were selected as a factor if
loadings were +/- .675 or greater. The results are presented in Table 37 and shows that the
internal consistency indices ranged from -.132 to .860. Additional review of Factor IV, V,
XVII, and XIX are necessary to determine if additional variables should be utilized in
further analyses.
Correlations
The six demographic and the mental health-age variables were compared with each
of the 22 factor scores. The factor scores were computed (by adding each item responses
to the other variables within the factor). None of the 22 correlations reached significance
at the .05 level for either the demographic or mental health-age variables.
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Table 36
Means and Standard Deviations for the Antihypertensive Acquisition Beliefs and
Behaviors Variables
Perception Statement

M

SD

Overall
M

Factor I: Health Beliefs
16a Health status - belief about health
Factor II: Perceptions about Antihypertensives
8a. Perception that your blood pressure would
be high if not take antihypertensive
12a. Perception that antihypertensives lower
hypertension to healthy levels
13a. Antihypertensives needed to control hypertension
15a. Perception of risk for antihypertensives

3.24
3.24

.906
48.63

89.00

15.798

84.97
4.27
16.27

22.336
.827
3.417

Factor HI: Perceptions about Acquisition of Antihypertensives
10a. Monthly cost of antihypertensives
33.58

33.58
58.090

Factor IV: Perceived influence of Hypertension on Health
6a. Avoid getting hypertension
7a. Danger of hypertension

.55
8.16

.803
2.247

Factor V: Self-efficacy
5a. Confident can acquire antihypertensives as prescribed

1.43

.891

Factor VI: Knowledge about Effect of Hypertension
23a. Knowledge about hypertension related to health

3.37

1.085

Factor VII: Perceived Cost Barriers
9b. Not fill antihypertensive at all
9c. Put off or postpone having a antihypertensive filled
9e. Take antihypertensive less frequently
Factor VIII: Willingness to Pay
18a. Pay for Medicare Part D
19a. Pay out-of-pocket for primary antihypertensive

4.35

1.43

3.37

.25

.28
.22
.25

.670
.573
.636

43.74
24.93

62.115
38.579

34.33
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Table 36 (continued)
Perception Statement

M

SD

Overall
M

Factor IX: Affordability
20a. Professional or social worker provide
ways to pay for antihypertensives
20b. Talk about which antihypertensives definitely not skip
20d. Information where to get less expensive
antihypertensives
20e. Information about programs that help pay
for antihypertensives

.28

.16
.27

.386
.447

.34

.478

.36

.483

Factor X: Social Support
24c. Siblings
24d. Friend
24e. Neighbor

.30
.58
.30

.779
1.017
.779

Factor XI: Adherence
26a. Ever forget to take antihypertensives
26b. Stop taking - feel worse
26d. Stop taking - feel better

.76
.51
.18

.775
.786
.458

Factor XII: Side Effects
21a Headache
27b. Nausea
27c. Dizziness
27d. Loss of Appetite
27e. Insomnia
27f. Dry Mouth
27g. Incontinence
27h. Allergic Reaction

.61
.40
.75
.45
.82
1.34
.73
.45

1.435
1.129
1.429
1.259
1.435
1.647
1.442
1.197

Factor XIII: Information
28b. Health Publications
28d. Friends
28e. Other

1.19
.58
.43

1.340
.956
1.076

Factor XIV: Media Events
29a. Medicare Mailings
29b. Newspaper Article
29c. Public Service Announcement

.90
.94
.75

1.316
1.229
1.159

.39

.48

.69

.73

1.04
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Table 36 (continued)
Perception Statement

M

SD

Overall
M

29d. Health Presentation
29e. Health Fair Brochure
29f. Television Program

.60
.70
1.33

.954
.938
1.175

Factor XV: Medication Taking
22a. Number of different antihypertensives prescribed
30a. Began taking antihypertensives
31a. Number of antihypertensives taken

2.09
2.15
2.06

1.063
1.158
1.071

Factor XVI: Access Methods
32a. Local pharmacy
32c. Share with someone
32d. Mail order
Factor XVII: Insurance
36a. Type of Plan
37a. Extra Help Status
Factor XVIII: Acquisition with Medicare Part D
38a. Difficulty getting enrollment card
38b. Left pharmacy without antihypertensive-plan not cover
38c. Left pharmacy without antihypertensive-cannot afford
38d. Switched antihypertensive-not covered by plan
38f. Billing mistake for a premium or antihypertensive
38g. Pay costs had not anticipated

2.10

1.38
3.57
.03
.54

1.1118
.244
1.295
.97

1.70
.24

.798
.430
.22

.03
.21
.21
.28
.07

.171
.410
.538
.454
.265
.33

Factor XIX: Perception about choosing a Medicare Part D plann
42a. Difficulty in choosing
2.79
43a. Made a good choice
1.72

2.40
.930
.901

Factor XX: Most important to choosing a Medicare Part D plann
44a. Amount for each antihypertensive
.13
44d. The amount of monthly premiums
.09
44e. The specific antihypertensive covered
.10

.11
.344
.288
.308

Factor XXI: Decision-making influence
45b. Monthly premiums
45c. Prescription drugs covered by the plan

.561

2.51
2.04
2.10

.976
1.116
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Table 36 (continued)
Perception Statement

M

SD

Overall
M

45d. Amount the plan charges for each prescription drug
45e. Specific antihypertensives covered

2.09
2.81

.933
1.145

Factor XXII: Perceptions for Part D
experiences compared with pre-Part D
48a. How much pay for antihypertensive
48b. Cost of monthly premiums
48c. Getting antihypertensives needed
48d. Getting answers to questions

1.93
2.25
2.34
2.34

1.049
1.106
1.081
1.162

3.385
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Table 37
Coefficient Reliability Measures for the Antihypertensive Acquisition Beliefs and
Behaviors Scales
Alpha

Perceptions
Factor I

Health Beliefs

.490

Factor II

Health Status

.491

Factor III

Perceptions about Acquisition of Antihypertensives

.466

Factor IV

Perceived Influence of Antihypertensives

.270

Factor V

Self-Efficacy

.132

Factor VI

Knowledge about Antihypertensives

.313

Factor VII

Perceived Cost Barriers

.634

Factor VIII

Willingness to Pay

.732

Factor IX

Affordability

.688

Factor X

Social Support

.693

Factor XI

Adherence

.550

Factor XII

Side Effects

.853

Factor XIII

Information

.604

Factor XIV

Media Events

.789

Factor XV

Medication Taking

.833

Factor XVI

Access Methods

.515

Factor XVII

Insurance

. 186

Factor XVIII

Acquisition with Medicare Part D

.522

Factor XIX

Perception about Choosing a Medicare Part D Plan

.686

Factor XX

Most Important to Choosing a Medicare Part D Plan

.305

Factor XXI

Decision-making Influence

.838

Factor XXII

Perceptions for Part D Experiences Compared with Pre-Part D

.860
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Hypotheses Testing Results
The results of the hypotheses testing are summarized in Table 38. Tables 39
through 45 present data about specific hypotheses. The following hypotheses were tested:

Table 38
Hypotheses Results Summarized
Hypotheses Number

Type of Test

Results

HI

Logistic Regression

Accepted

H2

Multiple Regression

Accepted

H2a

Multiple Regression

Rejected

H2b

Multiple Regression

Accepted

H2c

Chi-Square

Rejected

H2d

Chi-Square

Rejected

H2e

Chi-Square

Rejected

H3

Model Comparison

Rejected

H3a

Model Comparison

Rejected

H3b

Model Comparison

Rejected

H4

Model Comparison

Rejected

Ho 1: Medicare elders do not legally acquire 100% of prescribed antihypertensive.
Ha 1: Medicare elders legally acquire at least 70% of their prescribed antihypertensives.
This hypothesis is accepted. Medicare elders participating in this study legally acquired
95.5% of prescribed antihypertensives.
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Table 39
Legal Acquisition of Prescribed Antihypertensives
Dependent

Independent

Variable

Variables

a

Reference

SE

OR

of a

95% for OR
Lower

Upper

Legal
Acquisition

Gender

0 = Male
1 = Female

-1.877

Education

0 = Not HS

.095

1.26

.153

.013

1.808

1.254

1.100

.094

12.849

.735 5.130

.042

.748

.972

.033

1.486

Graduate
1 = HS Graduate
or Higher
Access*

0 = Low

-1.72

1 = High
Perception
Choose Part D

0 = Not good -1.510

.527

Choice
1 = Good Choice

*p < .05
Ho2:

The enhanced Health Belief Model overall does not explain Medicare elders'
antihypertensive behaviors.

Ha2:

The enhanced Health Belief Model overall explains less than 60% of
antihypertensive behaviors for Medicare elders.

This hypothesis is accepted. The enhanced Health Belief Model overall explains less than
60% (53.8%) of antihypertensive behaviors for Medicare elders.
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Table 40
The Enhanced Health Belief Model for Legal Acquisition of Antihypertensives
Unstandardized
Variable

Coefficients

Standardized 95% Confidence
Coefficients

B

SE

a

.052

.36

.216

-.019

.029

.007

level for B
Upper

P

-.021

.126

.159

-.081

-.050

.070

.738

.033

.031

-.060

.074

.834

-.060

.038

-.237

-.135

-.211

.118

.008

.084

.014

-.161

.176

.928

Perceived Seriousness

-.048

.119

-.055

-.287

.191

.687

Perceived Need

-.060

.038

-.237

-.135

.016

.118

Perceived Barriers: Cost

.026

.042

.085

-.059

.111

.536

Perceived Benefits

.003

.001

.280

.000

.005

.056

Education
Self-efficacy
Perceived Health Status
Perceived Need
Perceived Susceptibility

Lower

Ho2a: Individual perceptions for the dangerousness of high blood pressure have
no influence on Medicare elders' decision to acquire antihypertensives.
Ha2a: Medicare elders who perceive their hypertension as dangerous may be more
likely to acquire legally their antihypertensives as prescribed.
This hypothesis is rejected. Hypertension was not perceived as dangerous enough to be a
statistically significant influence on Medicare elders' decision to acquire antihypertensives.
Perceived safety of antihypertensives was statistically significant atp < .05.
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Table 41
Legal Acquisition ofAntihypertensives Related to Perceived Dangerousness
Zero-Order r
Variable

Perceived Perceived Perceived
Safety

Seriousness Threat

Perceived Safety

-.098

sr2

Acquire

a

-.146

-.120

.011

-.033

.451

-.152

-.177

.002

-.004

.253

-.274

-.281*

.001*

-.005

Perceived Threat
Perceived Seriousness

Legally
b

Intercept =
Mean

1.63

8.90

8.16

.96

SD

2.800

1.580

2.247

.208

R2 =

1.288

.12*

*p < .05

Ho2b: Perceived benefit of taking antihypertensives has no influence on Medicare
elders' decision to acquire antihypertensives.
Ha2b: Medicare elders who perceive the benefits of taking antihypertensives will
be more likely to acquire legally their antihypertensives.
This hypothesis is accepted. Perceived benefit does have a statistically significant (p < .5)
influence on Medicare elders' decision to acquire legally their antihypertensives.
Ho2c: Perceived barriers have no influence on Medicare elders' acquisition of
antihypertensives.
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Table 42
Legal Acquisition of Antihypertensives Related to Perceived Benefits
Zero-Order r

Variable

Perceived

Perceived

Legally

Benefit

Need

Acquire

.105

.199

.034

.021 -.134

.254

.002

.003

.001

Perceived Need
Perceived Benefit

.342

sr2

Intercept =
4.27

Mean

.827

SD

8.50

.96

2.23

.208

.353
5.410

R2 = .13*

*p < .05

Ha2c: Medicare elders' monthly out-of-pocket expenditures will have a
statistically significant influence on their decision to acquire antihypertensives.
This hypothesis is rejected. Out-of-pocket expenditures were not a statistically significant
(p > .05 for both) influence on deciding whether to acquire antihypertensives.
Ho2d: Perceived seriousness of hypertension will have no influence on Medicare
elders' decision to acquire antihypertensives.
Ha2d: Medicare elders who perceive hypertension as serious will be more likely to
acquire antihypertensives than those who do not perceive hypertension as serious.
This hypothesis is rejected. Perceived seriousness does not have (p >.05) a statistically
significant influence on Medicare elders' decisions to acquire antihypertensives.
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Table 43
Out-of-Pocket Expenditures and Antihypertensive Acquisition
Not

Out-of-Pocket Monthly HBP Rx

Acquire

Legally

Legally

Acquire

2.1 (1)

97.3 (36)

6.7 (2)

93.3 (28)

0.0(0)

100.0(37)

10.0 (3)

90.0 (27)

($10 or Less)
Out-of-Pocket Monthly HBP Rx
($11 or More)
Out-of-Pocket Monthly Medicare
Part D Premium
($30 or Less)
Out-of-Pocket Monthly Medicare
Part D Premium
($31 or More)

Ho2e: Cues to action has no influence on Medicare elders' decision to acquire
antihypertensives.
Ha2e: Medicare elder's decision to acquire their antihypertensives is influenced by
information and side effects.
This hypothesis is rejected. Side effects does not have a statistically significant (p >.05)
influence on Medicare elder's decisions to acquire their antihypertensives.
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Table 44
Perceived Seriousness Influence on Antihypertensive Acquisitions
Not

Perceived Seriousness

Acquire

Legally

Legally

Acquire

0.00 (0)

100 (8)

(Low, 70 or less)
Perceived Seriousness
(High, 71 or more)

51.0 (3)

94.9 (56)

Ho3: Constructs from the both the Medication Adherence Model and Consumer Choice
do not significantly explain Medicare elders' antihypertensive acquisition behaviors.
Ha3:

Constructs from both the Medication Adherence Model and Consumer Choice

significantly explains Medicare elders' antihypertensive acquisition behaviors.
This hypothesis is rejected. Neither Medication Adherence nor Consumer Choice
significantly explains Medicare elders' antihypertensive acquisition behaviors. Each
construct adds to the model but not at a statistically significant level. Comparing the
enhanced Health Belief Model with the addition of Medication Adherence and Consumer
Choice increased the overall percentage from 94.9 to 95.8.
Ho3a: Constructs from the Medication Adherence Model added to the enhanced
Health Belief Model does not help to explain antihypertensive acquisition behavior
for Medicare elders significantly greater than the enhanced Health Belief Model.
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Table 45
Influence of Information and Side Effects on Acquisition Behaviors
Not
Acquire

Legally

Legally

Acquire

Side Effects (No = 0)

8.7 (2)

91.3 (21)

Side Effects (Yes =1)

2.3 (1)

97.7 (43)

Ha3a: Constructs from the Medication Adherence Model helps to explain
Medicare elders' antihypertensive acquisitions significantly greater than the
enhanced Health Belief Model.
This hypothesis is rejected. The model constructs from Medication Adherence do not
significantly help to explain acquisition behaviors better than the enhanced Health Belief
Model. The enhanced Health Belief Model alone explains 94.9% and the addition of the
Medication Adherence constructs increased the overall percentage to 95.5.
Ho3b: Constructs from Consumer Choice added to the enhanced Health Belief
Model do not help to explain Medicare elders' antihypertensive acquisition
behaviors significantly greater than the enhanced Health Belief Model.
Ha3b: Constructs from Consumer Choice added to the enhanced Health Belief
Model does help to explain Medicare elders' antihypertensive acquisition behavior
significantly greater than the enhanced Health Belief Model.
This hypothesis is rejected. The enhanced Health Belief Model helps to explain Medicare
elders better, though not significantly better than the Consumer Choice constructs. The
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enhanced Health Belief Model overall explains 94.9% and adding Consumer Choice
increased the percentage to 95.2.
Ho4: The proposed Pharmaceutical Acquisition Model for Medicare Elder (enhanced
Health Belief Model with constructs from Consumer Choice Theory and
Medication Adherence) does not explain antihypertensive acquisition behavior for
Medicare elders significantly better than the enhanced Health Belief Model.
Ha 4: The proposed Pharmaceutical Acquisition Model for Medicare Elderly (enhanced
Health Belief Model with constructs from Consumer Choice Theory and
Medication Adherence) explains antihypertensive acquisition behavior for Medicare
elders significantly better than the enhanced Health Belief Model.
This hypothesis is rejected. The Pharmaceutical Acquisition Model for Medicare Elderly
explains antihypertensive acquisition slightly better than the enhanced Health Belief Model
but not at a statistically significant level. The enhanced Health Belief Model overall
explains 94.9% and the Pharmaceutical Acquisition Model for Medicare Elderly overall
explains 96.6%.
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Chapter 5
DISCUSSION
The purpose of this study was to test the usefulness of the proposed
Pharmaceutical Acquisition Model for Medicare Elders (PAMME); an expansion of the
enhanced Health Belief Model (HBM) (Janz & Becker, 1984), using constructs from
Consumer Choice Theory (Friedman, 1990) and the Medication Adherence Model
(Johnson, 2002) with respect to decision making for antihypertensive acquisitions. The
various components of the PAMME were tested to determine which factors exerted
influence with respect to decision making for antihypertensive acquisitions. The
performance of the proposed PAMME was compared to that of the enhanced HBM to
determine which model is better at predicting antihypertensive acquisition behaviors of
Medicare elders.
Limitations
Data Collection
Invitation sample size. The target population was selected from Senior Services of
Southeastern Virginia's Medicare Medication Management database. Initially, database and
file review identified 1,179 individuals with hypertension. From the initial review 320 were
excluded for not meeting the selection criterion of 65 years of age or older. A total of 868
invitations were mailed in three phases from April 2009 to June 2009. During Phase 1, 679
invitations were mailed; 147 and 43, respectively, were mailed during Phase 2 and Phase 3.
Invitees were selected from those eligible Medicare elders identified as meeting the initial
selection criterion (aged 65 years of age or older, hypertensive, and prescribed at least one
antihypertensive). When postage costs increased, an additional screening identified those

149

lost to follow-up or unable to contact us (deceased, undeliverable mail, mental illness,
including dementia and Alzheimer's) as well as those with disconnected administered
numbers or who moved from the coverage area.
True population eligible to be surveyed. When those deceased, not capable,
undeliverable, or otherwise lost to follow-up were excluded from the 869 potentially
eligible, the true population eligible to participate was 269. Of those truly eligible, 67
surveys were completed, which is the minimum required for statistical significance given
power calculations for alpha = .05 (National Statistical Service, 2009). The other 599
were excluded for the following reasons: deceased (17.6%), not capable (14.7%), not
eligible (14.4%), undeliverable (16.9%), and lost to follow-up (25.9%).
Response to invitations sent. Medicare elders who responded to the invitation/
consent letter consented either to be included in the study or declined to participate.
Responders were those Medicare elders who either wrote or called to confirm their
interest or to decline the invitation. Overall, 117 of those Medicare eligible to participate
replied to the invitation (43.5% response rate). Of the 117, 81 Medicare elders responded
favorably (consented) to the invitation to participate (favorable response rate of 69.2% of
respondents). Of those who consented, 67 were able to complete successfully the survey
(82.7%). Approximately 6% did not complete the survey after they had consented due to
death, developing Alzheimer's, moving from the area, or declining upon being contacted.
Thirty-six (36) Medicare elders declined to participate in the study (30.8% of respondents)
when invited. Overall, 152 Medicare elders who were sent invitations did not reply (nonresponders). However, 14 (9.2%) were excluded from the list of non-responders for
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identifiable reasons. Of those, 14.3% from the population of eligible participants were
identified as undeliverable through address or telephone number not being current.
Survey Administration
Mailing costs. When the surveys were initially mailed, the cost of a first-class
stamp was $.42. That cost later increased to $.44, raising the cost of mailing invitations.
Further screening was done on those awaiting invitations to determine if there were
foreseeable reasons for non-response to minimize those undeliverable or not capable of
being interviewed. Mailing the "thank you" gift of the pillbox increased from $.61 to $.78
per gift. This increase in postage also affected the cost of mailing the results of the survey.
Timing of mailing. The survey was originally scheduled to be conducted at the
beginning of the year while FY 2008 was still fresh in Medicare elders' minds. However,
delays in both survey approval and the mailing of the invitation/consent letters resulted in
the first batch of surveys not being administered until the end of April 2009, with the last
batch of survey responses collected through the end of August 2009.
Informed consent. Initially, invitation letters were sent to potential participants to
provide them with the study details and to request their written consent for follow-up
contact for the purposes of completing the administered survey. While the informed
consent letters were mailed with postage-paid return envelopes, many of the invitation/
consent letters were not returned (67.9%). While the invitation response rate was in line
with other research using mailed methods (approximately 32.1 %), further file review was
necessary to determine if non-responders would be able to be reached via another method.
However, after several unsuccessful attempts were made to contact Medicare elders by
mail and by telephone they were declared lost to follow-up.
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Volunteers. The dedication level of the volunteers assisting the primary researcher
was lower since the volunteers did not have a stake in the outcome. The volunteers had
other priorities and were not as vigilant about data collection as the primary researcher
was. While any assistance was greatly appreciated, the number of surveys completed may
possibly have been reduced by the time constraints of the primary researcher. It may be
necessary to hire paid employees in future research to have some control over the
productivity of those involved with survey administration and other data collection efforts.
Target population demographics: The target population comprised individuals 65
years of age and older who were not taking prescription drugs for mental health (i.e.,
dementia, Alzheimer's among others). In this population, there is the possibility of losing
Medicare elders to follow-up based upon death, relocation (out-of-state, assisted living,
nursing home or with family), or declining health. Increases in the time between encounters
reduces the ability to follow-up as other researchers have found that more than six months
following an encounter, it may become difficult to locate those with chronic illness
(Brinkhof, Pujades-Rodriguez, & Egger, 2009). The target population of hypertensive
Medicare elders in southeastern Virginia contains approximately 39,197 individuals
(Virginia Department of Health, Center for Health Statistics, 2008) of whom 1,178 had
been assisted by SSSEVA with Medicare Part D enrollment.
Administered interviews. Survey administration could not always be conducted via
telephone due to the mental illness or trust issues of the consenting Medicare elders, or the
researcher's inability to contact them after three attempts.
Mental illness. Administered surveys were unable to be successfully completed by
those individuals who consented and were contacted, but had mental health issues. Those

152

attempts were not included in the assessment, but were identified as not capable. It was
later determined that those individuals with mental health issues were already being treated
so no referrals to their respective doctors were necessary.
Trust. While the consenting respondents had indicated that they were comfortable
with talking on the telephone, trust issues entered into the equation with frequent
screening of calls and/or not answering calls from telephone numbers they did not readily
recognize. The Medicare elders explained that they prefer to see the interviewer's face to
decide whether to complete the survey. Several participants explained that they screen
their calls and do not answer any surveys by telephone because they do not know if they
can trust the person calling them. Those surveys would not have been completed if the
interviewer had not been able to meet with them at their nutrition sites.
Inability to reach. In addition to the trust issues, Medicare elders at rural locations
were not easily contacted via telephone due to regular attendance at congregate meal sites.
Three site visits were conducted (Isle of Wight, Suffolk, and Franklin) to reach those
consenting Medicare elders. The site directors and staff set up appointment times for the
consenting Medicare elders to meet with a trained interviewer. Inability to contact
Medicare elders by mail or telephone (mail came back as undeliverable, telephone numbers
were no longer in service, or calls left on answering machines were not returned after three
attempts) as well as death notices proved to be an obstacle to gaining approval for further
contact.
Survey length. Medicare elders who consented also were concerned about the
survey length (52 questions). A few respondents took advantage of the option to take a
break and reschedule the completion of their Part D and Extra Help experiences for
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another day (taking either one or two days more to complete). For those who were able to
continue with the survey, the interviewer was able to inform them that the remainder of the
survey (Medicare Part D and Extra Help questions) would not take more than 10 minutes
to complete.
Incentive for survey completion. The seven-day pillbox given to help manage pill
taking was not always seen as an incentive. Many other activities (nutrition, exercise, and
health presentations) through Senior Services of Southeastern Virginia used the pillboxes
as incentives as well. Consenting Medicare elders did complete the survey, but declined the
pillbox, stating that they had too many already. The interviewer explained that an extra
pillbox was nice for traveling, but not all accepted the incentive, even with that assertion.
Survey Instrument Development
The administered survey instrument was developed by combining previously tested
survey instruments for assessment of mental health, medication adherence, perception of
affordability, and experiences with the Medicare Part D drug benefit. The combined
instruments were then sent to expert reviewers who reviewed the survey instrument for
appropriateness for use with Medicare elders. The expert panel was comprised of
gerontologists, elder care managers, elder caregivers, and Medicare elders. The expert
panel was asked to assess the survey instrument for question appropriateness, whether any
questions were harmful, and if they appeared to measure the intended concepts. After the
expert panel provided input, the survey instrument was revised to reflect the expert panel's
suggestions. The improved survey instrument was then administered to 35 Medicare elders
(taking at least one antihypertensive) who would not be included in the final survey
administration. After the survey instrument was pilot-tested, revisions were made to
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exclude questions that did not load well (alpha coefficient of less than .675) during factor
analyses or were confusing to the pilot respondents.
Survey Instrument Analyses
The principal component and factor analyses of the Antihypertensive Belief and
Behaviors survey instrument revealed that Medicare elders who responded to this survey
were influenced by cost of both the monthly premium and out-of-pocket expenses when
making acquisition decisions. Surprisingly, Medicare elders were candid in their practice of
sharing with someone who could be another family member, friend, or neighbor or having
someone share with them. In addition, the doctor or healthcare professional who
prescribed the antihypertensives was not a variable that loaded on any of the factors.
Pharmacists were seen as more helpful, which could be a possible reason that Medicare
elders are still using the local pharmacy despite Medicare claims that mail order could save
them more money (Centers for Medicare and Medicaid Services, 2009). Affordability
remains an issue for those Medicare elders who left the pharmacy without their
antihypertensives because they could not afford them. Surprisingly, spouse and children
did not load on the social support factor; many respondents were widowed (without
children or children were not close) or single (widowed, divorced, or never married).
Lessons Learned
The most important lesson learned was that Medicare elders are very busy with
social activities, doctor visits, and other daily living activities, so trying to reach them to
complete a telephone survey is not an easy task. Additionally, with the increasingly popular
use of cellular telephones, it becomes very important when requesting a telephone number
for conducting a telephone survey that the researcher specifies, At which number can you
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best be reached1} Without obtaining Medicare elders' home and/or mobile administered
telephone numbers, it may be difficult to reach them. As increasingly more Medicare elders
are mastering the computer, it may be possible within the next couple of years to survey
them via their e-mail address versus their home or mobile administered telephone number.
Future Research Proposed
One method that could be used to research this topic further would be contacting
non-responders to determine a statistically significant difference between the response of
those who participated and those who did not.
Another method would be to widen the scope to additional chronic disease states.
Medicare elders usually have more than one chronic illness and while this study utilized
hypertension and antihypertensives, additional research could expand this focus to other
disease classes. A similar study could be conducted with the inclusion of questions to
identify other chronic illnesses for which Medicare elders were taking prescription drugs.
Funding for the study could be sought from either the National Institutes of Health or the
Centers for Disease Control and Prevention with trained assistants being paid to collect
data. Additionally, by widening the focus to more than just hypertension, it may be possible
to attract a larger number of participants.
Conclusion
Overall, this study was helpful in exploring the possible linkages between health
beliefs, consumer choice, and medication adherence. While the hypotheses were not all
statistically significant in their results, the information gained allows other researchers to
build upon this beginning. The inclusion of both consumer choice and medication
adherence into this study may yet prove to be tools necessary to understand better the
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complexity of the decision-making challenge of Medicare elders with respect to
antihypertensive and other prescription drug acquisitions.
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APPENDIX I: Definition of Terms
Several key terms are defined as follows:
1. Medicare Elders: An individual over 65 years of age eligible for the Medicare
program (Centers for Medicare & Medicaid Services, 2005).
2. The Medicare Modernization Act of 2003 (MMA): A long awaited benefit
added to Original Medicare to extend benefits for prescription drug coverage.
The intention of MMA is to reduce overall annual prescription drug costs for
Medicare elders (Centers for Medicare & Medicaid Services, 2005). Along
with the prescription drug discount plan there are provisions for Health
Savings Accounts (HSAs) and other health care cost saving initiatives
(Centers for Medicare & Medicaid Services, 2005).
3. Medicare Part D: As a result of the enactment of the Medicare Modernization
Act of 2003, the prescription drug discount program designed to provide
coverage to Medicare elders previously lacking any other prescription
coverage (Centers for Medicare & Medicaid Services, 2005).
4. Extra Help: Included in the Medicare Modernization Act of 2003, the
provision for a Low-Income Subsidy (LIS) which is the Extra Help that lowincome, low-asset Medicare elders require to help with premiums for Part D
plans and to minimize co-pays for prescription drug acquisitions (Centers for
Medicare & Medicaid Services, 2005).
5. Formularies: Prescription Drugs that are included in each plans negotiated
discounted pricing schedule which includes name brand and generic offerings
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(Hoadley, Hargrave, Merrell, Cubanski & Neuman, 2006; Centers for
Medicare & Medicaid Services, 2005).
6. Coverage Gap ("Donut Hole"): Period of time where Medicare beneficiary is
responsible for 100 percent of out-of-pocket prescription drug costs until
catastrophic coverage begins (Centers for Medicare & Medicaid Services,
2006).
7. Hypertension: Blood pressure levels above 140/90 are required to be
clinically diagnosed with hypertension (aka high blood pressure) (American
Heart Association, 2007). The chronic illness is called the "silent killer" as
often times there are no symptoms to alert individuals to potentially life
threatening conditions (American Heart Association, 2007a).
8. Hypertension Treatment:
a. ACE Inhibitors: Angiotensin converting enzyme (ACE) inhibitors are used
to help protect the kidneys from hypertension and diabetes by improving
blood flow through dilation of blood vessels (American Heart Association,
2007a; Small, Freeman-Arnold et al., 1997).
b. Angiostein II Receptor Blockers (ARBs) are often prescribed when ACE
inhibitors are not tolerated and function in lowering chemicals that narrow the
blood vessels to allow blood to flow more freely (Small, Freeman-Arnold et
al., 1997).
c. Diuretics are often prescribed to help eliminate unnecessary sodium and
water through urination. Reducing excess fluid and salt allow the heart to
pump more easily (American Heart Association, 2007a).
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d. Beta-Blockers are used to help the heart work more efficiently by blocking
the effects of the sympathetic nervous system (American Heart Association,
2007a).
e. Calcium Channel Blockers are utilized to slow calcium movement into
heart cells and blood vessel walls to improve heart functioning through
widening of blood vessels (American Heart Association, 2007a).
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APPENDIX II: Sample Size Calculations
Source: Six Sigma, 2007
Determining sample size is a very important issue because samples that are too large may
waste time, resources and money, while samples that are too small may lead to inaccurate
results. In many cases, we can easily determine the minimum sample size needed to
estimate a process parameter, such as the population mean J2.
When sample data is collected and the sample mean x is calculated, that sample mean is
typically different from the population mean/*. This difference between the sample and
population means can be thought of as an error. The margin of error E is the maximum
difference between the observed sample mean * and the true value of the population
mean/*:

"™ 4n
where:
A is known as the critical value, the positive z value that is at the vertical boundary for
the area of / 2 in the right tail of the standard normal distribution,
o" is the population standard deviation.
«is the sample size.

2=°
H
Rearranging this formula, we can solve for the sample size necessary to produce results
accurate to a specified confidence and margin of error.

V7
This formula can be used when you know o" and want to determine the sample size
necessary to establish, with a confidence of 1 - a , the mean value /'to within ± E . You
can still use this formula if you don't know your population standard deviation o"and you
have a small sample size. Although it's unlikely that you know o" when the population
mean is not known, you may be able to determine °" from a similar process or from a
pilot test/simulation.
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Appendix III: Survey Instruments (A - E)
A.

Seniors' Early Experiences with Their New Drug Plan - June 2006
Source: The Henry J. Kaiser Family Foundation
Methodology
Seniors' Early Experiences with Their Medicare Drug Plans - the 13th in a series
that comprises three large surveys and ten smaller tracking polls - is based on
interviews with 1,585 adults ages 65 and older. The survey was designed and
analyzed by researchers at the Kaiser Family Foundation.
A nationally representative random sample of 1,217 adults ages 18 and
older, including 285 participants ages 65 and older, was interviewed about a few
topics in the news as part of the ongoing Kaiser Health Poll Report survey
(referred to as the "main survey"), and asked the Medicare questions that follow.
In addition, a nationally representative random sample of 1,300 adults ages 65 and
older was asked the Medicare questions only, for a total of 1,585 seniors.
Individuals were contacted by administered by Princeton Survey Research
Associates International between June 8 and June 18,2006. Interviews were
conducted in English and Spanish.

191

Throughout these findings, we report on several different groups of seniors:
• All seniors (unweighted n=l,585)
• Seniors enrolled in Medicare drug plans, including those who reported being
in stand-alone prescription drug plans, Medicare and Medicaid enrollees
(i.e. dual eligibles), and Medicare HMO enrollees (40 percent of all
seniors, unweighted n=623).
• Seniors enrolled in stand-alone Medicare drug plans - same as above, but
excluding those in Medicare HMOs (32 percent of all seniors, unweighted
n=509)
• Seniors enrolled in stand-alone Medicare drug plans that they chose on their
own (as opposed to being assigned to a plan) (25 percent of all seniors,
unweighted n=392)
• Seniors who have used their Medicare drug plans (28 percent of all seniors,
unweighted n=443)
This survey is representative of seniors in the U.S. living outside institutions,
but not of all Medicare elders because the survey did not include seniors living in
institutional settings, such as nursing homes, nor younger, pre-65 Medicare elders
with permanent disabilities.
The margin of sampling error for the survey is plus or minus 3 percentage points
for all seniors, and plus or minus 4 points for seniors enrolled in Medicare drug
plans. For results based on smaller subsets of respondents the margin of sampling
error is higher. Note that sampling error is only one of many potential sources of
error in this or any other public opinion poll.
Values less than 0.5percent are indicated by an asterisk (*). "VOL" indicates that
a response was volunteered by respondent, not an explicitly offered choice.
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1.

For each item I name, please tell me how important it will be in your vote for
Congress this year (2006). Will it be one of the single most important issues, very
important, somewhat important or less important than that? (First/Next,)
(READ AND RANDOMIZE)?
Single
Most
Important
a. Situation in Iraq
b. The US (United
States) campaign
against Terrorism
c. Prescription
drug benefit for
the elderly
d. The economy
e. Healthcare
overall
f. Immigration
Issues
g. Local issues
where you live
h. Corruption in
Washington
i. Gas Prices
j . The overall
performance of the
President
k. The overall
performance of
Congress
1. The overall
performance of
your
Congressional
Representative

Very
Somewhat
Less
Important Important Important

DK/
Refused
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As you may know, a new prescription drug benefit is now available for people on
Medicare. Given what you know about it, in general, do you have a favorable or
unfavorable view of the new Medicare drug benefit?
Favorable Unfavorable

Neither/Neutral

DK/Refused

Is your impression of the new Medicare drug benefit based mainly on... (READ
AND RANDOMIZE 1-3)?
Based on those with a favorable or unfavorable impression of Medicare
drug benefit
Your own experience
What you've seen and heard on television, radio, and in
newspapers
What you've learned from friends and family
Some other source
(DO NOT READ) Don't know/Refused
Do you have ANY health insurance plan or program that helps you pay for
prescription drugs, or not?
Yes

No

Don't Know

Refused

I'm going to read you some statements about your health insurance and how your
health care bills are paid. For each one, please tell me whether you think it
describes your situation or not. (First/Next,)... (READ IN ORDER) (Does this
describe your situation, or not?)
Based on seniors with any health insurance plan or unsure (n= 1,203)
DK/
Yes
No Refused
a. You have Medicare and have also signed up or been
enrolled in a separate Medicare drug plan, sometimes
called "Part D"
b. You have Medicare and Medicaid or
the program that provides health insurance and long
term care to certain low-income seniors
c. You are a member of a Medicare HMO
d. You have Medicare and health care from the
Veteran's Administration or VA
e. You have Medicare and a plan from a current or
former employer
Item f based on those who said no/don't know to all
other items (n=166)
f. You have something else I haven't mentioned
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6.

You said yes to more than one of the above. Please tell me which one of the
following BEST describes your health coverage?

Yes

No

DK/
Refused

a. Medicare and a plan from an employer or union
b. Medicare plus a separate Medicare drug plan,
sometimes called "Part D"
c. A Medicare HMO
d. Medicare and Medicaid or (State Medicaid
program name)
e. Medicare and VA
f. Something else
7.

Have you also signed up or been enrolled in a separate Medicare prescription drug
plan, sometimes called "Part D", or not?
Yes

8.

No

No

Don't Know

Refused

To the best of your knowledge, if seniors wait until next year or later to enroll in a
Medicare drug plan will they have to pay higher premiums, sometimes called a
"premium penalty", or not?
Yes

10.

Refused

To the best of your knowledge, if seniors wait until next year or later to enroll in a
Medicare drug plan will they have to pay higher premiums, sometimes called a
"premium penalty", or not?
Yes

9.

Don't Know

No

Don't Know

Refused

Did you apply to Social Security for the program that gives low-income seniors
extra help with prescription drug costs, or not?
Yes

No

Don't Know

Refused

a. Was your application approved, or not?
Approved

Disapproved

Don't Know

Refused
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11.

Would you say it was very easy, somewhat easy, somewhat difficult, or very
difficult to choose a Medicare drug plan, OR were you just put in a plan and
didn't make a choice for yourself?
Very
Easy

12.

Somewhat
Easy

Somewhat
Difficult

Very
Difficult

Put in a Plan
Didn't Make a
Choice

Refused

In choosing your Medicare drug plan, please tell me how important each of the
following was to your decision. (First,) how about... ? (READ AND
RANDOMIZE). READ FOR FIRST ITEM, REPEAT AS NECESSARY: Was
this very important, somewhat important, not too important or not at all important
(in choosing your Medicare drug plan)?
Single
Most
Important
a. The reputation
of the company
offering the plan
b. The amount
the plan charges in
monthly premiums
c. The specific
drugs covered by
the plan
d. The amount
the plan charges
for each
prescription
e. A
recommendation
from someone you
trust

Very
Not too Not at all
Important Important Important

DK/
Refused
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13.

Which one was the MOST important to your decision to choose your Medicare
drug plan? (IF NECESSARY, READ ITEMS RATED "VERY IMPORTANT"
INQ12)
a.

The amount for each prescription

b.

A recommendation from someone you
trust

14.

c.

The reputation of the company

d.

The amount of monthly premiums

e.

The specific drugs covered

f.

All are important

g.

None are important

h.

Don't Know/Refused

How satisfied are you with the (IF Q6=4: drug coverage under your plan/IF
(Q6=l,3 OR Q7=l): Medicare drug plan you are enrolled in)? Would you say you
are very satisfied, somewhat satisfied, not too satisfied, not at all satisfied?
Very
Satisfied

15.

Somewhat
Satisfied

Not too
Satisfied

Not at all
Satisfied

Don't
Know

Refused

All in all, have your experiences using your (IF Q6=4: plan/IF (Q6=l, 3 OR
Q7=l): new Medicare drug plan) been very positive, somewhat positive,
somewhat negative, or very negative?
Very
Positive

Somewhat
Positive

Somewhat
Negative

Very
Negative

Don't
Know

Refused
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16.

Compared with how you got your prescriptions before, please tell me whether
your new Medicare drug plan is better, worse, or about the same in terms of each
of the following. (READ AND RANDOMIZE). (READ FOR EACH ITEM)
Compared with how you got your prescriptions before, is your new drug plan
better, worse, or about the same in terms of (INSERT)...
Better

Worse

Same

Don't
Know

Refused

a. How much you pay for
prescriptions
b. The cost of your monthly
premiums
c. Getting the medicines you
need
d. Getting answers to your
questions
17.

Overall, do you feel you made a good choice in selecting your Medicare drug
plan, or do you think you would have been better off with a different plan?
Based on seniors enrolled in stand-alone Medicare drug plans that
they chose on their own
Made a Good
Choice

18.

Don't Know

Refused

If you had to choose today, would you pick the same plan or would you choose a
different drug plan?
Based on seniors enrolled in stand-alone Medicare drug plan
Would pick the
same plan

19.

Better off with a different
plan

Would choose a different
plan

Don't
Know

Refused

(IF Q6=4: Since January of this year,) Have you tried to fill any prescriptions
under your (IF Q6=4: plan/IF (Q6=l, 3 OR Q7=l): new Medicare drug plan yet),
or not?
Based on seniors enrolled in Medicare drug plans
a.
Yes

No

Don't Know

Refused

20.

Compared to what you paid for prescriptions last year, are you now saving
money, paying more or paying about the same overall for your prescriptions?
Saving money

21.

Paying more

Saving Just a
little

Don't Know

Refused

Would you say that you are paying a lot more money, or just a little more?
Paying a lot more
money

23.

Refused

Would you say that you are saving a lot of money, or just a little?
Saving a lot of
money

22.

Paying about the same

Paying just a
little more

Don't Know

Refused

Have these additional costs been a major problem, a minor problem or not a
problem for you?
Based on seniors who are paying more
Major
Problem

Minor
Problem

Not a Problem

Don't Know

Refused
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24.

Please tell me whether or not you've had any of the following experiences related
to getting your prescription medicines since (IF Q6=4: January 2006/IF (Q6=l,3
OR Q7=l): joining your new Medicare drug plan). Have you... or not? (READ
AND RANDOMIZE)
Have
a. Had difficulties getting enrollment card
b. Left the pharmacy without your
prescription because one of your drugs
wasn't covered by y\our plan
c. Left the pharmacy without your
prescription because you could not afford
it
d. Had to switch drugs because one of
your drugs that you were taking wasn't
covered by your plan
e. Had to switch from a brand-name to a
generic drug
f. Had to deal with a billing mistake for a
prescription or a premium
g. Had to pay costs you hadn't expected either for a prescription or a premium

Have
Not

Don't
Know

Refused
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25.

Was this a major problem, minor problem or not a problem for you? Based on
seniors who have used their Medicare drug plans (YES - Had an experience)
Major
Problem
a. Had
difficulties
getting
enrollment card
b. Left the
pharmacy
without your
prescription
because one of
your drugs
wasn't covered
by y\our plan
c. Left the
pharmacy
without your
prescription
because you
could not afford
it
d. Had to switch
drugs because
one of your drugs
that you were
taking wasn't
covered by your
plan
e. Had to switch
from a brandname to a generic
drug
f. Had to deal
with a billing
mistake for a
prescription or a
premium
g. Had to pay
costs you hadn't
expected - either
for a prescription
or a premium

Minor
Problem

No - Did Not
Not a
Problem
Have An
Experience

Don't
Know/
Refused
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26.

Thinking about the (IF 2+ PROBLEMS IN Q25A-G: problems/IF ONE
PROBLEM IN Q25A-G: problem) you had related to getting your prescriptions,
would you say (IF 2+ PROBLEMS IN Q25A-G: they have/IF ONE PROBLEM
IN Q25A-G: it has) been resolved to your satisfaction, or not?
Based on seniors who have used their Medicare drug plans
Experienced one or more problems related to filling
prescriptions
Problems resolved to satisfaction
Problems NOT resolved
Had one or more experiences, but not a problem
Didn't have any of the listed experiences
Don't know/Refused

27.

Earlier you said you changed a medication since (IF Q6=4: January 2006/IF
(Q6=l, 3 OR Q7=l): joining your new Medicare drug plan). Do you think the
new drug works better, just as well or not as well as the old one?
Works better
Just as well
Not as well as the old one
Don't know/Refused

28.

Since (IF Q6=4: January 2006/IF (Q6=l,3 OR Q7=l): joining your new drug
plan), have you NOT filled a prescription, skipped doses, or taken less than the
prescribed dose of a medication because of the cost, or not?
Based on seniors enrolled in Medicare drug plans
Yes
No
Don't know/Refused

29.

To the best of your knowledge, if you are dissatisfied with your (IF Q6=4: plan/IF
(Q6=l,3 OR Q7=l): new Medicare drug plan) can you change to a different plan
whenever you want, or do you have to wait for a specific period?
Based on seniors enrolled in Medicare drug plans
Can change to different plan
Have to wait
Don't know/Refused
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30.

Some plans have what's called a "coverage gap" or "donut hole" - a point where
the plan stops paying for prescriptions and seniors are required to pay the full cost
of their medicines for a while. Does your (IF Q6=4: plan/IF (Q6=l,3 OR Q7=l):
Medicare drug plan) have such a coverage gap, or not?
Based on seniors enrolled in Medicare drug plans
Yes, coverage gap
No, no coverage gap
Don't know/Refused

31.

Since (IF Q6=4: January 2006/IF (Q6=l,3 OR Q7=l): joining your new Medicare
drug plan), have you asked your DOCTOR for help getting your plan to pay for
the drugs you need, or not?
Based on seniors enrolled in Medicare drug plans
Yes
No
Don't know/Refused

32.

How much help have you received from your DOCTOR in getting your plan to
pay for the drugs you need? Would you say you received (READ)
Based on seniors enrolled in Medicare drug plans who asked their
doctor for help
A little help
Some help
Don't know/Refused

33.

Since (IF Q6=4: January 2006/IF (Q6=l,3 OR Q7=l): joining your new Medicare
drug plan), have you asked your PHARMACIST for help getting your plan to pay
for the drugs you need, or not?
Based on seniors enrolled in Medicare drug plans
Yes
No
Don't know/Refused

34.

How much help have you received from your PHARMACIST in getting your plan
to pay for the drugs you need? Would you say you received (READ)
Based on seniors enrolled in Medicare drug plans who asked their
pharmacist for help
Yes
No
Don't know/Refused
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35.

Overall, what message would you send to policymakers in Washington? Would
you say the new Medicare drug benefit (READ)
Based on seniors enrolled in Medicare drug plans
A
B
C
D

36.

Is working well and no real changes are needed
Could be improved with some minor changes OR
Is not working and needs major changes
Don't know/Refused

Thinking back to last year, in 2005, did you have any insurance plan or program
that helped you pay for prescription drugs, or not?
Yes
No
Don't know/Refused

37.

Do you currently take any prescription medicine on a daily basis, or not?
Yes
No
Don't know/Refused

38.

How many different prescription drugs do you take?

39.

In general, would you say your health is excellent, very good, good, only fair, or
poor?
Excellent
Very good
Good
Only fair
Poor
Don't know/Refused
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DEMOGRAPHICS:
(READ) Finally, I have just a few questions we will use to describe the people who
took part in our survey...
Dl.

RECORD RESPONDENT'S SEX
Male
Female

D2.

What is your age? (RECORD EXACT AGE AS A TWO-DIGIT CODE)

D3.

In politics today, do you consider yourself a Republican, Democrat, or
Independent?
Republican
Democrat
Independent
(VOL.) No preference/Not interested in politics
(VOL.) Other party
Don't know
Refused

D4.

These days people are so busy they can't find time to register to vote, or move
around so often they don't get a chance to re-register.. .Are you NOW registered
to vote in your precinct or election district, or haven't your been able to register so
far?
Yes, registered
No, not registered
Don't know/Refused

D5.

What is the LAST grade or class that you COMPLETED in school? (DO NOT
READ)
None, or grade 1-8
High school incomplete (grades 9-11)
High school graduate (grade 12 or GED certificate)
Technical, trade or vocational school AFTER high school
Some college, no four-year degree (includes associate degree)
College graduate (B.S., B.A., or other four-year degree)
Post-graduate or professional schooling after college (e.g.,
toward a Master's degree or PhD; law or medical school)
Refused
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D6.

Are you currently married, living with a partner, widowed, divorced, separated, or
have you never been married?
Married
Living as married
Divorced
Separated
Widowed
Never been married
Don't know/ Refused

D7.

Last year — that is, in 2005 ~ what was your total family income from all sources,
before taxes? Just stop me when I get to the right category. (READ)
$10,000 or less
$10,001 to $15,000
$15,001 to $20,000
$20,001 to $30,000
$30,001 to $50,000
$50,001 to $75,000
$75,001 to $100,000
$100,001 to $200,000
More than $200,000
(DO NOT READ) Don't know
(DO NOT READ) Refused

D8.

Are you, yourself, of Hispanic or Latino background, such as Mexican, Puerto
Rican, Cuban, or some other Spanish background?

D9.

What is your race? Are you white, black, Asian or some other race? (IF
RESPONDENT SAYS HISPANIC ASK: Do you consider yourself a white
Hispanic or a black Hispanic? CODE AS WHITE (1) OR BLACK (2). IF
RESPONDENTS REFUSED TO PICK WHITE OR BLACK HISPANIC,
RECORD HISPANIC AS "OTHER," CODE 4)
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B.

The Short Portable Mental Status Questionnaire (SPMSQ)
1.

What are the date, month, and year?

2.

What is the day of the week?

3.

What is the name of this place?

4.

What is your phone number?

5.

How old are you?

6.

When were you born?

7.

Who is the current president?

8.

Who was the president before him?

9.

What was your mother's maiden name?

10.

Can you count backward from 20 by 3's?

SCORING:*
0-2 errors: normal mental functioning
3-4 errors: mild cognitive impairment
5-7 errors: moderate cognitive impairment
8 or more errors: severe cognitive impairment
*One more error is allowed in the scoring if a patient has had a grade school
education or less.
*One less error is allowed if the patient has had education beyond the high school
level.
Source: Pfeiffer, E. (1975). A short portable mental status questionnaire for the
assessment of organic brain deficit in elderly patients. Journal of American Geriatrics
Society. 23,433-41.
Compiled by the Great Plains Area Chapter of the Alzheimer's Association, 1999.
http://www.hospitalmedicine.org/geriresource/toolbox/pdfs/short_portable_mental_statu.
pdf
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C.

Questions to Identify Patients Experiencing Medication Cost Problems
1.

2.
3.
4.

5.

6.

7.

Not counting the costs paid by your insurance, how much do your
prescription drugs cost you and your family each month? In other words,
how much do you typically pay "out-of-pocket" per month for
prescription drugs?
In the past 12 months, how often did you worry about being able to pay
for your prescription medicines?
During the past 12 months, you spent less on food, heat, or other basic
needs so that you would have enough money for your medicines?
In the past 12 months, did you ever have to borrow money from a friend
or relative outside of your household to pay for your prescription
medicines?
In general, over the past 12 months did you have to increase the amount
of credit card debt you carried month-to-month because of the cost of
your prescription drugs?
In the past 12 months, how often have you ever done any of the following
because you were concerned about the cost of your prescription drugs?
A. Take fewer pills or a smaller dose
B. Not fill a prescription at all
C. Put off or postpone getting a prescription filled
D. Use herbal medicines or vitamins when you felt sick rather than
take your prescription medication
E. Take the medication less frequently than recommended to stretch
out the time before a refill
In the past 12 months, did someone at your health center ever...
A. Arrange for you to meet with a social worker or other professional
to help you find a way to pay for your drugs?
B. Talk with you about which drugs you definitely should not skip?
C. Ask you whether you could afford the medication when they gave
you a prescription?
D. Give you information about where to get less expensive drugs?
E. Give you information about programs that help people pay for their
drugs?

Source: California Healthcare Foundation (November 2005),
Rx for Affordability: Helping Patients Cope with Medication Costs
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D.

Medication Adherence - Morisky Scale

Option 1:
Thinking of the drugs PRESCRIBED to you by your doctor, please answer the following
questions. No=0; Yes=l
Yes

No
A Do you ever forget to take your drugs
B Are you careless at times about taking
your drugs?
C When you feel better, do you
sometimes stop taking your drugs?
D Sometimes if you feel worse when you
take your drugs, do you stop taking
them?
Option 2:
May also be administered as a 5-point response option

Thinking of the drugs PRESCRIBED to you by your doctor, please answer the following
questions. Never=0; Rarely=l; Sometimes=2; Often=3; Always=4
Never

Rarely

Sometimes

Often

Always

A Do you ever forget to
take your drugs
B Are you careless at
times about taking your
drugs?
C When you feel better,
do you sometimes stop
taking your drugs/
D Sometimes if you feel
worse when you take
your drugs, do you stop
taking them?
Source: Vik, Maxwell, Hogan, Patten, Johnson, Romonko-Slack, 2005, el54-el55.

E.

Senior Services of Southeastern Virginia (SSSEVA): Access & Acquisition of
Prescription Drugs Survey

Date/Time Contacted:
Number of Contact Attempts:
Demographic Information:
Name: From Database
Address:

(Verify Database Information)

From Database

Administered: From Database
Gender:

M

F

Birth date:
• What age were you on your last birthday?
Ethnicity:

African/American/Black
Caucasian/White

Hispanic
Other

Asian

Medicare Status:
• Do you have Medicare?

YES

NO

Medicaid Status:
• Do you have Medicaid?

YES

NO

Employment Status:
o Never Worked
o Retired - Not Working
o Retired - Working Part-time
o Retired - Working Full-time
o Not Retired Yet: Working - Part-time
o Not Retired Yet: Working - Full-time
o Other
Annual Income
o 0-$5000
o $5001-$10,000
o $10,001-$15,000
o $15, 001-$20,000
o $20,001 - $25,000
o $25,001-above

Insurance Status:
• Do you have insurance that covers your prescriptions?
If YES, Plan Name:

YES

NO

If NO, How do you pay for your prescriptions?
•

Does your employer (or previous employer) help pay for your prescriptions
(creditable coverage)?
YES
NO
If NO, Continue with Part D Status
If YES, Part D NOT REQUIRED, Continue with Extra Help Status

Part D Status:
• Have you enrolled in a Part D plan?
If NO, Why not?

YES

NO

YES

NO

If YES received card, have you used your card?

YES

NO

If YES, have you noticed any savings?

YES

NO

If YES enrolled, Have you received your card?
If NO, When did you enroll?

How much do you think you have saved?
If NO, Why do you believe you have not saved money?
•

Have you had any problems using your card?
If YES, What happened?

YES

NO

•

Have you switched plans?
If YES, Why did you switch?

YES

NO

•

What is your current plan?

Cognitive Processes Part D:
Did anyone help you to enroll in a Part D plan?
IF YES, Who helped?
o Friend
o Family member(s)
o Media Broadcasts
o Information Sessions
o Senior Services
o Auto-Enrolled/Facilitated Enrollment
o Other

YES

NO

•

What made you decide to enroll in a Part D plan?
o Fear of late enrollment penalty
o Anticipated Savings
o No prescription coverage
o Cost of plans
o Plan coverage
o Wanted to save money
o Other

•

How did you enroll in Part D?
o Help from Senior Services
o Applied on-line
o Called Medicare's 800 number
o Caregiver or family member enrolled
o Enrollment event
o Other

•

How important is price to you in selecting a Part D plan?
o Very Important
o Important
o Somewhat Important
o Not Very Important

•

How important is price to you in choosing to fill a prescription?
o Very Important
o Important
o Somewhat important
o Not Very Important

•

Do you have any suggestions for improving the Part D enrollment process?
YES
NO

If YES, please give a FEW examples
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Extra Help Status:
• Did you receive a letter from Social Security telling you about Extra Help?
YES
NO
If YES, what did it tell you?
•

Have you been screened eligible for Extra Help?

YES

NO

•

Did you apply for Extra Help?

YES

NO

•

Were you approved for Extra Help?

YES

NO

If YES, What percentage of help were you approved for?
100%

75%

50%

25%

Don't Know

If NO, Why not?
Cognitive Processes Extra Help:
•

Did anyone help you to apply for Extra Help?

•

What helped you decide to apply for Extra Help?
o Friends
o Family
o Media Broadcasts
o Information Received in Mail
o Couldn't afford Part D premiums
o Other

Social Supports:
• Does anyone help you with health care decisions?
If YES, who helps?
•

Has anyone discussed Part D enrollment with you?
If YES, Who?

(If Applicable)
• Has anyone helped you enroll in Part D?
If YES, who helped?
•

YES

NO

YES

NO

YES

NO

YES

NO

YES

NO

Has anyone talked to you about applying for Extra Help?
If YES, who talked to you?

(If Applicable)
• Did anyone help you apply for Extra Help?
If YES, who was involved?

YES

NO

YES

NO

YES

NO

YES

NO

YES

NO

Other Programs Status (i.e. T P C . )
• Have you received free drugs through any program(s)?
If YES, Which program(s)?
Which drugs were you able to get?
•

Axe you still getting free drugs?
If NO, Why not?

Disability Status:
•

Are you currently receiving disability benefits?
If YES, How long have you been receiving them?
What age did you start receiving benefits?

Accessibility:
• Are you currently taking any prescriptions?
If YES, How many have been prescribed?
How many do you regularly fill?
Which ones?
•

Have you been able to fill all prescriptions prescribed by your doctor?
YES
If NO, Why not?

•

What prescriptions have you been able to fill?

•

What methods have you tried to get your prescriptions?

•

Have you had been able to take all prescriptions as prescribed?
YES

NO

NO
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If NO, What has prevented you from doing so?
•

Have you used any techniques to extend your drugs?
If YES, What have you tried?
o Skipped dosages?
o Split pills?
o Shared pills with anyone else?
o Someone shared pills with you?
o Other

YES

NO

YES
YES
YES
YES

NO
NO
NO
NO

YES

NO

Health Status:
• How would you assess your health?
o Poor
o Fair
o Good
o Excellent
•

In the past year, have you had to go to emergency room?
If YES,

•
•

•

•

Why?
How many times have you gone?

Within the past six months, have you gone to see your doctor?
YES
NO
What conditions or illnesses has your doctor told you that you have?
• For which conditions or illnesses are you currently taking prescription
drugs?
Does your doctor provide you with free prescription samples?
YES
• If YES, which ones?

NO

What other methods are you using to control or prevent illness (all that apply)?
o OTC (over-the-counter) remedies
o Home remedies
o Vitamins/Natural Supplements
o Other
Transportation:
• How do you get to doctor visits?
o Friend/Neighbor drives
o Relative drives
o Take bus
o Drive my own car
o Walk
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o Senior Services Transportation
o Other
How do you get drugs from the pharmacy?
o Friend/Neighbor takes
o Relative brings me
o Take bus
o Drive my own car
o Walk
o Senior Services Transportation
o Home Delivered
o Other
Follow-up:
• Would you be willing to share your ideas in a focus group?
YES

NO

If YES, please request best times to contact. Let respondent know they will be
contacted about meeting time and location.
Please note any special needs (transportation, disability, etc.)

•

Anything else you would like to add?

YES

NO

If YES, allow for a few comments and proceed to THANK YOU.

Thank you for your time and for helping to provide information that may help in
improving the Part D and Extra Help programs.

F.

Modified Administered Survey Instrument

Name:
Administered Number:
Attempt #1:
Date:

Time:

Completed

Yes/No

Attempt #2:
Date:

Time:

Completed

Yes/No

Attempt #3:
Date:

Time:

Completed

Yes/No

Hello! My name is

and I am calling to get

your ideas and opinions about Medicare Part D and to determine whether you are able
to get your blood pressure medicine or not. We are conducting this administered
survey to find out if Part D is working for you and if you are able to get your blood
pressure medicines as prescribed by your doctor.
Thank you for agreeing to participate in this research. When you complete the
survey you will receive a seven day pill box. Your answers are voluntary and you
may choose not to answer any questions you feel uncomfortable answering. You may
decide to stop the interview at any time.
Let's get started.
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(READ) First, I have just a few questions we will use to describe the people who
took part in our survey...
DEMOGRAPHICS;
D1.

RECORD RESPONDENT'S GENDER (Do not Ask)
A
B

D2.

What is your ethnicity? Are you white, black, Hispanic, Asian or some other
ethnicity?
A
B
C
D
E

D3.

Male
Female

Caucasian/White
African/American/Black
Hispanic
Asian
Other

Are you currently married, living with a partner, widowed, divorced, separated,
or have you never been married?
A
B
C
D
E
F
G

Married
Living as married
Divorced
Separated
Widowed
Never been married
Don't know/ Refused

D4. Last year - that is, in 2007 — what was your gross monthly income?
(ROUND TO WHOLE DOLLAR AMOUNT)

D5. Last year — that is, in 2007 - what was your total family income from all
sources, before taxes? Just stop me when I get to the right category. (READ)
A
B
C
D
E
F
G
H
I
J
K

$10,000 or less
$10,001 to $15,000
$15,001 to $20,000
$20,001 to $30,000
$30,001 to $50,000
$50,001 to $75,000
$75,001 to $100,000
$100,001 to $200,000
More than $200,000
(DO NOT READ) Don't know
(DO NOT READ) Refused

D6. What is the LAST grade or class that you COMPLETED in school?
(DO NOT READ)
A
B
C
D
E
F
G
H

None, or grade 1-8
High school incomplete (grades 9-11)
High school graduate (grade 12 or GED
certificate)
Technical, trade or vocational school AFTER high
school
Some college, no four-year degree (includes
associate degree)
College graduate (B.S., B.A., or other four-year
degree)
Post-graduate or professional schooling after
college (e.g., toward a Master's degree or PhD;
law or medical school)
Refused
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Next, I am going to start by asking you a few questions to verify the date,
(month, day, year) and day of the week. Then I will ask how old you are and
when were you born.
1.

What are the month, day and year?

2.

What is the day of the week?

3.

How old are you?

4.

When were you bom?
Next, I am going to ask you some questions about your high blood pressure

experiences and the drugs prescribed.
Individual Perceptions
SELF-EFFICACY
5.

How confident are you that you can get your blood pressure medicine as
prescribed?
Very
Confident

Somewhat
Confident

Somewhat
Negative

Very
Negative

Don't
Know

Refused

A
PERCEIVED SUSCEPTIBILITY
6.

To your knowledge, can you avoid getting high blood pressure?
Very
Confident

Somewhat
Confident

Somewhat
Negative

Very
Negative

Don't
Know

Refused

A
PERCEIVED THREAT
7.

How dangerous do you perceive that high blood pressure is to your health? (on a
scale from 0 to 10 with 0 = Not Dangerous to 10 = Extremely Dangerous)
0
Not
Dangerous

10
Extremely
Dangerous
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PERCEIVED SERIOUSNESS
8.

On a scale from zero (0) to 100, how likely is it that your blood pressure would be
high if you didn't take your blood pressure drugs? (on a scale from 0 to 100 with
0 = No Chance to 100 Extremely Likely)
0
No
Chance

100
Extremely
Likely

PERCEIVED BARRIERS - COST
9.

In the past 12 months, how often have you ever done any of the following because
you were concerned about the cost of your blood pressure drugs?
Never
A
B
C
D

E

F
G
H

10.

Rarely Sometimes

Often

Always

Take fewer pills or a
smaller dose
Not fill a prescription
at all
Put off or postpone
getting a prescription
filled
Use herbal medicines
or vitamins when you
felt sick rather than
take your prescription
medication
Take the medication
less frequently than
recommended to
stretch out the time
before a refill
Split pills to make them
last
Shared pills with
anyone else
Someone shared with
you

Not counting the costs paid by your insurance, how much do your blood pressure
drugs cost you and your family each month? In other words, how much do you
typically pay "out-of-pocket" per month for your blood pressure
drugs?

221

PERCEIVED BARRIERS - TRANSPORTATION
11.

In the past 12 months, have you ever not filled your blood pressure drugs because
you did not have transportation to get to the pharmacy?
A
B
C
D

Yes
No
Don't Know
Refused

PERCEIVED BENEFIT
12.

On a scale from zero (0) to 100, how likely is it that your blood pressure drugs
lower your blood pressure? (on a scale from 0 to 100 with 0 = No Chance to 100
Complete Cure)
— 100
Complete
Cure

0
No
Chance
PERCEIVED NEED
13.

Do you believe that the blood pressure drugs prescribed are needed to control
your high blood pressure?
Not at all
Necessary

A Little
Necessary

Somewhat
Necessary

Very
Necessary

Extremely
Necessary

Don't
Know

A
14.

Are you currently taking any prescribed blood pressure drugs, or not?
A
B
C
D

Yes
No
Don't Know
Refused

PERCEIVED SAFETY
15.

To what extent do you believe that blood pressure drugs are risky to your health?
(on a scale from 0 to 100 with 0 = Not Harmful to 100 Extremely Harmful)
0
Not
Harmful

— 100
Extremely
Harmful
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Next, I am going to ask you a few questions about your health, willingness to pay
and affordability.
HEALTH STATUS
16.

In general, would you say your health is excellent, very good, good, only fair, or
poor?
A

Excellent

B

Very good

C

Good

D

Only fair

E

Poor

F

Don't know/Refused

WILLINGNESS TO PAY
17.

How much would you be willing to pay to have better health?
A

Nothing

B

Up to $100

C

Between $101 and $500

D

Between $501 and $1000

E

Over $100lor more

F

Don't Know/Refused

18.

How much are you willing to pay (per month) for a Medicare Part D plan?
(RECORD)

19.

How much are you willing to pay (per month) for your primary blood pressure
drug? (RECORD)

AFFORDABILITY
20.

In the past 12 months, did someone ever...
Yes
A

B
C
D
E

Arrange for you to meet with
a social worker or other
professional to help you find a
way to pay for your drugs?
Talk with you about which
drugs you definitely should
not skip?
Ask you whether you could
afford the medicine when they
gave you a prescription?
Give you information about
where to get less expensive
drugs?
Give you information about
programs that help people pay
for the drugs?

No

Don't
Know

Refused
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Modifying Factors
Next, I am going to ask you when you were diagnosed with high blood pressure,
the number of drugs prescribed and how much you know about the effects of high
blood pressure.
TIME SINCE DIAGNOSED
21.

How long ago did the doctor tell you had high blood pressure? (When First
Diagnosed) (RECORD)

MEDICATION TAKING BEHAVIORS
22.
How many different blood pressure drugs has your doctor prescribed?
(RECORD NUMBER)
KNOWLEDGE
23.

Are you knowledgeable of the effect high blood pressure has on your health?
Not at All
A

Very
Little

Some

Very
Much

Extremely
Much
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Now, I am going to read you a list of people and I would like you to tell me how
much support you receive from each of them.
SOCIAL SUPPORT
24.

How much support do you get in making blood pressure drug decisions
from each of the following: (READ)
None
A

Spouse

B

Children

C

Siblings

D

Friend

E

Neighbor

F

H

Visiting
Nurse
Social
Worker
Doctor

I

Pharmacist

J

Other

G

25.

Very
Little

Some

A Lot

Don't
Know

How much help have you received from your DOCTOR in getting free samples of
your blood pressure drugs? (READ)
A
B
C
D

A little help
Some help
(DON'T READ) Don't know
(DON'T READ) Refused

CUES TO ACTION - SYMPTOMS
26.

Thinking of the blood pressure drugs PRESCRIBED to you by your doctor,
please answer the following questions.
Never
A

B

C

D

Do you ever
forget to take
your blood
pressure
drugs?
Are you
careless at
times about
taking your
blood pressure
drugs?
When you feel
better, do you
sometimes stop
taking your
blood pressure
drugs?
Sometimes if
you feel worse
when you take
your blood
pressure drugs,
do you stop
taking them?

Rarely

Sometimes

Often

Always
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CUES TO ACTION - SIDE EFFECTS
27.

Have you ever experienced any of the following side effects after taking your
blood pressure drugs? (Read List in Random Order)
Never
A

Headache

B

Nausea

C

Dizziness

D

Loss of
Appetite

E

Insomnia

F

Dry Mouth

G

Incontinence

H

Allergic
Reaction

I

Other
(specify)

Rarely

Sometimes

Often

Always

Don't
Know

CUES TO ACTION - INFORMATION
28.

Where do you get your information about high blood pressure treatment?
Never
A
B

Healthcare
Provider
Health
Publications

C

Internet

D

Friends

E

Other

Rarely

Sometimes

Often

Always
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CUES TO ACTION - MEDIA EVENTS
29.

What media events have influenced you to learn more about how to get your high
blood pressure drugs?
Never
A

Medicare
Mailings

B

Newspaper
Article

C

Public Service
Announcement

D

Health
Presentation

E

Health Fair
Brochure

F

Television
Program

Rarely

Sometimes

Often

Always

MEDICATION TAKING BEHAVIORS
30.

How soon after your doctor prescribed a blood pressure drug did you start taking
it? (RECORD)

31.

What are the names of the blood pressure drugs you actually take (per day)?
Ask whether it is a Name Brand or Generic. (Record Names & Type)
Name Brand
RxNamel:
RxName2:
Rx Name3:
Rx Name4:
RxName5:
Rx Name6:

Generic
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ACCESS BEHAVIORAL METHOD
32.

Where do you usually get (acquire) your primary blood pressure drug?
Never
A

At the local
Pharmacy

B

Receive free
samples

C

Share with
Someone

D

From Mail
Order

E

Other

Seldom Sometimes Often

Always

OUTCOME
33.

Which of the previously mentioned blood pressure drugs do you acquire as
prescribed (either 30 day or 90 day supply)?
(Record Names &
Frequency of refill)
Name
Refill Frequency

34.

Have you gotten less than the prescribed supply of your blood pressure
drug?
Never

Seldom

Sometimes

Often

Always

A

35.

Have you ever not gotten any of your blood pressure drugs?
Yes
A
If YES, Why?

No

Don't Know

Refused
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Now, we have completed the blood pressure portion of the survey. At this point you
can decide to take a break and I will call you back later to discuss the Medicare Part
D and Extra Help, or we can continue. Which would you prefer?
IF would like to take a break:

Thank you for your time. What is a good day

and time for me to call you back? (RECORD DAY & TIME). Schedule a call back.

IF would like to continue:
Next, I am going to ask you a few general questions about Medicare Part D and
Extra Help.

MEDICARE PART D & EXTRA HELP STATUS
36.

What type of Medicare Part D plan do you have?
Prescription
Drug Discount
Plan
(Stand Alone)

Medicare
Advantage
Plan with Rx

Other

Don't
Know

Refused

A
37.

Are you receiving Extra Help to help pay for prescription drug costs, or not?
Yes
A

No

Don't
Know

Refused
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Now, I would like to ask you a few questions about your Medicare Part D
experiences and your opinions about how you think the policy is working.
MEDICARE PART D AND EXTRA HELP EXPERIENCES AND OPINIONS:
38.

Please tell me whether or not you've had any of the following experiences
related to getting your blood pressure prescription medicines since joining
your Medicare Part D drug plan.
Have you... or not? (READ AND RANDOMIZE)
Have Have
Not
Had difficulties getting
A enrollment card
Left the pharmacy without
your prescription because one
B of your drugs wasn't covered
by your plan
Left the pharmacy without
your prescription because you
C could not afford it
Had to switch drugs because
one of your drugs that you
D were taking wasn't covered
by your plan
Had to switch from a brandE name to a generic drug
Had to deal with a billing
F mistake for a prescription or a
premium
Had to pay costs you hadn't
G expected - either for a
prescription or a premium

39.

Don't
Know

Refused

Given what you know about Part D, in general, do you have a favorable or
unfavorable view of the Medicare Part D drug benefit?

Favorable
A

Unfavorable

Neither/Neutral

Don't
Know

Refused
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40.

Is your impression of the Medicare Part D drug benefit based mainly on...
(READ AND RANDOMIZE 1-3)?
Based on those with a favorable or unfavorable impression of Medicare Part
D drug benefit
Yes

41.

42.

A

Your own experience

B

What you've seen and heard on television,
radio, and in newspapers

C

What you've learned from friends and family

D

Some other source

E

(DO NOT READ) Don't know

F

(DO NOT READ) Refused

No

Since many plans are now requiring generics to be substituted for name brand
drugs, to cut costs, do you think the generic drug works better, just as well or
not as well as the name brand?
A

Works better

B

Just as well

C

Not as well as the name brand

D

Don't know

E

Refused

Would you say it was very easy, somewhat easy, somewhat difficult, or very
difficult to choose a Medicare drug plan, OR were you just put in a plan and
didn't make a choice for yourself?
Very
Easy
A

Somewhat
Easy

Somewh
at
Difficult

Very
Difficult

Put in a
Plan Didn't
Make
a Choice

Refused
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43.

Overall, do you feel you made a good choice in selecting your Medicare
prescription drug discount plan, or do you think you would have been better off
with a different plan?
Made a Good
Choice

Better off with a
different plan

Don't Know

Refused

A
44.

Which one was the MOST important to your decision to choose your Medicare
drug plan?
A

The amount for each prescription

B

A recommendation from someone you trust

C

The reputation of the company

D

The amount of monthly premiums

E

The specific drugs covered

F

All are important

G

None are important

H

Don't Know

I

Refused
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45.

In choosing your Medicare drug plan, please tell me how important each of the
following was to your decision. (First,) how about... ? (READ AND
RANDOMIZE)
READ FOR FIRST ITEM, REPEAT AS NECESSARY: Was this very important,
somewhat important, not too important or not at all important (in choosing your
Medicare drug plan)?
Single
Not
Not at
DK/
Most
Very
too
all
Important Important Important Important Refused
The reputation of
the company
offering the plan
The amount the
B plan charges
in monthly
premiums
The specific
C drugs covered
by the plan
The amount the
D plan charges for
each prescription
A
E recommendation
from someone
you trust

A

46.

To the best of your knowledge, if seniors waited to enroll in a Medicare drug plan
would they have to pay a "late enrollment penalty", or not?
Yes

No

Don't Know

Refused

A
47.

To the best of your knowledge, if you are dissatisfied with your Medicare drug
plan can you change to a different plan whenever you want, or do you have to
wait for a specific period?
A
B
C
D

Can change to different plan
Have to wait
Don't know
Refused

48.

Compared with how you got your prescriptions before, please tell me whether
your Medicare drug plan is better, worse, or about the same in terms of each of
the following. (READ AND RANDOMIZE). (READ FOR EACH ITEM)
Compared with how you got your prescriptions without Medicare Part D, is your
drug plan better, worse, or about the same in terms of (INSERT)...
Better
A
B
C
D

49.

Worse

Same

Don't
Know

Refused

How much you
pay for
prescriptions
The cost of your
monthly
premiums
Getting the
medicines you
need
Getting answers
to your questions

Compared to what you paid for blood pressure drugs before Medicare Part D,
are you now saving money, paying more or paying about the same overall for
your prescriptions?
Saving money

Paying more

Paying about
the same

Refused

A
50.

Would you say that you are saving a lot of money, or just a little?
Saving a lot of
money

Saving Just a little
Don't Know

Refused

A

51.

Would you say that you are paying a lot more money, or just a little more?
Paying a lot more
Paying just a little
Don't
money
more
Know
Refused
A
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52.

Overall, what message would you send to policymakers in Washington? Would
you say the Medicare Part D drug benefit (READ)
A
B
C
D
E

Is working well and no real changes are needed
Could be improved with some minor changes
Is not working and needs major changes
Don't know
Refused

Thank you for completing this survey about blood pressure medication and for helping to
improve the Medicare Part D policy. As mentioned before you will be receiving a seven
day pill box as our thank you for participating.
If you would like to receive a copy of the survey results we will be happy to send them to
you when the study is complete.
Wants report? Yes

No

Verify Address to send gift to:
Name:
Street Address:
City:

State:

Zip code:

APPENDIX IV:

Senior Services of Southeastern Virginia Consent Letter

Senior Services of
Southeastern Virginia

%

T H E C E N T E R FOR A G I N G
November 7.2008
Ms. Arvi Marie Kopitzke, BBA, MPA, PhD(c)
1168 Boiling Avenue
NorfoBc,VA 23508
Dear Ms. Kopitzke:
We are approving your request to utilize the Medicare Management Access database to
develop a contact list for the purpose of dissertation data collection. Additionally, permission
to contact enroltees to assess prescription drug plan enrollment and acquisition experiences
is granted.
Letters of consent wH be sent to Medicare elders, enrolled through Senior Services of
Southeastern Virginia, for whom complete contact data is available. Data collection must be
safeguarded utflizing MIPPA and IRB guidelines.
Results of data analyses must be shared with Senior Services of Southeastern Virginia
(SSSEVA) to enhance medication education, assistance and enrollment efforts. Senior
Services of Southeastern Virginia must be acknowledged in any publications or print media
which arise from this research.

Sincerely,

9"

John N. Skirven
Chief Executive Officer

Interstate Corporate Center, 6350 Center Drive, Bldg. 5, Suite 101, Norfolk, VA 23S02-4107
Phone: 757-4*1-9481- Fax: 757-461-1068- E-Mail: services9ssseva.org- Web: wwvvjsseva.org

APPENDIX V:
DATE

Sample Consent Letter
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NAME
ADDRESS
CITY, STATE ZIP
Dear NAME,
As a follow-up to your Part D enrollment, we would like to invite you to be part of a
research study that will help us to find out if Medicare's prescription drug discount
benefit is working for you and if you are able to save any money.
If you are called, we will be asking questions about how you chose your Part D plan and
whether you had any problems using the plan. There will also be a few questions about
Extra Help and your opinions and experiences. We will also ask about your health status
and how you get your blood pressure medicines. If you are willing to finish the
administered survey, we will send you a seven day pill box as a thank you.
If you want to accept this invitation, please fill out and sign the reply card. If you want to
call us to tell us you would like to be included in this study, please leave your name,
administered number and the best days and times for you to be called at 757-461-9481
x7230.
If you have any questions about this study you may contact me at 757-683-6180. Thank
you for your time.
Sincerely,
Ann Marie Kopitzke, BBA, MPA, PhD Candidate
Medication Education Coordinator
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Please include me in your study. I am interested in being contacted for my opinions and
experiences with Medicare Part D. I would also like to tell you about how I get my blood
pressure medicines.
Printed Name
Signature
Date Administered
Good days and times to call
After you fill out and sign, please put this invitation reply card into the stamped,
addressed return envelope and mail it back to us.
Thank you for your time.
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2009

Doctoral Degree of Philosophy, Health Services Research
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2112, College of Health Sciences, Old Dominion University, Norfolk, VA
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Bachelor Degree of Business Administration, College of Business
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